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Introduction  
Neuromuscular disorders (NMDs) are defined as a wide range of syndromes and diseases 
affecting the muscles and their nervous control. The most frequent symptoms are muscle 
weakness and fatigue. Two of the most common types of neuromuscular disorders are spinal 
muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD). 
  Children and adults with NMD often report problems with feeding and swallowing.
1-3
 
A feeding disorder is defined as a problem with eating activities like bringing a spoon to the 
mouth, selectivity or avoidance of food or mastication. A swallowing disorder or dysphagia is 
defined as a disorder in one or more phases of the swallowing process; the oral, the 
pharyngeal or esophageal phase. The overall prevalence of feeding disability reported by 
patients with NMD is 34%.
1
 In the face of the serious consequences of muscle weakness and 
fatigue in general, these may seem minor problems. However, difficulties with mastication 
and swallowing can adversely affect health, both directly and indirectly. Poor mastication in 
combination with weak pharyngeal clearance may increase pharyngeal post swallow residue 
and may cause complications, e.g. choking or the feeling of sticking food in the throat.
4 
In 
addition, problems with feeding can have a psychological aspect like embarrassment and 
social isolation and this can adversely affect quality of life.
5
 As a consequence patients may 
for example try to avoid prolonged feeding times, which may lead to inadequate nutrition and 
an increased rate of disease progression.
6,7
  
   In patients with SMA and DMD, the orofacial muscles are often affected. This may 
cause specific abnormalities in mandibular function and in the craniofacial morphology, shape 
of the dental arches and the dental occlusion.
8-16
 The mechanisms that cause impairment of 
mandibular function in SMA and DMD are poorly understood. Fatty degeneration of muscle 
fibers, causing stiffness and weakness of the masticatory muscles (mouth openers and 
closers), and reduced head balance may have an effect on the mandibular function. 
 As each NMD has its distinct pathology and characteristics, each disorder may have a 
different impact on the masticatory system. To be able to develop disease-specific 
recommendations, it is necessary to study the underlying mechanisms of impaired mandibular 
function in SMA and DMD. Treatment of the mandibular dysfunction depends on insight in 
these mechanisms. 
 The focus of this thesis is on SMA and DMD as two major and distinct classes of 
NMDs. The primary aim is to explore the impact of SMA and DMD upon aspects of 
mandibular function of patients with SMA and DMD focusing on mastication and mandibular 
mobility. The second aim is to establish whether the differences in pathophysiology and 
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clinical presentation of SMA and DMD cause distinct patterns of compromised mastication. A 
third aim is to investigate whether specific training advice influences mandibular function in 
DMD. 
  In this introduction, NMD in general, SMA, DMD and the masticatory system 
specifically will be discussed and the outline and the operational aims of this thesis will be 
described. 
 
Neuromuscular disorders 
NMDs have an impact on the central or the peripheral nervous system and are characterized 
by progressive muscle weakness with variable distribution and severity. According to the 
distribution of the predominant muscle weakness and the location of the defects, the major 
NMDs can be classified into four main groups (Table 1.1).
17 
Table 1.1. Classification of the major neuromuscular diseases, adapted from Dubowitz, 
1996.
17
 
 
NMD Defects Most common diseases 
Motor neuron diseases Lower motor neurons
a
 and sometimes 
upper motor neurons
b
 
Amyotrophic lateral sclerosis  
Spinal muscular atrophy   
Neuropathies Peripheral nervous system  
is affected 
Charcot-Marie-Tooth disease 
Hormonal disorder diabetes  
Neuromuscular junction 
disorders 
Transmission of the signal to muscle 
contraction is blocked  
Myasthenia gravis 
 
Myopathies incl.  
muscular dystrophies 
Forestall the maintenance and repair  
of muscle tissue 
Becker muscular dystrophy  
Duchenne muscular dystrophy 
Congenital muscular dystrophy 
 
a
Lower motor neuron:  a motor neuron whose cell body is located in the brainstem or the spinal cord and whose 
axon innervates skeletal muscle fibers; 
b
Upper motor neuron: a motor neuron whose cell body is located in the 
motor area of the cerebral cortex and whose processes connect with motor nuclei in the brainstem or the anterior 
horn of the spinal cord. 
 
NMDs are likely to affect the masticatory system as well. Feeding disorders, reported by 
patients with NMD, may be secondary to progressive weakness of the masticatory muscles. 
Mastication problems may induce post swallow residue, which has been suggested to 
contribute to a greater risk of food aspiration.
18,19
 Furthermore, a common problem in many 
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NMDs is dysphagia expressed as a difficulty in inhaling and exhaling and consequently with 
coughing. Therefore, the complications of swallowing disorders can be devastating, including 
aspiration and pneumonia and may ultimately lead to death.
3,20,21 
 
Spinal muscular atrophy 
SMA is a recessive neuromuscular disorder caused by the homozygous deletion of the 
survival motor neuron (SMN) 1 gene that has been mapped to chromosome 5q11.2–13.3.20,22 
 
 
Figure 1.1. Spinal muscular atrophy and degeneration and loss of the motor neurons in the anterior horn cells in 
the spinal cord (see red dot) and the brain stem nuclei, resulting in a reduction of nerve signals from the motor 
neurons to bunches of muscle fibers (see red line). Reduced signals to muscle fibers cause atrophy and weakness 
of muscles used for activities such as controlling head movement.  
(Figure adapted from www.stemcellthailand.org and www.neuroanatomy.wisk.edu)  
 
SMN 1 is critical to the function and survival of motor neurons. An absence or shortage of 
SMN 1 leads to degeneration of the lower motor neurons in the spinal cord, causing 
predominantly progressive proximal muscle weakness (Figure 1.1).
21,22
 As a result, activities 
such as walking and sitting are affected; in the more severe types, the muscles used for 
breathing and swallowing are affected as well. With an incidence of about 1:6.000 to 1:10.000 
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it is one of the most common autosomal recessive diseases and an important hereditary cause 
of childhood morbidity.
23,24
  
  SMA severity varies considerably, and age at onset and maximum motor function 
achieved are used to distinguish 4 subgroups (Table 1.2). Patients with SMA type 1 
(Werdnig-Hoffmann disease) have disease onset before the age of 6 months and never learn to 
sit. Patients with SMA type 2 have an onset before the age of 18 months and never learn to 
stand or walk. Patients with SMA type 3 (Kugelberg-Welander disease) and adult onset type 4 
with onset after the age of 18 months and 30 years, respectively, are able to learn to walk.
22,25-
28 
Additionally SMA type 3 can be divided into type 3a with an onset before 3 years and type 
3b with an onset after the age of 3 years.
 26
  
 
Table 1.2. Classification of spinal muscular atrophy, adapted from Munsat and Davies, 
1992.
25
 
 
 SMA type 1 SMA type 2 SMA type 3 SMA type 4 
Severity  Severe Intermediate Mild Mildest 
Age of onset < 6 months < 18 months 18-36 months 30 years 
Highest function  Never sits Sits, never stands Stands, walks Walks 
Life expectancy  < 2 years > 2 years Adult Adult 
 
Orofacial consequences 
Patients with SMA or their caretakers often report mastication difficulties, limited 
mouth opening, and swallowing difficulties. However, only few studies have systematically 
investigated these issues.
1,3,16
 It has been suggested that reduced mandibular range of motion 
(ROM), weakness of the masticatory and tongue muscles, limited efficiency of the movement 
of the tongue, abnormal craniofacial growth patterns and dental malocclusions in patients with 
SMA may lead to a compromised masticatory performance.
8,11,29
 A low masticatory 
performance may result in less fragmentation of food. Less fragmentation of food may 
increase post swallow residue.
18,30
 Video fluoroscopic swallow studies showed an increased 
pharyngeal post swallow residue of solid food in advanced stages of SMA.
4,18,30
 When large 
amounts of residue remain post swallow, the risk for aspiration is increased when the patient 
inhales after the swallow and the airway opens naturally.
30-32
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To our knowledge no objective assessments using masticatory performance tests in 
SMA have been described in the literature. The mechanism behind the limitations of the 
mandibular function is unclear and to our knowledge predictive factors for a compromised 
mandibular ROM have not been investigated yet. 
 
Duchenne muscular dystrophy 
DMD is characterized by a progressive loss of muscle cells and replacement by fat and 
connective tissue.
33
 DMD is an X-linked recessive disorder or, in one-third of all cases, a 
consequence of de novo gene mutation. Female carriers have no symptoms. It is caused by a 
defective gene for dystrophin, an essential component of the dystrophin–glycoprotein 
complex (DGC) maintaining the membrane integrity of muscle fibers (Figure 1.2).
34
 As the 
disease progresses and destroyed muscle fibers are removed by macrophages, fatty and 
connective tissue will fill the empty spaces and muscle pseudohypertrophy will appear.
35
 
DMD is affecting eventually all voluntary muscles including the heart and breathing muscles. 
With an incidence of about 1: 3500 live male births it is the most prevalent type of muscular 
dystrophy in children.
36
 The onset of DMD symptoms occurs at around 2 to 6 years of age. By 
3-4 years of age most boys with DMD show difficulty climbing stairs or rising from a seated 
position on the floor. Enlargement of the calf muscles (pseudohypertrophy or hypertrophy) is 
common. When the condition is not treated, muscle strength deteriorates, and boys require the 
use of a wheelchair before their teens.
37
 Learning disability and neurobehavioral problems are 
present in about 30% of boys and young men with DMD.  
 
Orofacial consequences 
There are reports that the weakness of the craniofacial muscles and the tongue muscles in 
DMD consequently affect the development and morphology of craniofacial structures.
10,12-15,38
 
Weakness of the jaw muscles, in combination with changes in the craniofacial morphology 
may impair mandibular function, including masticatory performance and mandibular range of 
motion.
39
 Dental abnormalities like delayed eruption of the permanent dentition, agenesis, 
microdontia, and hypoplasia typically of premolars may occur and may influence 
mastication.
12,40,41
 To our knowledge, masticatory performance so far has not been assessed 
objectively using masticatory performance tests. Hence it is still unclear which factors 
influence the mandibular function in these patients.  
  Patients with DMD are at risk for dental caries, gingivitis and periodontal disease 
because of heavy plaque and calculus deposits. The increased deposits are mainly caused by 
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loss of muscle function of the arms and hands, reduced mouth opening and dental 
abnormalities, weakness of the masticatory muscles, macroglossia and weakness of the tongue 
muscles resulting in poor clearing of food and liquids from the mouth.
 3,12,14,15, 38-40,42,43
 
 
 
Figure 1.2. The protein dystrophin is located on the cytoplasmic surface of skeletal muscle cell membranes and 
forms a mechanical link between the axtin filaments inside the muscle cells and the extacellular matrix. 
Dystrophin has a major structural role in mechanical stability during muscle contractions.
34 
(Figure adapted from www.mda.org) 
 
Mandibular function 
Functional outcomes of the masticatory system can be measured in terms of e.g. the 
masticatory performance, maximal voluntary bite force and mandibular range of motion.
44
 
The dominant factors influencing masticatory performance in healthy subjects are the number 
of occlusal contacts in the (pre)molar regions and the bite force.
45
 Furthermore, tongue 
function is of importance because of its role in food-bolus formation and positioning.
46
 
Mastication, the process of chewing food before swallowing and digestion, is considered to be 
a part of the oral phase of swallowing. The food is prepared into a bolus by (1) breaking large 
pieces of food into small pieces, (2) softening of food and transformation into a size 
conducive to swallowing, and (3) lubrication of food by impregnating it with saliva.
47
 All 
components of the masticatory system, such as the teeth and their surrounding structures, 
masticatory muscles, temporomandibular joints, lips, cheeks, palate, and the tongue are 
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involved. During mastication, the mandible moves not only vertically, but also 
anteroposteriorly and laterally.
48 
  Bite force is one indicator of the functional state of the masticatory system that results 
from the action of jaw elevator muscles.
49
 Many factors like the dimensions of the masticatory 
muscles, dental occlusion, facial morphology, and pain during functional, influence the bite 
force magnitude.
50
 The great variation in bite force values depends on these factors, but also 
on e.g. the physiological characteristics of the subject, the motivation of the patient and the 
mechanical characteristics of the bite force transducer.
51
 Comparing the bite force values 
within the literature must take place carefully.
50 
  
The temporomandibular joint (TMJ) plays an important role in mandibular function. 
The TMJ is a synovial bi-articular, hinge-type joint and contains a fibrocartilaginous articular 
surfaces and disc dividing each joint into an upper and lower joint cavity. Movement in the 
upper joint compartment is mostly sliding of the mandibular condyle, whereas in the lower 
joint compartment rotation is predominant.  
  Masticatory muscles and the supra- and infrahyoid muscles are responsible for the 
various mandibular movements (Table 1.3). The most important influencing factors upon the 
mandibular ROM in healthy subjects are the length of the mandible, functional capacity of the 
mandibular opening and closing muscles, morphology and status of the TMJ, and pain 
conditions in the masticatory system.
52,53
 
 
Table 1.3. Mandibular movements and the muscles primarily involved  
Mandibular movements  Muscles in action 
Opening (depression) Lateral pterygoid; suprahyoid; infrahyoid 
Closing (elevation) Temporalis; masseter; medial pterygoid 
Protrusion  Lateral pterygoid; masseter (superficial fibers); medial pterygoid 
Retrusion  Temporalis; masseter (deep fibers) 
Lateral  Temporalis ipsilateral; lateral pterygoid; contralateral; masseter 
 
The following movements of the mandible are distinguished:
54-57 
(1) opening: as the jaw opens, the mandibular elevators, i.e., masseter, temporalis, and medial 
pterygoid muscles, relax and allow gravity to assist. When opening against resistance (e.g., 
tension in the mouth closing muscles), the suprahyoid muscles contract while the infrahyoid 
muscles stabilize the hyoid bone. In mouth opening, rotation of the condyle inside the TMJ 
Chapter 1 
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between the disk and the condylar head in both joints dominates. The rotation movement 
allows a partial opening of approximately 20 to 25 mm, measured between the incisal edges 
of the anterior teeth. The second type of movement in the TMJ is a sliding movement of the 
condyle and disk along the articular eminence of the temporal bone. This movement occurs 
through contraction of the lateral pyterygoid muscle, which are pulling the condyle anteriorly. 
Both rotation and sliding must occur for the jaw to fully open.  
(2) closing: jaw closure or mandibular elevation is accomplished through contraction of the 
mandibular elevators and retraction of the disc by the elastic fibers of the upper stratum of the 
bilaminar zone.  
(3) protrusion: protrusion occurs by contraction of the lateral and medial pterygoid muscles 
and the masseter muscles on both sides. The lateral pterygoid muscles cause the condyles and 
the articular discs to slide anteriorly along the articular eminence of the temporal bone.  
(4) retrusion: during retrusion, the disks and condyles slide posteriorly with the condyles in 
the joint cavities which is accomplished by the temporalis muscles (posterior fibers). 
(5) mandibular range of motion: lateral movements occur through simultaneous contraction of 
the temporalis and digastric muscle on the ipsilateral side and the lateral pterygoid and 
superfacial masseter muscle on the contralateral side. 
 
Assessment of mandibular function 
Mandibular function can be assessed subjectively through self-report, or objectively by 
performing a clinical examination or a combination of both.
58
 In this thesis we applied the 
latter approach by using questionnaires as well as clinical examination.  
  The questionnaire Screen was designed to assess pain in the head and neck region, and 
mandibular function and related issues.
59,60
 Mandibular Functional Impairment Questionnaire 
(MFIQ) was designed to measure impairments of the function of the masticatory system.
61 
  
Further, the participants in our studies were clinically examined following the 
validated procedure as described by Lobbezoo-Scholte et al. (1993, 1994).
62,63
 Clinical 
examination consisted of: history taking of the main complaints; the current and experienced 
limitations of mandibular function; the dental, medical, and personal history of the patient; an 
extra-oral inspection of the head and neck; and an intra-oral inspection of the dentition and the 
soft tissues.  
  Additionally the impact of neuromuscular disease on the masticatory system was 
assessed by measuring the anterior maximum voluntary bite force (MVBF) with the VU 
University Bite Force Gauge (VU-BFG) and the masticatory performance using the mixing 
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ability test.
64,65 
  
We combined the dental data from our patient groups with the medical information 
(i.e., medication, body height, body length, ventilation support), general physical abilities and 
quantitative muscle ultrasound imaging (QMUS) of the tongue and the suprahyoid muscles. 
For the assessment of the general physical ability at the department of Rehabilitation, 
Radboud university medical center the Motor Function Measure (MFM) was used and at the 
department of Neurology and Neurosurgery and Spieren voor Spieren Kindercentrum, Brain 
Center Rudolf Magnus, the Hammersmith functional motor scale was used.
66,67
 
 
Objectives and Research questions of this thesis  
Although all NMDs ultimately result in muscle weakness, the pathophysiology is completely 
different in SMA and DMD. In SMA, the neuronal input to the muscle is impaired because of 
the motor neuron disease, whereas in DMD the muscle itself is affected. It is conceivable that 
the mandibular function is impaired differently in SMA and DMD. The overall objectives of 
this thesis are therefore (1) to characterize the impairments of the mandibular function in 
patients with SMA and DMD compared to healthy subjects, ( 2) to assess possible differences 
in pathophysiology and clinical presentation of compromised mastication in SMA and DMD 
patients and (3) to investigate whether specific training programs can help to cope with the 
impaired mastication and improve or stabilize detoriation of the mandibular function in DMD. 
 
The general research questions of this thesis are: 
PART I: Spinal muscular atrophy 
 What is the prevalence of impaired mandibular function in SMA? 
 Is the bulbar muscle function affected by SMA type 2 and 3? 
 What is the underlying mechanism for the impairment of mandibular function in SMA? 
PART II: Duchenne muscular dystrophy 
 What is the prevalence of impaired mandibular function in DMD? 
 What are predictive factors for mandibular function in DMD?   
 What is the underlying mechanism for the impairment of mandibular function in DMD? 
 What is the efficacy of training the masticatory muscles using chewing gum in DMD? 
1 
2 
3 
4 
5 
6 
7 
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PART III: Comparison, integration and implementation 
I. What are the similarities between SMA and DMD? 
II. Are there differences between SMA and DMD in clinical presentation and underlying 
mechanisms in the masticatory system?  
III. Is there a need for specific training advice for SMA and DMD? 
IV. Which disease-specific recommendations for training protocols can be given in SMA 
and DMD? 
 
Outline of the thesis   
After the general introduction (chapter 1), the research questions have been addressed in the 
following chapters. Chapter 2 describes a pilot study on the impairment of mandibular 
function in SMA type 2. Chapter 3 describes the mandibular movements, bite force and 
masticatory performance of patients with SMA type 2 and 3 and the predictive factors for 
mandibular dysfunction in these patients. In chapter 4, a cross-sectional study of MMO in 145 
patients with SMA types 1-4 and 119 healthy controls is described. By performing magnetic 
resonance imaging (MRI) in 12 patients the masticatory muscles and mandibular condylar 
shape and sliding are visualized. Associations of a reduced MMO with SMA severity and 
complaints of dysphagia are analysed. Chapter 5 describes whether the masticatory 
performance and bite force in patients with DMD is different from these parameters in healthy 
individuals. The predictive factors for the masticatory performance in DMD are analyzed. In 
Chapter 6 the mandibular movements in patients with DMD are described and compared to 
those in healthy individuals. The predictive factors for the maximum mouth opening in DMD 
are analyzed. Chapter 7 describes the investigation of the efficacy of mastication in DMD by 
using a structured exercise program with chewing gum. In Chapter 8 the findings of the 
studies described in the previous chapters are discussed. Some recommendations for further 
research in this field are also provided. Chapter 9 summarizes the studies of the thesis, in the 
English and Dutch language respectively. 
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Abstract 
Objectives: The aim of the study is to assess mandibular function in young patients with 
spinal muscular atrophy (SMA) type 2.  
Methods: Twelve children and young adults with SMA type 2 and 12 healthy gender and age 
matched controls participated.  
Results: The mandibular function impairment was moderate to severe in 50% of patients. A 
limited active maximum mouth opening (aMMO ≤ 30 mm) was observed in 75% of the 
patients. In patients with a severe reduction of the mandibular range of motion the 
temporomandibular joint mainly rotated during mouth opening instead of the usual 
combination of rotation and sliding. The severity of the limited aMMO correlated with the 
severity of the disease (Motor Function Measure scores).  
Conclusions: This study shows that mandibular dysfunction is common among young 
patients with SMA type 2. Early recognition of mandibular dysfunction may help to prevent 
complications such as aspiration as a result of chewing problems.  
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Introduction 
Spinal muscular atrophy (SMA) is a severe neuromuscular disorder characterized by 
degeneration of α motor neurons in the spinal cord, causing weakness and muscular atrophy.1 
With an incidence of about 1: 6000 to 10.000 it is one of the most common autosomal 
recessive diseases and an important hereditary cause of childhood morbidity.
2,3 
SMA is 
caused by the homozygous deletion of the survival motor neuron (SMN) 1 gene that has been 
mapped to chromosome 5q11.2–13.3.4 SMA severity varies considerably, and age at onset 
and the extent of motor impairment are used to distinguish 4 subgroups. 
5-9
 
 Problems with biting and chewing are often reported by patients with SMA but there 
are few studies that have systemically addressed this issue. These studies mentioned feeding-
related problems, weaker bite force of the masticatory muscles, reduced mandibular range of 
motion (ROM), abnormal craniofacial growth patterns and dental malocclusions which might 
cause chewing difficulties in children and young adults with SMA type 2 .
10-13
 Rehabilitation 
and modern management of complications have improved the quality of life and life 
expectancy of children with SMA.
14
 Management of non-fatal complications of the disease, 
such as strong limitations in the mandibular function that compromise feeding, chewing, oral 
hygiene and dental care becomes increasingly important. The mechanisms that cause 
mandibular dysfunction are not well known. Dysfunction of the temporomandibular joint, 
weakness of the masticatory muscles (mouth openers and closers) and reduced head balance 
may all be involved. Management of the mandibular dysfunction depends on insight in these 
mechanisms. The aim of the present study was to systemically investigate mandibular 
function by a combination of questionnaires and comprehensive clinical examination in young 
patients with SMA type 2.  
 
Methods 
A cross-sectional study was performed from June 2008 to June 2009. The studied population 
consisted of 12 patients with a genetically confirmed diagnosis of SMA type 2. Age limits 
were set from 5 to 19 years, to ensure patient cooperation. Patients with SMA type 2 were 
recruited in the Netherlands from the multidisciplinary outpatient clinic of the Children 
Hospital at the Radboud university medical center, department of Oral and Maxillofacial 
Surgery of the University Medical Centre Utrecht and from the multidisciplinary 
neuromuscular outpatient clinic of the Wilhelmina Children Hospital (Spieren voor spieren 
Centre for pediatric neuromuscular disorders), University Medical Centre Utrecht. All 
patients were wheelchair bound and had weakness of the neck muscles and scoliosis of the 
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spine. Ten patients had been treated surgically for scoliosis.  
 A group of 12 healthy children and young adults matched for age and gender acted as 
a control. They underwent the same clinical examination as the patients with SMA. 
 The study was approved by the Committee on Research Involving Human Subjects of 
Arnhem, Nijmegen and Utrecht, the Netherlands, and informed consent of the parents and 
children was obtained. 
 
Questionnaires 
The patients completed 3 questionnaires. The first (Screen) was developed to assess pain 
characteristics in the head and neck region, and temporomandibular function.
15,16 
The second 
questionnaire (Mandibular Function Impairment Questionnaire) consists of 17 questions 
which can be answered on a five-level Likert scale, to assess to what extent the patient has 
difficulties to perform particular mandibular functions such as chewing and yawning. The raw 
score of the scale (ranging from 0 to 1) can be converted to a qualitative level of impairment; 
no/low (I), moderate (II) and high (III).
17  
Previous studies have considered the Mandibular 
Function Impairment Questionnaire to be a reliable and valid tool.
18
 The third questionnaire 
(Patient Specific Approach) identifies complaints of mandibular function through the 
selection of the activities from a list of 27, which cause discomfort.
19
  
 
Physical motor skills 
Motor skills were assessed in 6 patients from the multidisciplinary outpatient clinic of the 
Children Hospital, Radboud university medical center, the Netherlands by using the Motor 
Function Measure (MFM), performed by one physiotherapist.
20
 Items 13 to 23 of the MFM 
test were designed to collect information about posture, arm and neck function and head 
control. 
 
Clinical examination 
Patients in this study were clinically examined following the validated procedure as described 
by Lobbezoo-Scholte et al. (1993, 1994).
21,22
 Clinical examination consisted of the following 
parts: history taking of the main complaints; the current and experienced limitations of 
mandibular function; the dental, medical and personal history of the patient; an extra-oral 
inspection of the head and neck; and an intra-oral inspection of the dentition and the soft 
tissues. 
  The mandibular function was assessed by examining the mandibular ROM, including 
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active maximum mouth opening (aMMO) measured at the mesioincisal angle of the upper and 
lower front teeth (Figure 2.1), left and right lateral movement and protrusion, and passive 
maximum mouth opening (pMMO). The overbite and overjet were measured (Figure 2.1).  
 
 
Figure 2.1. Measurement of the maximum voluntary mouth opening: the distance between the mesioincisal 
angle of the right upper and lower front teeth plus the overbite. Overbite refers to the vertical overlap of the front 
teeth and overjet to the horizontal overlap. 
 
  The patients’ pain report during mandibular movements was recorded on a 5-point 
scale: 0 = no pain, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe. The masticatory 
muscles (masseter, temporales, sternocleidomastoïd and occipital muscles) were palpated to 
assess painfulness. The temporomandibular joints were palpated on the left and right side with 
the mouth closed and open (lateral pole and posterior via the external acoustical meatus).  
Pain provocation and the extent of condylar movements were assessed. The mobility of the 
temporomandibular joint was assessed by traction and translation. 
 
Statistical analysis 
SPSS 15.0 was used to analyse the collected data. The correlation between MFM scores and 
level of aMMO was tested using the nonparametric Kendall rank correlation. The level of 
significance was set at p = 0.05.  
 
Results 
Patients with spinal muscular atrophy type II had a mean age of 11.8 years (range, 6 years and 
4 months to 19 years); controls had a mean age of 12.3 years (range, 6 years and 4 months to 
19 years and 3 months). Characteristics of the patients are summarized in Table 2.1. 
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Table 2.1. Characteristics of the spinal muscular atrophy type 2 group (n = 12) to investigate 
manbibular function 
 
Patient number Gender Age (yrs. mths) Age at diagnosis (mths) 
1 F 6.5 21 
2 M 7.2 12 
3 M 7.8 12 
4 F 8.9 prenatally 
5 F 10.3 8 
6 M 9.5 8 
7 F 13.0 21 
8 M 13.2 3 
9 F 13.4 21 
10 F 15.4 16 
11 F 16.9 10 
12 F 19.0 12 
 
Abbreviations: M, male; F, female. 
 
Questionnaires 
Screen 
One of the patients did not complete the questionnaires. The patients with SMA type 2 did not 
spontaneously report pain in rest or when using the masticatory system. Three patients did not 
have chewing difficulties and didn’t report any limitation of mandibular function. Seven were 
aware of mouth opening limitations. They were not able to recall the time of onset of these 
limitations. They all experienced the limitations of mandibular function as a part of their 
disease.  
Mandibular Function Impairment Questionnaire 
Functional impairment, expressed as the raw score of the degree of masticatory and non-
masticatory impairment, ranged from 0 to 0.6 (Table 2.2). Two patients had a severe 
Chapter 2 
33 
 
impairment, 3 had a moderate impairment, and 6 no/low impairment.  
Patient Specific Approach  
The main complaints of the 9 patients with limitation of mandibular function assessed through 
screen and the Mandibular Function Impairment Questionnaire were problems when chewing 
food, eating sticky and hard food and brushing the teeth. 
 
Table 2.2. Mean values and standard deviations for the extent of functional impairment of 
patients with spinal muscular atrophy type 2 based on the total score in the Mandibular 
Function Impairment Questionnaire and active maximum mouth opening 
Functional 
impairment
b 
N MFIQ raw score
a
 aMMO
c  
in mm (SD)
 
I 6 0.12  32.33 (13.19) 
II 3 0.41 25.33 (4.51) 
III 2 0.53   19.5 (0.71) 
 
ªMFIQ: seventeen questions with answers on a five-level Likert scale, to assess the extent of the difficulties 
experienced to perform a particular mandibular task. The total score of the scale (C) is the sum of the 17 items 
(S) divided by 4 times the number of items (n): C = S / 4n.   
b
Functional impairment is a conversion of the raw score: I= no/low, II= moderate, III= severe.  
c
aMMO: active maximal mouth opening, the maximum interincisal distance on opening as wide as possible.  
 
Physical abilities 
A total of 3 out of 6 patients from the department of Rehabilitation, Children’s Hospital, 
Radboud university medical center, the Netherlands, had a low score on the MFM indicating 
problems with head balance. One out of 6 patients could keep head balance but had to 
compensate during item 14 of the MFM; Two out of 6 patients had no difficulty keeping head 
balance (Table 2.3).  
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Table 2.3. Active maximal mouth opening and Motor Function Measure in patients with 
spinal muscular atrophy  type 2 (n = 6). 
 
Patient 
number 
Gender Age 
yrs. mths 
aMMO
a
  MFIQ,
 
raw 
score
b 
MFM
 
total
c
 
% 
MFM 
13
d
 
MFM 
14
e
 
6 M 9.5 19 0.60 43 0 1 
2 M 7.2 19 0.25 39 3 2 
5 F 10.3 20 0.46 64 0 1 
9 F 13.4 29 0.22 94 3 3 
1 F 6.5 38 0 93 3 3 
7 F 13.0 44 0 91 3 3 
 
a
aMMO: active maximal mouth opening, the maximum interincisal distance on mouth opening as wide as 
possible. 
b 
MFM = Motor Function Measure, MFM score / percentage of maximal score of the items 13 to 23 (total score 
33 points = 100%); MFM scoring per item: 0 = does not initiate movement or starting position cannot be 
maintained; 1 = partially completes the exercise; 2 = completes the exercise with compensations, slowness or 
obvious clumsiness; 3 = completes the exercise with a standard pattern. 
c 
MFM score item 13: Seated on the chair. Without support of upper limbs or leaning against the back of the 
chair, maintains the sitting position, head and trunk in the axis; score 0 – 3. 
d 
MFM score item14: Seated on the chair or in their wheelchair. Head in flexion: from the fully flexed position, 
raises the head and maintains the raised position, head in the axis during the movement and when maintained; 
score 0 – 3.  
 
Examination of the masticatory system 
Ranges of motion during active mandibular movements and passive maximum mouth opening 
(pMMO) were significant less in the patient group than in the control group (Table 2.4). 
  In patients with a severe reduced mandibular ROM (≤ 30 mm) the temporomandibular 
joints mainly rotated in aMMO, instead of the usual combination of rotation and sliding of the 
mandibular condyle. Mild pain could be provoked in 2 out of 12 patients during traction and 
translation, compression and resistance tests. Mild pain was reported in the masseter muscle 
region in 8 out of 12 patients during pMMO. In the control group none of the patients 
reported pain during clinical examination. 
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The severity of the limited aMMO correlated with the severity of the disease assessed by the 
MFM total scores (Table 2.3, p ≤ 0.05). 
 
Table 2.4. Group comparison and descriptive statistics of the mandibular range of motion of 
the mandible during clinical examination in the patient group (n=12) and in the control group 
(n=12) 
 
Clinical examination Patient group 
Mandibular ROM (mm) 
Control group 
Mandibular ROM (mm) 
 
p-value 
a 
Mean SD range Mean SD range 
aMMO
b
 27.6 10.5 16 – 48 54.7 6.4 44 – 66 <0.001* 
pMMO
 
28.7 10.7 16 – 49 56.8 6.6 44 – 65 <0.001* 
Lateral movement right 4.1 3.7 0 – 9 9.8 2.8 5 – 13 <0.001* 
Lateral movement left 4.1 4.0 0 – 11 9.8 2.2 6 – 12 <0.001* 
Protrusion 1.3 1.6 0 – 5 7.9 2.7 4 – 13 <0.001* 
Overbite
d
 1.8 3.7 -7 – 5 3.0 1.5 1 – 6   0.288 
Overjet
e 
6.0 3.2 3 – 14 3.1 2.0 1 – 7 0.014* 
 
a
p-value, significant difference (*) between the patient group and the control group (p ≤ 0.05).
 
b
aMMO: active maximal mouth opening, the maximum interincisal distance on opening as wide as possible. 
c
pMMO:
 
passive maximum mouth opening, the maximum interincisal distance on active opening, with a slight 
overpressure on the edges of the upper and lower front teeth by the examiner plus the vertical overbite. 
d
Overbite and 
e
Overjet: see Figure 2.1. 
 
Discussion 
The aim of our study was to systematically investigate mandibular function by using 
questionnaires and detailed clinical examination in young patients with SMA type 2. We 
found a striking difference in the mandibular ROM between the patient group and control 
group, both statistically significant and clinically relevant.  
  Four out of 9 children with a severe limitation of aMMO (≤ 30 mm) scored a low 
function impairment on the MFIQ (Table 2.2) which indicates a discrepancy between these 
limitations and the awareness of the patients and parents. This lack of awareness may result in 
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limitations of mandibular function that are more extensive than if they were observed earlier. 
In the 9 patients with a severe reduced aMMO (≤ 30 mm), the stiff end feel in assisted mouth 
opening and mainly rotation of the mandibular condyles in pMMO indicates changes in the 
morphology of the temporomandibular joints. These changes might be initiated by inadequate 
movement of the lower jaw caused by the progressive weakening of the chewing muscles and 
the neck muscles leading to contracture of the temporomandibular joints. Some of our patients 
had a limited aMMO at a very young age, i.e. 7 years old. It is therefore important to 
investigate whether early physiotherapy, starting when mandibular movements are still within 
the normal range, might be more efficacious than late intervention. This requires early 
recognition of the reduced mouth opening. Physicians may not be aware of mandibular 
dysfunction as a complication of SMA, despite the fact that it may reduce the quality of 
chewing of solid food and compromise swallowing. A recent study showed that swallowing 
of solid food by patients with SMA type 2 resulted in more post-swallow residue especially in 
the vallecula and above the upper esophageal sphincter than with liquid.
23 
Hampered chewing 
due to malocclusion, reduced bite force, and fatigue caused by the involvement of the 
chewing muscles (central nerve V3, VII, IX and XII), results in a hampered food 
comminution, inadequate food bolus formation and oral transport. Thus, the already impaired 
swallowing process may be further hampered by the compromised chewing capability. 
Impaired chewing may be a clinically relevant impairment in children with SMA type 2. 
Moreover, the limited mandibular ROM has an impact on the oral hygiene and dental care. 
  Weakness of neck muscles may further contribute to impaired mandibular function.  
Head retraction by the neck muscle in an attempt to stabilize the balance of the head may 
increase reduction of the opening capacity of the mouth.
23
 This is supported by the finding 
that MFM scores, which reflect motor disability in patients with neuromuscular disorders, 
were associated with mandibular dysfunction (Table 2.3, p ≤ 0.05).20 
  Limitations of aMMO can be easily assessed by means of a ruler. Interincisal distances 
(including the overbite; Figure 2.1) of ≤ 35 mm in children younger than 12 years of age, and 
≤ 40 mm in children older than 12 years suggest limited aMMO and warrants referral to a 
specialized dental team.  
  More research is needed to further assess the causative factors of a reduced mandibular 
function and to establish the additional value of an early physiotherapeutic intervention.  
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Conclusion 
This study shows that mandibular dysfunction is common among young patients with 
SMAtype 2. This may reduce the quality of chewing and swallowing. Early recognition of 
mandibular dysfunction may help to prevent complications such as aspiration as a result of 
chewing problems. 
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Abstract 
Objectives: Problems with feeding and swallowing are often reported by patients with 
hereditary proximal spinal muscular atrophy (SMA) but have not been studied objectively. 
We aimed to determine: 1) the impact of SMA type 2 and 3 on the mandibular function 
reflected as masticatory performance, mandibular range of motion, and bite force; 2) the 
predictors of mandibular dysfunction. 
Methods: Sixty patients with SMA type 2 and 3 (mean age 16.7±7.7 years) and 60 age-
matched controls filled out questionnaires about the impairments of the mandibular function. 
All participants underwent detailed clinical examination to document the mandibular range of 
motion including maximal mouth opening, bite force and masticatory function. 
Results: All mandibular movements including mouth opening, lateral range of motion and 
protrusion of the mandible, were reduced in patients with SMA type 2 and 3 compared to 
healthy controls (p < 0.001). Maximal bite force was 19% lower in patients than controls, and 
more in patients with SMA type 2 than type 3. The strongest predictive factor was SMA type 
for impairment of mandibular range of motion (R
2
 = 0.82) and weakness of neck muscles for 
bite force (R
2
 = 0.47).  
Conclusions: Reduced mandibular mobility and bite force are common complications in 
SMA. SMA type and neck muscle strength are important correlates of these complications. 
We provide further evidence for clinically relevant bulbar involvement in patients with SMA. 
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Introduction 
Hereditary proximal spinal muscular atrophy (SMA) is caused by the homozygous deletion of 
the survival motor neuron (SMN) 1 gene and is characterized by degeneration of the alpha 
motor neurons in the spinal cord.
1
 Weakness is most prominent in axial and proximal muscle 
groups but also affects bulbar muscles.
2, 3
 There is large variation in SMA severity, and age at 
onset and highest achieved motor milestones are used to distinguish 4 types in descending 
order of severity.
4, 5
 Natural history studies have shown that weakness is slowly progressive.
5
 
The function of bulbar muscle groups in patients with SMA has not been studied extensively, 
despite the fact that bulbar dysfunction may complicate chewing and swallowing, and may 
increase the risk of airway tract infections, weight problems and insufficient oral hygiene.
6, 7, 8
 
The most common complaints in questionnaire based studies were chewing difficulties (28%), 
perceived limitations in the ability to open the mouth (30%) and swallowing difficulties 
(25%) in a cohort of patients with SMA type 2;
 
difficulty bringing food to the mouth (20%), 
difficulty chewing (20%) and choking (31%) in a sample of patients with SMA type 2 and 3.
6, 
9, 10
  
The oral phase of the swallowing process requires the concerted action of the tongue and 
muscle groups involved in mouth opening and mastication. Reduced mandibular range of 
motion and weakness of masticatory and tongue muscles complicate eating and swallowing in 
patients with SMA,
7, 12
 but the function of these muscle groups has only been studied in small 
patient groups.
11
 In this study we therefore investigated the prevalence and determinants of 
reduced mandibular range of motion, bite force and masticatory performance in a cohort of 60 
patients with SMA types 2 and 3. 
 
 
Methods  
Participants  
We performed a cross-sectional study between October 2013 and July 2014. We invited 93 
patients with SMA types 2 and 3 aged 5 years or older listed in the Dutch SMA registry to 
participate in this study. All patients had a genetically confirmed diagnosis of SMA. We used 
diagnostic criteria of the SMA Consortium to define SMA types 2 and 3.
14-16
 In short; SMA 
type 2 was defined as an onset between the ages of 6 and 18 months and having learned to sit 
but not to walk independently. SMA type 3 was defined as an onset after the age of 18 months 
and having learned to walk independently at some stage in life. Patients with type 3 and an 
onset before 3 years were classified as type 3a whereas an onset after the age of 3 was 
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classified as type 3b.
7
 The presence of homozygous SMN1 deletion was confirmed in all 
patients using Multiplex Ligation-dependent Probe Amplification (MLPA) (SALSA MLPA 
kit P060 version B2, (www.mlpa.com; www.mrcholland.com). 64 patients gave informed 
consent; 4 participants were excluded from final analysis because of their medical history 
(osteotomy of the mandible) and temporomandibular joint disorder (TMD). Patient 
characteristics are summarized in Table 3.1.  
We enrolled 60 age and gender-matched healthy controls. The control group was recruited at 
a primary and a secondary school located in the western part of the Netherlands, and consisted 
of children and parents. Controls aged 18 years and older were additionally recruited at the 
College of Dental Sciences, Nijmegen, The Netherlands. Inclusion criteria for healthy 
controls were the absence of a history of neuromuscular disease, temporomandibular 
disorders, ongoing orthodontic treatment or the presence of morphologic dental malocclusions 
(i.e. cross bite or tendency to cross bite).  
This study was registered at the Central Committee on Research involving Human Subjects, 
the Dutch registry for clinical trials. The Medical Ethical Committee of the University 
Medical Center Utrecht approved the research protocol. Written informed consent was 
obtained from all participants and the legal guardians of the under aged participants. 
 
 
Protocol 
All patients and controls were examined at their homes or in the dental office by one of the 
authors who is a dental specialist (H.W.v.B.). The participants in both the patient and the 
control group completed structured questionnaires and were interviewed to document their 
medical history and difficulties with feeding and swallowing. A feeding disorder was defined 
as selectivity or avoidance of food or mastication. A swallowing disorder or dysphagia was 
defined as a disorder in one or more phases of the swallowing process; the oral, the 
pharyngeal or esophageal phase, i.e. problems to move food or fluids from the oral cavity to 
the throat or delayed passage of food or drink through the esophagus. Choking was defined as 
frequent blockage of the throat by food or drinks. The participants underwent a systematic 
clinical examination of the masticatory system, including anterior maximum voluntary bite 
force (MVBF) and masticatory performance measurements. Motor abilities were documented 
during the intake by one of the authors (R.I.W.) using the Hammersmith Functional Motor 
Scale Expanded (HFMSE) and muscle strength of neck flexors and extensors with the 5-point 
Medical Research Council (MRC) scale. 
19, 20
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Questionnaires 
The patient group and the control group completed two questionnaires: ‘Screen’ and the 
‘Mandibular Functional Impairment Questionnaire’ (MFIQ).21-23 Screen was developed to 
assess pain in the head and neck region, mandibular function and related issues and general 
health factors (e.g. medication, family history). Participant’s ≥ 10 years of age reported pain 
on a Visual Analogue Scale (VAS, 0-100 mm) and children < 10 years on a 5-point Likert 
smiley pain scale which was converted to a VAS score.  
MFIQ measures impairments of the function of the masticatory system reliably.
24 
 MFIQ 
consists of 17 questions, which can be subdivided into two dimensions - functional capacity 
and feeding - and is rated on a 5-point Likert scale ranging from ‘0’ (no difficulty) to ‘4’ (very 
difficult or impossible without help). The ratings are added to give a sum score (S, range 0–
68). A higher score indicates more perceived mandibular function impairments and a MFIQ 
score of ‘0’ indicates no impairment in mandibular functioning.  
 
Clinical examination 
We examined all participants following a validated procedure as described by Lobbezoo-
Scholte and co-writers.
25, 26
 All participants were in the upright position with their heads in a 
neutral position, non-ambulant patients with SMA were in their wheel chairs with their heads 
as far as possible in neutral position.  
We assessed mandibular movements, including active maximum mouth opening (aMMO), 
left and right lateral ROM and protrusion, overbite and overjet with a metal ruler (mm) 
(Figure 3.1 A, B).
9
 The aMMO was the distance measured between the incisal edges of the 
upper and lower right central incisors plus the overbite.  
The masseter and temporalis muscles were palpated and both condyles in an open and closed 
mouth position to quantify pain felt by the patient (Figure 3.1 C). We assessed the mobility of 
the temporomandibular joint during aMMO by palpation of the lateral pole of the mandibular 
condyle with the index finger.
27
  
We documented the number of occlusal contacts (OC-score) between the premolar and molar 
teeth of the upper and lower jaw after using wax records (Moyco beauty pink plate wax, 2270 
g). A perforation in the wax record indicated an occlusal contact. Unilaterally, the maximum 
OC-score is 5 (1 OC per posterior occluding pair); bilaterally the maximum is 10. 
Dental occlusion, defined as the static contact between the masticating surfaces of the 
maxillary and mandibular teeth in a closed position, was assessed regarding the presence or 
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absence of uni- or bilateral abnormal transverse relationship of single or multiple posterior 
teeth (i.e. premolars or molars) (Figure 3.1 D, E).  
 
Measurement of the anterior maximum voluntary bite force  
To measure the bite force we used the VU University Bite Force Gauge (VU-BFG) (Figure 
3.1 F).
28
 This is a handheld device that uses a load cell (LPM 510 250lb) to measure 
maximum voluntary bite force (MVBF) in kg, ranging from 0 to 50 kg in a linear fashion. The 
bite force transducer was calibrated before, half way and at the end of the data collection. 
Patients and healthy subjects clenched, with the strain gauge between the incisors, as hard as 
possible for 3 seconds and repeated clenching three times with an interval of 30 seconds rest 
periods; the highest value of the three measurements was used. 
 
Masticatory performance: mixing ability test 
We defined masticatory performance as an individual’s capacity to grind or pulverize a test 
food after a fixed number of chewing cycles. For this purpose, we used the mixing ability test 
(Figure 3.1 G, H).
29
 Each participant performed 20 chewing strokes on a wax tablet (at room 
temperature, 20 °C) consisting of a red and a blue layer. As a result the colours would mix 
and the degree of mixing represented the masticatory performance. 
 
 Statistical analysis 
IBM SPSS version 20 was used for statistical analysis. The level of significance was set at  
p = 0.05. Descriptive statistics in terms of mean and standard deviation were used to describe 
the independent scale variables in the patient and control group. Paired Student’s t-test was 
used to compare between-group continuous variable outcomes, and for dichotomous variables 
the chi-square test was used. To compare test outcomes between SMA type 2 and 3 ANOVA 
or Kruskal-Wallis test was used for scale variables and chi-square test for dichotomous 
variables. 
  To study the association between mandibular function variables and predictive factors, 
univariate linear regression analyses were performed. To identify contributing factors to 
reduced aMMO, the variables age, SMA type, disease duration, HFMSE, MRC sum score, 
MFIQ raw score, mixing ability, number of occlusal contacts, scoliosis surgery, mastication 
difficulties, dysphagia, difficulties biting of food and food adaptation were used. To identify 
determinants of reduced anterior MVBF, the variables age, SMA type, disease duration, 
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HFMSE, MRC sum score, MFIQ raw score, aMMO, number of occlusal contacts, scoliosis 
surgery, dysphagia, difficulties biting of food and food adaptation were used. The independent 
variables, which were possibly associated with the aMMO and the anterior MVBF (p < 0.1) 
were included in the multiple linear regression analyses (stepwise backward method; p-value 
to remove > 0.05) in order to determine the set of variables that best predict impaired aMMO 
and anterior MVBF in SMA patients.  
 
 
 
Figure 3.1.  Main parameters to determine the bulbar involvement of the oral phase of swallowing in patients 
with SMA and the dentition of participants. (A) Measurement of the maximum voluntary mouth opening: the 
distance between the mesioincisal angle of the right upper and lower front teeth plus the overbite; B) overbite 
refers to the vertical overlap of the front teeth and overjet to the horizontal overlap; (C) palpation of the masseter 
muscle; (D) mandible in intercuspal position of a healthy subject; (E) dentition in intercuspal position of patient 
with SMA type 2 with cross bite on the right hand side and tendency to crossbite on the left side; (F) 
measurement of the anterior bite force; (G) a wax tablet ;(H) a chewed wax tablet of the mixing ability test.
24 
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Results 
Questionnaires  
Screen and anamnestic information 
19 patients (32 %) reported limitations in the ability to open the mouth (Table 3.2). The 
maximum intensity of the recorded pain in these 3 patients was ‘mild’. 
17 patients (28%) mentioned mastication difficulties. In 8 out of 17 patients (47%), 
mastication problems interfered with daily and social activities ranging from sometimes to 
very often. Dysphagia was reported by 28 patients (47%), more often in SMA type 2 than 
type 3a and 3b (Table 3.2). The controls did not report mastication problems or dysphagia. 
Mandibular Function Impairment Questionnaire  
Information on food adaptation by the patients, derived from the MFIQ, showed that 32 
patients (54%) had to adapt food composition and consistency (Table 3.2). The controls did 
not report impairment of the mandibular function. 
 
Clinical examination 
Range of motion 
aMMO, active lateral ROM and protrusion were significantly smaller in the patient group 
than in the control group (Table 3.1). Patients with type 2 had significantly smaller aMMO 
than type 3a and 3b (Table 3.2). The mean aMMO was smaller or equal than 40 mm in 50% 
of the patients with SMA. The mean active lateral ROM was smaller than 8 mm in 48% of the 
patients; in type 2 the active lateral ROM was significantly smaller than type 3a and 3b (Table 
3.2). The active protrusion was smaller than 5 mm in 32% of the patients; in the SMA type 2 
cohort protrusion was significantly smaller than in SMA type 3 (Table 3.2). 
Active lateral ROM smaller than 5 mm was found in 3 controls (5%). 
TMJ mobility 
Clinical examination of the temporomandibular joint mobility showed that 45 patients (75%) 
had a normal sliding of the mandibular condyle with a mean aMMO of 45.2 mm (range 14 – 
71 mm); 15 patients (25%) had a reduced sliding or no sliding with a mean aMMO of 17.1 
mm (range 4 – 33 mm) (Table 2). All controls had normal sliding of the mandibular condyle 
with a mean aMMO of 54.8 mm (range 46 – 70 mm). 
Pain 
In two patients with SMA type 2, pain could be provoked during aMMO and during palpation 
of the masseter muscle (VAS 10/100 mm, 65/100 respectively). 
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Dental occlusion 
The OC score in the posterior teeth of the upper and lower jaws was reduced in 14 % of the 
patients (average OC score 6.6, SD 2.2, range 1–10) compared with the controls (average OC 
score 7.7, SD 1.2, range 5–10) (Table 3.1). Twenty one patients (35%) showed tendency to 
cross bite; lateral cross bite was present in 17 (28%) patients (Table 3.2).  
 
Maximum voluntary bite force  
The MVBF was 19.0% lower in the patient group than in the control group (Table 3.1). Mean 
MVBF was 154.9 N (SD 85.3, range 18.6–374.6 N) in the patient group and 191.2 N (SD 
86.3, range 67.7–490.3 N) in the control group. Patients with type 2 had a significantly lower 
MVBF than patients with SMA type 3 (Table 3.2). 
 
Table 3.1. Group comparison and descriptive statistics of the mandibular range of motion, 
occlusal contacts, anterior maximum voluntary bite force (MVBF) in Newton and mixing 
ability during clinical examination in the patient group (n = 60) and in the control group  
(n =  0). Mean and standard deviation of the measurements are referred to as x  (SD). 
 
* = Statistically significant differences. 
Clinical examination Patient group Control group p-value 
Age 
range 
32.3 (17.4) 
8.7 – 70.3 
31.1 (17.6) 
8.2 – 70.9 
0.397 
aMMO
a  
(mm) (SD) 
range 
38.9 (15.3) 
4.0 – 71.0 
54.8 (5.4) 
45.0 – 68.0 
<0.001* 
Lateral ROM
 
L/R
b
 (mm) (SD) 
range 
8.0 (4.5) 
0.0 – 19.0 
10.4 (2.4) 
5.0 – 15.5 
<0.001* 
Protrusion
c 
(mm) (SD) 
range 
6.5 (4.0) 
0.0 – 14.0 
9.6 (2.1) 
5.0 –15.0 
<0.001* 
Occlusal contacts
d
           
range 
6.6 (2.2) 
1.0 – 10.0 
7.7 (1.2) 
 5.0 – 10.0 
0.001* 
Anterior MVBF
e 
range  
154.9 (85.3) 
18.6 – 374.6 
191.2 (86.3) 
67.7 – 490.3 
0.018* 
Mixing ability
f 
range 
18.6 (3.0) 
14.3 – 25,2 
18.1 (2.8) 
13.0 – 24.6 
0.222 
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a
aMMO: active maximum mouth opening, the maximum interincisal distance on opening as wide as possible 
plus the vertical overbite. 
b
Lateral ROM L/R: active mandibular lateral excursion, mean value between the left and right side.  
c
Protrusion: active forward movement of the mandible. 
d
Occlusal contacts: the number of occlusal contacts between the premolar and molar teeth of the upper and lower 
jaw after the teeth were brought into occlusion. 
e
Anterior MVBF: maximum vertical interocclusal bite forces between the central incisors of the upper and lower 
jaw. 
f
Mixing ability: individual’s capacity to grind a two colored wax tablet during 20 strokes of chewing. 
 
Mixing ability test 
Masticatory performance was comparable in the patient (18.6, SD 3.0) and control group 
(18.1, SD 2.8) (Table 3.1) and between SMA types (p > 0.1) (Table 3.2).  
 
Predictive factors for aMMO and bite force 
Univariate linear regression analyses showed that most of the selected determinants were 
associated with aMMO except for age (p = 0.138) and disease duration (p = 0.736). Multiple 
linear regression analysis showed that SMA type, MFIQ, difficulties biting of food and food 
adaptation as the independent predictive factors for reduced aMMO (R
2
 = 0.80, Table 3.3). 
Univariate linear regression analyses showed that all the selected determinants were 
associated with reduced MVBF. Multiple linear regression analysis identified age, and MRC 
sum score as the independent predictive factors for a reduced MVBF (R
2 
= 0.47, Table 3.4). 
Chapter 3 
51 
 
Table 3.2. Characteristics of patients with spinal muscular atrophy (n = 60) presented by 
stages. Mean and standard deviation of the measurements referred to as x  (SD); number of 
patient as n / %.  
  SMA stage   p-value  
 Total  
(n = 60) 
Type 2 (1) 
(n = 31) 
Type 3a (2) 
(n = 18) 
Type 3b (3) 
(n=11) 
 1-2 
2-3a 
2-3 
3a-3b 
1-3 
2-3b 
Mean age, yrs.mths 
range 
32.3 (17.4) 
8.7 – 70.2 
26.2 (15.0) 
8.7 – 70.2 
35.7 (19.6) 
8.7 – 65.7 
43.8 (12.4) 
21.8  – 58.1 
 0.115 0.402 0.009* 
Disease duration, mths 
range 
312.6 (193.4) 
52.7 – 777.7 
266.4 (176.8) 
55.5 – 777.7 
369.2 (225.3) 
52.7 – 687,6 
350.2 (163.6) 
90.5 – 534.7 
 - - - 
HFMSEa 
range 
14.8 (19.3) 
0 – 66  
3.7 (5.0)  
0  – 20 
17.7 (18.1)  
0  – 45 
41.1 (20.0)  
8 – 66 
 0.177 0.118 <0.008* 
MRC sum score, neckb 
range 
3.6 (1.0) 
2 – 5 
3.0 (0.7) 
2 – 4.5 
4.0 (0.8) 
2.8 – 5 
4.9 (0.2) 
4.5 – 5 
 0.075 0.024* 0.001* 
MFIQ raw scorec 
range  
0.14 (0.17) 
0.36 – 0.31 
0.20 (0.20) 
0.0 – 52.0 
0.10 (0.11) 
0.0 – 0.35 
0.03 (0.03) 
0.0 – 0.09 
 0.341 0.459 0.012* 
aMMO  
range (mm) 
38.9 (15.3) 
4.0 – 71.0 
28.9 (12.5) 
 4.0 – 53.0 
44.7 (8.2)  
23.0 – 54.0 
57.5 (7.4) 
48.0 – 71.0  
 0.001* 0.090 <0.001* 
Lateral ROM L/R  
Range (mm) 
8.0 (4.5) 
0.0 – 19.0 
5.8 (4.3) 
0.0 – 15.0 
8.8 (2.5) 
4.0 – 13.0 
12.5 (3.9) 
6.5 – 19.0 
 0.058 0.190 <0.001* 
Protrusion  
Range (mm) 
6.5 (4.0) 
0.0 – 14.0 
4.6 (3.6) 
0.0 – 13.0 
7.9 (3.6 
0.0 – 14.0 
9.3 (3.5) 
5.0 – 14.0 
 0.006* 0.595 0.001* 
Anterior MVBF 
range (N) 
154.9 (85.3) 
18.6 – 374.6 
118.7 (68.6) 
18.6  – 261.8 
177.5 (88.3) 
47.1 – 374.6 
218.7 (78.5) 
83.4 – 345.2 
 0.031* 0.353 0.001* 
Mixing ability 
range  
18.6 (3.0) 
14.3 – 25,2 
19.7 (3.3) 
14.3 – 25.2 
17.7 (2.2) 
14.3 – 24.1 
17.2 (1.4) 
15.0 – 19.4 
 0.109 1.000 0.106 
Occlusal contacts 
range 
6.6 (2.2) 
1 – 10 
6.5 (2.1) 
2 – 10 
6.8 (1.9) 
1 – 8 
7.5 (0.8) 
6 – 8 
 0.269 0.122 0.005* 
Ventilatory support  
  None 
  Part-time (nocturnal)  
  Cont. noninvasive 
  Conti. + tracheostomy 
 
47 / 78 % 
7 / 12 % 
3 / 5 % 
3 / 5 % 
 
22 / 74 % 
5 / 16 % 
3 /10 % 
1 / 3 % 
 
14 / 78 % 
2 / 11 % 
0 / 0% 
2 / 10% 
 
11 / 100 % 
0 / 0 % 
0 / 0% 
1 / 10% 
 0.409 
Scoliosis surgery 30 / 50% 23 / 74 7 / 39 % 0 / 0%  <0.001* 
Dysphagiad 28 /47 % 19 / 61 % 8 / 44 % 1 / 10%  0.010* 
aMMO reduced, subjectivee 19 / 32 % 17 / 55 % 2 / 10 % 0 / 0 %  <0.001* 
Sliding of the TMJf 15 / 25% 14 / 45 % 1 / 6 % 0 / 0%  0.001* 
Mastication difficultiesg 17 / 28 % 12 / 39 % 4 / 22 % 1 / 10%  0.159 
Difficulties biting of foodh 24 / 40 % 19 / 61 % 5 / 28% 0 / 0 %  <0.001* 
Food adaptationi 32 / 53 % 21 / 68 % 9 / 43% 2  / 18 %  0.017* 
* = Statistically significant differences. 
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SMA = spinal muscular atrophy; SMA type 2 = onset between the ages of 6 and 18 months and learned to sit or 
even shortly stand but not to walk independently; type 3a = onset after the age of 18 months but before 3 years 
and learned to walk independently at some stage in life; type 3b = onset after the age 3 years and learned to walk 
independently at some stage in life. 
 
a
HFMSE: the Hammersmith Functional Motor Scale Expanded contains 33 items with total scores ranging from 
0 to 66. Each activity (item) is scored on a 3 point scoring system, with a score of 2 for unaided, 1 for assistance 
and 0 for inability. A total score can be achieved by summing the scores for all the individual items. The total 
score can range from 0, if all the activities are failed, to 66, if all the activities are achieved. All items have to be 
tested without spinal jacket or orthoses. 
b
MRC sum score = the sum score of the neck muscle strength evaluated by the Medical Research Counsil scale, 
a categorical scale to measure the entire range of muscle strength, from 0 (no visible or palpable muscle 
contraction) through 5 (movement through the complete range of motion against gravity and maximum 
resistance). 
c
MFIQ raw score: seventeen questions with answers on a five-point Likert scale, to assess the extent of the 
difficulties experienced to perform a particular mandibular task. The total score is the score of the degree of 
masticatory and non-masticatory impairment that represents the total function impairment. The total score of the 
scale (C) is the sum of the 17 items (S) divided by 4 times the number of items (n): C = S / 4n. 
d
Dysphagia: rated on a 5-point scale. 0 = never; 1 = sometimes; 2 = regularly; 3 = often; 4 = not applicable. 
Patients with a score >1 are considered to have difficulty in passing food or drinks from the mouth into the 
stomach expressed as choking solid food and, or sticking food in the throat. 
e
aMMO reduced, subjective: limitation in the ability to open the mouth noted by the patients in Screen or by 
anamnestic information. 
f
Sliding of the temporomandibular joint was assessed by palpation: reduced = no or hardly any sliding of the 
lateral pole of the mandibular condyle, normal = sliding to and beyond the crest of the articular eminence. 
g
Mastication difficulties: rated on a 5-point scale. 0 = never; 1 = sometimes; 2 = regularly; 3 = often; 4 = very 
often. Patients with a score >1 are considered to have mastication difficulties during mastication of hard, sticky 
or soft food. 
h
Difficulties with biting of food: rated on a 5-point scale. 0 = never; 1 = sometimes; 2 = regularly; 3 = often; 4 = 
very often. Patients with a score >1 are considered to have difficulties with biting of food. 
i
Food adaptation: patients unable to eat hard biscuits, meat, raw carrots, French loaf or nuts. 
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Table 3.3   Multiple linear regression analysis of predictors for the active maximal  
mouth opening (aMMO) in spinal muscular atrophy patients 
Model 
 
95 % Confidence Interval 
for Effect 
 
 
 
p-value Effect 
Lower 
Bound 
Upper 
Bound 
(Constant) 38.98 34.955 43.006 <0.001* 
 SMA type 
   type 2 
   type 3a 
   type 3b 
 
Reference 
9.87 
18.64 
 
 
5.396 
12.929 
 
 
14.333 
24.35 
 
 
<0.001* 
<0.001* 
MFIQ -39.21 -56.374 -22.047 <0.001* 
 Difficulties biting of food -9.22 -14.778 -3.667 0.002* 
 Food adaptation 4.78 -0.202 9.768 0.060* 
R
2
 = 0.80; * = Statistically significant differences. 
 
 
Table 3.4   Multiple linear regression analysis of predictors for anterior maximum  
voluntary bite force (MVBF) in spinal muscular atrophy patients 
 
 
  
Model 
 
95 % Confidence Interval 
for Effect 
 
 
Effect 
Lower 
Bound 
Upper 
Bound 
p-value 
 (Constant) -45.95 -119.26 27.36 0.214 
 Age (in years) 1.38 .30 2.45 0.013* 
 MRC sum score 21.69 12.44 30.94 <0.001* 
R
2
 = 0.38; * = Statistically significant differences. 
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Discussion 
Self-reported complaints of feeding, chewing, limitations in the ability to open the mouth, 
swallowing and choking range from 20-35% of patients with SMA type 2 and 3.
3,7,9
 Patients 
in this study reported dysphagia (48%) more often than in previous studies, which may be due 
to the use of different definitions of dysphagia.
3, 6, 9
 The frequency of mastication difficulties 
(28 %) was comparable with previous studies.
6, 9, 10
 Self-reporting may not reflect true 
prevalence of mandibular functional problems.
6, 10
 In our previous study, for example, we 
found a much higher than self-reported prevalence of limitations in mouth opening.
3
 
Moreover, although 28% of patients in our study reported mastication difficulties, more than 
half of the patients indicated that they adapted their food consistency. This underlines the 
importance of objectively measuring function of bulbar muscle groups.  
Our data suggest that at least two important aspects of the mandibular function, i.e. 
ROM and bite force are diminished in patients with SMA types 2 and 3. SMA type, MFIQ, 
difficulties biting of food and food adaptation were identified as independent determinants of 
reduced mouth opening in our multiple linear regression model (Table 3.3). The model 
suggests that SMA type and questions about food handling are useful tools to identify patients 
with reduced aMMO. We previously showed that selective fatty degeneration of the lateral 
pterygoid muscle is associated with this complication, which explains the reduced sliding 
ability of the TMJ and the reduced lateral ROM.
3
 As far as we know it is unclear at what 
value a lateral ROM may have a negative effect on masticatory performance. We assume that 
with a lateral ROM smaller than 3 mm the bolus formation is complicated.  
The second finding is a reduced anterior MVBF, indicating weakness of masticatory 
muscles (i.e., the mandibular closing muscles). Decreased bite force in patients with SMA has 
been reported before
 
and may be secondary to the fatty degeneration of the masseter and 
temporal muscles that we observed in a recent MRI-study of bulbar muscles.
6, 10
 Multiple 
linear regression analysis in this study indicated that age and MRC sum score are 
determinants of reduced MVBF. This may reflect the natural history of SMA that is generally 
characterized by progression of muscle weakness with advancing age. Our data support a 
model for mandibular dysfunction caused by gradually increasing weakness of muscles that 
mediate mouth opening, closing and horizontal movements, leading to bite force reduction 
and development of progressive contractures of the TMJ. 
It was surprising that masticatory performance did not differ between patients and 
control groups, since 28% of our patients reported masticatory difficulties. Moreover, self-
reporting mastication difficulties may not reflect true prevalence due to the high percentage of 
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food adaptation in our patient group.
6, 10 
The used methodology may lack sensitivity to 
identify masticatory problems for a number of reasons. First, masticatory performance as 
reflected by the wax tablet mixing test is primarily associated with the number of functional 
tooth units (OC score) and bite force in healthy subjects.
30 
The mean OC score in the patient 
group was only one occlusal contact lower than in the control group. This, in combination 
with sufficient bite force, may explain the retained capacity to mix the wax tablets.   
 Masticatory performance was measured in the first 20 chewing cycles and therefore 
mimics the start of a meal. Fatigability, which may be an important additional problem to 
weakness in patients with SMA, may compromise masticatory function, but is obviously not 
covered by this test.
31
 Future studies should preferably employ methodology designed to 
capture masticatory dysfunction in the course of a meal.  
Recognizing bulbar involvement in SMA by medical staff, patients, parents and 
caretakers is a first step to identify risks of dysphagia, aspiration and insufficient intake. The 
use of MFIQ, a short questionnaire to assess mandibular functional problems, in combination 
with measuring aMMO may be helpful to identify patients with SMA who are at risk for 
bulbar problems. We also need to develop and test efficacy of specific training programs that 
aim at preserving mandibular function. These programs should include training of aMMO and 
horizontal movements, and possibly on the strength of masticatory muscles. 
 
Conclusion 
This study provides further evidence for clinically relevant bulbar involvement in patients 
with SMA type 2-3. Mandibular range of motion, and bite force were significantly lower in 
the patients compared to healthy controls. Reduced mandibular mobility and bite force are 
common complications in SMA with SMA type as the strongest predictor for mouth opening 
and strength of the neck muscles for the anterior MVBF. 
 
Acknowledgements 
This project was financially supported by grants from Cornelia stichting, Prinses Beatrix 
Spierfonds and Stichting Spieren voor Spieren. The authors wish to thank the  participating in 
the study. We would like to thank Evert Dekker from the faculty of Psychology and 
Education, VU University Amsterdam, the Netherlands, for giving the opportunity to use the  
VU University Bite Force Gauge (VU-BFG) for research. Written informed consent for 
publication of the images in Figure 3.1. was obtained from the patient’s parents. 
Bulbar muscle dysfunction in patients with SMA type 2 and 3 
56 
 
References  
1. Lefebvre S, Burglen L, Reboullet S, et al. Identification and characterization of a spinal muscular 
atrophy-determining gene. Cell 1995;80:155–165. 
2. van den Engel-Hoek L, Erasmus CE, van Bruggen HW, et al. Dysphagia in spinal muscular atrophy 
type II: more than a bulbar problem? Neurology 2009;73:1787–1791. 
3. Wadman RI, van Bruggen HW, Witkamp TD, et al. Bulbar muscle MRI changes in patients with SMA 
with reduced mouth opening and dysphagia. Neurology 2014;83:1060–1066. 
4. Lunn MR, Wang CH. Spinal muscular atrophy. Lancet 2008;371:2120–2133. 
5. Mercuri E, Bertini E, Iannaccone ST. Childhood spinal muscular atrophy: controversies and challenges. 
Lancet Neurol 2012;11:443–452. 
6. Chen YS, Shih HH, Chen TH, Kuo CH, Jong YJ. Prevalence and risk factors for feeding and 
swallowing difficulties in spinal muscular atrophy types II and III. J Pediatr 2012;160:447–451.  
7. van Bruggen HW, van den Engel-Hoek L, van der Pol WL, et al. Impaired mandibular function in 
spinal muscular atrophy type II: need for early recognition. J Child Neurol 2011;26:1392–1396. 
8. Meyers JA, Sidman J. Children with limited oral opening can be safely managed without a 
tracheostomy. Otolaryngol Head Neck Surg 2014;150:133–138. 
9. Willig TN, Paulus J, Lacau Saint Guily J, Beon C, Navarro J. Swallowing problems in neuromuscular 
disorders. Arch Phys Med Rehab 1994;75:1175–1181.  
10. Messina S, Pane M, De Rose P, et al. Feeding problems and malnutrition in spinal muscular atrophy 
type II. Neuromuscul Disord 2008;18:389–393. 
11. van den Engel-Hoek L, Erasmus CE, van Hulst KC, et al. Children with central and peripheral 
neurologic disorders have distinguishable patterns of dysphagia on videofluoroscopic swallow study. J 
Child Neurol 2014;29:646–653. 
12. Granger MW, Buschang PH, Throckmorton GS, Iannaccone ST. Masticatory muscle function in 
patients with spinal muscular atrophy. Am J Orthod Dentofacial Orthop 1999;115:697–702. 
13. Munsat TL, Davies KE. International SMA consortium meeting. (26-28 June 1992, Bonn, Germany). 
Neuromuscul Disord 1992;2:423–428. 
14. Zerres K, Rudnik-Schoneborn S. Natural history in proximal spinal muscular atrophy. Clinical analysis 
of 445 patients and suggestions for a modification of existing classifications. Arch Neurol 
1995;52:518–523. 
15. Zerres K, Rudnik-Schoneborn S, Forrest E, et al. A collaborative study on the natural history of 
childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients. J 
Neurol Sci 1997;146:67–72. 
16. O'Hagen JM, Glanzman AM, McDermott MP, et al. An expanded version of the Hammersmith 
Functional Motor Scale for SMA II and III patients. Neuromuscul Disord 2007;17:693–697. 
17. Glanzman AM, O'Hagen JM, McDermott MP, et al. Validation of the Expanded Hammersmith 
Functional Motor Scale in spinal muscular atrophy type II and III. J Child Neurol 2011;26:1499–1507.  
18. Florence JM, Pandya S, King WM, et al. Intrarater reliability of manual muscle test (Medical Research 
Council scale) grades in Duchenne's muscular dystrophy. Phys Ther 1992;72:115–122.  
Chapter 3 
57 
 
19. Paternostro-Sluga T, Grim-Stieger M, Posch M, et al. Reliability and validity of the Medical Research 
Council (MRC) scale and a modified scale for testing muscle strength in patients with radial palsy. J 
Rehabil Med 2008;40:665–671. 
20. De Leeuw JR, Steenks MH, Ros WJ, et al. Multidimensional evaluation of craniomandibular 
dysfunction. I: Symptoms and correlates. J Oral Rehabil 1994;21:501–514. 
21. De Leeuw JR, Ros WJ, Steenks MH, et al. Multidimensional evaluation of craniomandibular 
dysfunction. II: Pain assessment. J Oral Rehabil 1994;21:515–532. 
22. Stegenga B, de Bont LG, de Leeuw R, Boering G. Assessment of mandibular function impairment 
associated with temporomandibular joint osteoarthrosis and internal derangement. J Orofac Pain 
1999;7:183–195. 
23. Kropmans JB, Dijkstra PU, van Veen A, Stegenga B, de Bont LGM. The smallest detectable difference 
of mandibular function impairment in patients with a painfully restricted temporomandibular joint. J 
Dent Res 1999;78:1445–1449. 
24. Lobbezoo-Scholte AM, Steenks MH, Faber JA, Bosman F. Diagnostic value of orthopaedic tests in 
patients with temporomandibular disorders. J Dent Res 1993;72:1443–1453. 
25. Lobbezoo-Scholte AM, de Wijer A, Steenks MH, Bosman F. Interexaminer reliability of six 
orthopaedic tests in diagnostic subgroups of craniomandibular disorders. J Oral Rehabil 1994;21:273–
285.  
26. Heir GM, Assessment of the TMJ Patient. In: Fonseca RJ, Marciani RD, Turvey TA, editors. Oral and 
Maxillofacial Surgery, vol. 2 2nd edition. St Louis (MO) Elsevier; 2009:815. 
27. Weijenberg RA, Lobbezoo F, Knol DL, Tomassen J, Scherder EJ. Increased masticatory activity and 
quality of life in elderly persons with dementia - a longitudinal matched cluster randomized single-blind 
multicenter intervention study. BMC Neurol 2013;16;13:26. 
28. Speksnijder CM, Abbink JH, van der Glas HW, Janssen NG, van der Bilt A. Mixing ability test 
compared with a comminution test in persons with normal and compromised masticatory performance. 
Eur J Oral Sci 2009;117:580–586.  
29. van der Bilt A. Assessment of mastication with implications for oral rehabilitation: a review. J Oral 
Rehabil 2011;38:754–780. 
30. Montes J, Blumenschine M, Dunaway S, et al. Weakness and fatigue in diverse neuromuscular diseases. 
J Child Neurol 2013;28:1277–1283. 
 58 
 
Chapter 4 
59 
 
Chapter 4 
 
Bulbar muscle MRI changes in patients with SMA  
with reduced mouth opening and dysphagia 
 
Wadman RI, van Bruggen HW, Witkamp TD, Sparreboom-Kalaykova SI, Stam M,  
van den Berg LH, Steenks MH, van der Pol WL
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Published as: 
Wadman RI, van Bruggen HW, Witkamp TD, Sparreboom-Kalaykova SI, Stam M, van den Berg LH, 
Steenks MH, van der Pol WL. Bulbar muscle MRI changes in patients with SMA with reduced mouth 
opening and dysphagia. Neurology 2014;83:1060-1066.
Bulbar muscle MRI changes SMA with reduced MMO and dysphagia 
60 
 
Abstract 
Objectives: We performed a study in patients with proximal spinal muscular atrophy (SMA) 
to determine the prevalence of reduced active maximal mouth opening (aMMO) and its 
association with dysphagia as a reflection of bulbar dysfunction and visualized the underlying 
mechanisms using magnetic resonance imaging (MRI).  
Methods: We performed a cross-sectional study of MMO in 145 patients with SMA types 1-4 
and 119 healthy controls and used MRI in 12 patients to visualize mandibular condylar shape 
and sliding and the anatomy of muscle groups relevant for mouth opening and closing. We 
analyzed associations of reduced aMMO with SMA severity and complaints of dysphagia. 
Results: Reduced MMO was defined as an interincisal distance ≤ 35 mm and was found in 
none of the healthy controls and in 100, 79, 50 and 7% of patients with SMA types 1, 2, 3a 
and 3b/4, respectively. MRI showed severe fatty degeneration of the lateral pterygoid muscles 
that mediate mouth opening by allowing mandibular condylar sliding but relatively mild 
involvement of the mouth closing muscles in patients with reduced aMMO.  Reduced aMMO 
was associated with SMA type, age, muscle weakness and dysphagia (p < 0.05).  
Conclusions: Reduced aMMO is common in SMA types 1-3a and is mainly caused by fatty 
degeneration of specific mouth opening muscles. Reduced aMMO is a sign of bulbar 
dysfunction in SMA. 
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Introduction  
Hereditary proximal spinal muscular atrophy (SMA) is an important genetic cause of 
mortality in infants with early-onset SMA and leads to significant disability in children and 
adults with later onset of disease. SMA is caused by homozygous deletion of the survival 
motor neuron (SMN) 1 gene and is characterized by progressive predominantly proximal 
muscle weakness.
1
 Degeneration of the alpha motor neurons in the spinal cord is the classic 
pathological hallmark of SMA. There is large variation in SMA severity, which is reflected by 
the distinction of SMA types 1-4.
2-6
 
  Involvement of the motor nuclei of the brainstem in SMA has been found in post-
mortem studies and is suggested by the frequent finding of fasciculations in the tongue, 
dysphagia and several other often reported complaints by patients.
5,
 
7-12
 Feeding problems 
were mentioned by more than a third of the patients with SMA type 2 in one survey and 
additional problems with mouth opening, biting and chewing that may further complicate 
eating have also been documented.
10, 11, 13-15
 Dysphagia in SMA is probably caused by 
combined weakness of specific bulbar muscle groups and neck extensors.
13, 15
 Limitations in 
mouth opening may represent a more straightforward model to study bulbar involvement in 
SMA.  
We therefore investigated active maximal mouth opening (aMMO) in 145 patients 
with SMA types 1-4 and 119 healthy controls and visualized structural changes of bulbar 
muscle groups and temporomanibular joint (TMJ) morphology and dynamics in 12 patients 
with SMA types 2-4 with magnetic resonance imaging (MRI).  
 
Methods 
Patients and clinical assessment 
We performed a cross-sectional study between July 2010 and July 2013 in 145 patients with a 
genetically confirmed diagnosis of SMA. All patients visited the outpatient clinic of the 
University Medical Center Utrecht. The presence of homozygous SMN1 deletion was 
confirmed in all patients using multiplex ligation-dependent Probe amplification (SALSA 
MLPA kit P060 version B2; MRC-Holland, Amsterdam, the Netherlands. 
 We documented medical history using National Institute of Neurlological Disorders 
and Stroke common data element Guidelines (www.commondataelements.ninds.nih.gov) and 
difficulties with eating, dysphagia or choking using a semi-structured systematic 
questionnaire from previous studies (appendix e-1 on the Neurology® web site at 
Neurology.org).
10, 11
 We defined eating problems as frequent difficulties with biting, 
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swallowing and/or chewing. Dysphagia was defined as frequently occurring problems with 
swallowing, i.e. problems to move food or fluids from the oral cavity to the throat or delayed 
passage of food or drinks through the esophagus. We defined choking as frequent blockage of 
the throat by food or drinks. 
 We assessed aMMO by measuring the interincisal distance between the upper and lower 
front teeth at the mesioincisal angles with a ruler in all 145 patients and in 119 consecutive 
healthy controls recruited through Dutch primary and secondary schools and the College of 
Dental Sciences.
15
 Two of the investigators (R.I.W. and H.W.v.B.) instructed and verbally 
stimulated participants to open their mouth as far as possible without pain.  
We used age at onset and achieved motor milestones to define SMA types according to the 
diagnostic criteria defined by the SMA Consortium.
2-4
 The definition of SMA type 1 was an 
onset before the age of 6 months and inability to sit independently. Patients with SMA type 2 
had onset between the ages of 6 and 18 months and had learned to sit or even shortly stand, 
but not to walk independently. Patients with SMA type 3 developed weakness after the age of 
18 months and had learned to walk independently at some stage in life. Patients with type 3 
and an onset before 3 years were classified as ‘type 3a’ whereas an onset after the age of 3 
was classified as ‘type 3b’.3 Finally, SMA type 4 was defined by an onset after the age of 30 
in ambulatory patients.
3
 In case there was a discrepancy between age at onset and achieved 
motor milestones, the latter was used to define SMA type. 
 One of the investigators (R.I.W.) assessed strength and motor function. We used the 
Medical Research Council (MRC) score to document muscle strength of neck flexors, neck 
extensors, deltoids, biceps, triceps, wrist flexors and extensors, finger flexors, extensors, and 
spreaders, illiopsoas, gluteus maximus and medius, hamstrings, quadriceps, adductors, tibialis 
anterior and plantar flexors of the feet in patients aged 5 years and older. The muscle sum 
score ranged between 34 and 170 (MRC 0 and MRC 1 were combined and given a score 
MRC 1). We used the Hammersmith Functional Motor Scale Expanded (HFMSE) to score 
motor function in all patients.
16, 17
 The intra-rater test-retest variability showed a mean 
difference of 0.4 points (SD 2.7; SE 0.9; 95% CI -1.9–2.65). 
 
Magnetic Resonance Imaging of the temporomandibular joint and associated muscles 
MRI (Philips Achieva 3T, Sense Head 8-channel, Best, the Netherlands) of the TMJ, muscle 
groups involved in mouth opening (lateral pterygoid muscle, anterior belly of the digastric 
muscle, geniohyoid muscle) and mouth closing (masseter muscle, temporalis muscle, medial 
pterygoid muscle) and the neck extensors was performed in 12 adult patients with SMA type 
Chapter 4 
63 
 
2-4 and a 25-year old control subject. Patients were recruited from 47 eligible adults without 
exclusion criteria for MRI (i.e. signs of nocturnal hypoventilation, severe swallowing 
difficulties, > 15% forced vital capacity postural change between sitting and supine, presence 
of MRI incompatible spinal rod fixation material) who were asked by letter wether they were 
interested to participate.  
 T1-weighted and T2-weighted images with a slice thickness of 3 mm were 
generated in the transverse and (oblique) sagittal planes. TMJ anatomy and dynamics, e.g. 
condylar shape and sliding of the mandibular condyle relative to the articular tubercle, were 
investigated in oblique sagittal images perpendicular to the long axis of the condyles for each 
joint in closed- and open mouth positions. The latter position was maintained by means of a 
perspex bite block between the incisors. 
 A radiologist (T.D.W.) and a dental specialist (M.H.S.) who were blinded for 
patient characteristics independently scored the images (Cohen’s kappa between investigators 
=  0.8). Disagreement between scores was resolved by reaching consensus. Fatty muscle 
degeneration was graded on a four-point-scale (1 = normal; 2 = mild atrophy or fatty 
infiltration; 3 = severe atrophy or fatty infiltration; 4 = complete atrophy or fatty 
infiltration).
18
 Condylar shape and condylar sliding were scored as normal or abnormal. 
Condylar sliding was assessed as abnormal when in the open mouth position the mandibular 
condyle did not protrude to or beyond the crest of the articular eminence.  
 
Standard protocol approvals, registrations, and patient consents 
The Medical Ethical Committee of the University Medical Center Utrecht approved the 
research protocol. All patients and parents of patients younger than 18 years gave informed 
consent prior to inclusion. This study was registered at the Central Committee on Research 
involving Human Subjects, the Dutch registry for clinical trials.  
 
Statistics 
We tested normality with the Kolmorogov-Smirnov and Shapiro-Wilk Test. Disease duration 
and the age at inclusion had a very high correlation (R
2 
= 0.94). Therefore, multivariate 
analyses were checked and corrected for colinearity. P values of < 0.05 were considered 
significant. Correlations were analyzed using Spearman’s rho. Comparisons of clinical 
characteristics (e.g. age, disease duration, MRC sum score, HFMSE, aMMO, presence of 
dysphagia) between SMA types were performed using Kruskal-Wallis or Mann-Whitney U 
test (continuous data) or Chi-square/Fisher Exact analysis (dichotomous data). Univariate and 
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multivariate tests including dichotomous data were performed using (binary or multinominal) 
logistic regression. Multivariate linear regression analyses were performed with items that 
showed significant associations in univariate linear regression analysis. Receiver-operating 
characteristics (ROC) curves were generated to analyze the predictive value of clinical motor 
scores and aMMO for the presence of dysphagia. We used SPSS (IBM SPSS Statistics 
version 19, Chicago, IL) for statistical analysis. 
 
Results 
Patient characteristics 
Patient characteristics are summarized in Table 4.1. Thirty-five percent of patients reported 
dysphagia or choking (Table 4.1). The majority of patients reported that they tried to prevent 
dysphagia and choking by changing the consistency of their food or posture during 
mealtimes.
12, 14
 Sixteen patients (14%) out 115 patients with SMA types 1-3a had a history of 
recurrent choking. Six (4%) patients (3 type 1, 1 type 2, 1 type 3a and 1 type 3b) used a nasal-
gastro- feeding tube and 13 patients (9%) with SMA types 1 and 2 had a percutaneous 
endoscopic gastrostomy. 
 
Active maximum mouth opening 
All healthy controls had aMMO of > 35 mm and reduced aMMO was therefore defined as ≤ 
35 mm. aMMO was reduced in 57% of all patients and 100%, 79%, 50% and 7% of patients 
with SMA types 1, 2, 3a and 3b/4 respectively (Table 4.1). aMMO differed between SMA 
types (p < 0.01). These differences between SMA types were apparent from an early age on 
(Figure 4.1). aMMO declined with age and disease duration in patients with SMA type 1 and 
2 (age: correlation coefficient -0.25, p = 0.02; disease duration: correlation coefficient  
-0.28, p = 0.01) (Figure 4.1). 
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Table 4.1. Patient characteristics 
 
Legend: F=female; M=male; MRC= medical research counsil; HFMSE= hammersmith functional motor scale; 
aMMO = active maximum mouth opening. aAll patients with Spinal Muscular Atrphy type 1 in this study 
survived infancy. 
 
MRI of TMJ and associated muscles 
MRI (Figure 4.2, Table 4.3) showed severe to complete atrophy and fatty infiltration of the 
lateral pterygoid muscle, which is the most important muscle for mouth opening by mediating 
sliding of the mandibular condyle, in all patients with SMA type 2 and 3a who had reduced 
aMMO. The anterior belly of the digastric muscles and geniohyoid muscles, involved in the 
first phase of swallowing and opening of the mouth by depressing the mandible, were 
moderately affected. In contrast, mouth-closing muscles, i.e. the masseter and temporalis were 
less affected and the medial pterygoid muscle was relatively spared in all patients (Table 4.2). 
Fatty infiltration and severe atrophy of the neck extensors were present in patients with and 
without reduced aMMO.  Impaired condylar sliding occurred only in patients with mild-to-
severe atrophy and/or fatty infiltration of lateral pterygoid muscles. 
 All 
(n=144) 
Type 1
a 
(n=11) 
Type 2 
(n=76) 
Type 3a 
(n=28) 
Type 3b 
(n=27) 
Type 4 
(n=3) 
Gender (F:M) 81:64 6:5 46:30 15:13 12:15 2:1 
Mean age at inclusion, yrs  
(range) 
25.3 
(1.8 – 78) 
20 
(4.1 – 48.9) 
18.4 
(1.8 – 65.7) 
30.5 
(2.3 – 64.7) 
38.8 
(14 – 78) 
48.0 
(41.3 – 52.5) 
Mean age at onset, mths  
(range) 
39.6  
(1 – 510) 
4.9 
(1 – 8) 
11.3 
(3.5 – 30) 
19.8 
(6 – 54) 
114.9 
(42 – 294) 
444  
(366 – 510) 
Mean disease duration, yrs  
(range) 
21.8 
(0.7 – 64.8) 
20.5 
(3.8 – 8.4) 
17.2 
(0.7 – 64.8) 
28.8 
(1.2 – 62.2) 
32.2 
(1.1 – 71.4) 
10.9  
(7.5 – 14.5) 
Mean MRC sum score  
(range) 
101 
 (34 – 167) 
58 
(34 – 82) 
87 
(39 – 140) 
108 
(54 – 160) 
142 
(87 – 167) 
156 
(147 – 162) 
Mean HFMSE score  
(range) 
15 
(0 – 66) 
0 
(0 – 1) 
8  
(0 – 40) 
20  
(0 – 49) 
34 
(2 – 66) 
48  
(43 – 53) 
aMMO, mm  
(range) 
31.4 
 (3 – 60) 
10.5  
(3 – 20) 
26.7  
(4 – 55) 
35.6  
(15 – 50) 
46.6  
(20 – 60) 
50  
(50) 
Reduced aMMO, n (%) 83 (57) 12 (100) 55 (79) 14 (50) 2 (7) 0 (0) 
Tongue fasciculations, n (%) 81 (60) 10 (100) 54 (76) 10 (37) 5 (20) 2 (67) 
Eating problems, n (%) 65 (45) 7 (64) 15 (21) 4 (17) 1 (4) 0 (0) 
Dysphagia, n (%) 46 (32) 7 (64) 27 (36) 11 (39) 1 (4) 0 (0) 
Choking, n (%) 16 (11) 6 (55) 9 (12) 1 (4) 0 0 (0) 
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In two out of 3 patients with SMA types 3b/4 and normal aMMO, MRI assessment did 
not show any abnormality of the muscles involved in mouth opening or closing, whereas the 
MRI of the third patient showed mild fatty infiltration of the lateral pterygoid mucles. 
 
 
Figure 4.1.  Correlation between age and aMMO. Active maximum mouth opening (aMMO) showed a 
correlation with age in patients with SMA type 1 and 2 (spearman’s rho -0.25, p = 0.02). The decline in patients 
with SMA type 3 with age was not significant (spearman’s rho -0.79, p = 0.56). The dotted line represents the 
lower limit of normal of aMMO (35 mm). 
 
Table 4.2. Characteristics of healthy controls 
 Healthy controls 
 All 
(n=119) 
Children  
<10 years (n=23) 
Children  
10-18 years (n=40) 
Adults 
(n=56) 
Gender F:M 58:61 11:12 18:22 28:28 
Mean age, yrs 
(range) 
12  
(5 – 41) 
7  
(5 – 9) 
14  
(10 – 17) 
24  
(18 – 41) 
aMMO, mm  
(range) 
51  
(38 – 65) 
48 
(38 – 54) 
50  
(42 – 60) 
53  
(40 – 65) 
Chapter 4 
67 
 
  
 
 
Figure 4.2.  MRI of bulbar muscles in a patient with SMA and a healthy control. 
Representative T2 Weighted MR Imaging results of patient 3 with SMA type 2 (panels A-B) and subject 13, a 
healthy control (panels C-D). Left panels (A and C) show masseter (closed arrow) and medial pterygoid muscles 
(dotted arrow); right panels (B and D) show lateral pterygoid muscles (arrow). Note the severe atrophy and fatty 
infiltration of lateral pterygoid muscles and mild abnormalities in medial pterygoid muscles and masseter in 
patient 3 compared to the normal aspect of all muscles in the control (subject 13). 
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Table 4.3. MR Imaging patient characteristics 
Legend: aMMO= active maximum Mouth Opening; MRC= Medical Research Council; HFMSE= Hammersmith 
Functional Motor Scale Expanded; TMJ= temporomandibular joint; Scores used for fatty degeneration of bulbar 
muscles; 0 = normal; 1 = mild atrophy or fatty infiltration; 2 = severe atrophy or fatty infiltration; 3 = complete 
atrophy or fatty infiltration.  Condylar surface and condylar sliding were assessed on a two point scale: 0 = 
normal and 1 = abnormal.  
 
Association of reduced aMMO with dysphagia, eating problems and choking 
The presence of fasciculations in the tongue, dysphagia, eating problems or choking events 
and characteristics associated with disease severity, including SMA type, age at onset, MRC 
score of the neck flexors and extensors, HFMSE and MRC sum scores, correlated with 
aMMO in univariate linear regression analysis  (all p < 0.05). Dysphagia was associated with 
muscle weakness of the neck muscles (log regression p < 0.001). Multivariate linear 
regression analyses showed that reduced aMMO (p = 0.01) and lower MRC sum score (p = 
0.01) in SMA types 1 and 2 were determinants of dysphagia. ROC analysis showed fair 
predictive value (PV) of the presence of dysphagia for reduced aMMO (area under the curve, 
AUC 0.71) or MRC sum score (AUC 0.77) and good PV for HFMSE (AUC 0.81) (Figure 
4.3). 
 
 
 Spinal muscular atrophy  
Type 2 Type 3 Type 4 Control 
1 2 3 4 5 6 7 8 9 10 11 12 13 
Disease duration, yrs 55.7 16.8 36.7 23.6 29.4 33.6 45.3 25.5 18.7 28.7 26.3 10.8 NA 
MRC sum score 99 96 55 113 76 95 112 141 123 142 141 148 0 
HFSME 1 2 0 6 2 0 4 22 18 47 32 43 0 
aMMO, mm 25 28 10 40 15 25 45 30 30 45 42 50 50 
Neck muscle score 3 3 3 2 3 2 2 1 2 0 0 1 0 
Lateral pterygoid score 1 2 3 1 3 2 1 1 2 0 1 0 0 
Masseter score 1 1 2 1 2 2 0 0 1 0 0 0 0 
Temporalis score 0 2 2 1 2 2 0 0 1 0 0 0 0 
Geniohyoid score 0 1 1 0 2 1 1 0 1 0 0 0 0 
Digastric score 1 1 1 0 1 1 1 0 1 0 0 0 0 
Medial pterygoid score 0 1 1 0 1 0 0 0 1 0 0 0 0 
TMJ Condylar sliding 1 1 1 0 1 1 0 0 1 0 0 0 0 
Condylar surface 0 0 0 0 0 0 0 0 0 0 0 0 0 
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Figure 4.3. Prediction of presence of dysphagia. ROC curves of clinical scores (MRC score, HFMSE and 
aMMO) reflecting their respective predictive values for the presence of dysphagia. HFMSE area under the curve 
(AUC) 0.81, MRC sum score AUC 0.77 and aMMO AUC 0.71. Cut-off value for reduced aMMO was set at  
35 mm. 
 
Discussion 
Reduced aMMO is a common complication in patients with SMA, in particular those with 
SMA types 1 and 2. MRI of bulbar muscles in 12 patients showed that reduced aMMO is 
caused by impaired condylar sliding due to severe fatty degeneration of the lateral pterygoid 
muscles with relative sparing of muscles that mediate mouth closing. Reduced aMMO is 
associated with self-reported chewing difficulties, frequent choking and dysphagia suggesting 
that it may reflect a more general process of bulbar motor neuron degeneration in patients 
with SMA. 
Few studies have investigated the cause and impact of dysfunction of bulbar muscles 
in patients with SMA.
7-11, 14
 Evidence for the involvement of bulbar motor neurons comes 
from clinical and pathological observations, e.g. the frequent finding of fasciculation in the 
tongue and post-mortem studies that showed degeneration of motor nuclei in the brainstem of 
severely affected patients.
7-9
 Several surveys furthermore reported a high frequency of feeding 
difficulties and dysphagia.
10, 11, 14
 The current view is that dysphagia is a multifactorial 
complication to which both weakness of bulbar and neck extensor muscles contribute.
10-15
 
This is compatible with the pattern of fatty degeneration of the anterior digastric, geniohyoid 
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and neck muscles on the MRI scans of our patients. Mouth opening and closing are mediated 
by a relatively limited number of muscle groups in comparison to swallowing and limitations 
in mouth opening may therefore more accurately reflect involvement of bulbar motor nuclei 
in SMA pathogenesis than dysphagia. 
Strengths of this study are the large number of patients of all ages encompassing 
nearly the full clinical spectrum of SMA, the large control group and the approach of MRI. It 
should be noted that patients with SMA type 1 included in this study were unusual in the 
sense that they all survived infancy and represent a subgroup of patients with long survival as 
reported previously
3, 19-22
 We used a strict definition of reduced aMMO (i.e. ≤ 35mm), based 
on the aMMO range in 119 Dutch healthy individuals, which virtually precludes the 
possibility that we overestimated prevalence of reduced aMMO. Similar definitions for 
healthy individuals, varying between 40 – 44 mm for men, 38 – 42 mm for women and 35 – 
38 mm for children, were used in previous studies.
23-25 
Our prevalence figure of reduced 
aMMO is nevertheless higher than reported in previous studies. Limitations in mouth opening 
were self-reported by only 30% of Italian patients with SMA type 2 and 11% of Taiwanese 
patients with SMA types 2 and 3.
10, 11
 Many Dutch patients were not aware that they had a 
significantly reduced aMMO, which implies that previous self-reporting surveys may have led 
to underestimation of the true prevalence. This may be partially explained by gradual 
adaptation to slow progression. Progression of aMMO limitations is suggested by the 
correlation of reduced aMMO with advancing age and longer disease duration, but this should 
be established in longitudinal studies.  
MRI is a useful technique to document specific patterns of fatty degeneration and 
atrophy in myopathies and other neuromuscular disorders and yields sufficient anatomical 
detail of the TMJ.
26
 In patients with reduced aMMO, MRI showed normal condylar shape but 
impaired condylar sliding and marked fatty degeneration and atrophy of the lateral pterygoid 
muscles. Muscles that mediate mouth closing, i.e. the masseter, temporalis and medial 
pterygoid muscles and other muscle groups than the lateral pterygoid muscles that mediate 
mouth opening, i.e. the anterior digastric and geniohyoid muscles, were relatively spared. This 
pattern explains the reduction in mandibular protrusion, laterotrusion and maximum opening 
of the jaw that was previously reported in patients with SMA.
13, 15
 Normal aMMO is achieved 
through a combination of rotation, mediated by the submandibular muscles which allows the 
first 20–30 mm mouth opening and condylar sliding that in combination with further rotation 
allows for a mouth opening up to 50–60 mm in healthy individuals. The lateral pterygoid 
muscles mediate condylar sliding and thereby horizontal mandibular movements and 
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counteract the retrusive forces of the geniohyoid and anterior digastric muscles during mouth 
opening, thus allowing mouth opening beyond 25–30 mm. Fatty degeneration and atrophy of 
the lateral pterygoid muscles will therefore lead to reduced or total absence of condylar 
sliding, causing severely reduced aMMO. aMMO of 20 mm or less is often associated with 
intra-articular pathology such as adhesions. This may occur secondary to significant 
degeneration of the lateral pterygoid muscle as suggested by the abnormal TMJ mobility in 
patients with SMA and severely reduced aMMO (i.e. Table 4.2, patients 1 – 3, 5, 6 and 9).  
Post-mortem studies showed degeneration of motor neurons in the brainstem of 
patients with SMA with a caudo-cranial gradient. The trigeminal motor nucleus was affected 
in patients with severe SMA, but less than lower cranial nerve nuclei.
7
 The high prevalence of 
reduced aMMO in patients with SMA suggests that motor neuron loss in the trigeminal 
nucleus is probably more common than reported in previous pathological studies. We can 
only speculate what causes the specific pattern of bulbar muscle involvement. Differences in 
motor unit size might explain differences in muscle atrophy and degeneration. Alternatively, 
specific motor neuron pools or specific bulbar muscle groups may differ in vulnerability to 
SMN deficiency. 
A weakness of our study is the fact that we used a questionnaire, which has been used 
previously in SMA studies, rather than video-fluoroscopy (VFSS) to assess the presence and 
severity of swallowing difficulties. Longitudinal studies using both MRI and VFSS in a larger 
number of patients are needed to investigate the natural history of changes in bulbar muscle 
composition and function in relation to aMMO and dysphagia. We did not include children 
with SMA and can therefore not conclude at which age muscle changes start to occur. Finally, 
we did not perform follow-up MRI to analyze the speed of progression of atrophy and fatty 
degeneration.
14
  
Dysphagia or choking were reported by 35% of our patients with reduced aMMO, 
figures slightly higher than in previous reports, but nevertheless self-reporting may not be 
sufficiently sensitive to detect early symptoms of dysphagia and swallowing problems.
10, 11
 
Reduced aMMO may compromise eating and interfere with maintaining body weight, oral 
hygiene, and dental and medical care. One of our patients (39 years of age) with a aMMO of 8 
mm experienced that intubation prior to elective surgery had become impossible. This shows 
that reduced aMMO affects patient safety and quality of life and that efficacy of interventions 
that prevent progression should be investigated. A second reason why measuring aMMO 
should be incorporated in the follow-up of patients with SMA is the finding that reduced 
aMMO is associated with an increased risk of dysphagia and choking. ROC characteristics of 
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aMMO suggest that it may represent an easy tool to assess the risk of involvement of bulbar 
muscle groups and dysphagia in patients with SMA, but this needs further study. 
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Abstract  
Objectives: Patients with Duchenne muscular dystrophy  (DMD) report masticatory and 
swallowing problems. Such problems may cause complications (e.g. choking, the feeling of 
sticking food in the throat). We investigated whether masticatory performance in DMD is 
objectively impaired, and explored predictive factors for compromised mastication.  
Methods: Twenty-three patients and 23 controls filled out two questionnaires about 
mandibular function, and underwent a clinical examination of the masticatory system and 
measurements of anterior bite force and masticatory performance. In the patients, moreover, 
quantitative ultrasound of the tongue and Motor Function Measurement (MFM) was 
performed. The patients were categorized into ambulatory stage (early or late), early non-
ambulatory stage, or late non-ambulatory stage. 
Results: Masticatory performance, anterior bite force and occlusal contacts were all reduced 
in the patient group compared to the controls (all p < 0.001). Mastication abnormalities were 
present early in the disease process prior to a reduction of MFM. The early non-ambulatory 
and late non-ambulatory stage groups showed less masticatory performance compared to the 
ambulatory stage group (p < 0.028 and p < 0.010, respectively). Multiple linear regression 
analysis revealed that stage of the disease was the strongest independent risk factor for the 
masticatory performance (R
2 
= 0.52).  
Conclusions: Anterior bite force, occlusal contacts and masticatory performance in DMD are 
severely reduced.  
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Introduction 
The most prevalent type of muscular dystrophy in children is Duchenne Muscular Dystrophy  
(DMD), which is characterized by a progressive loss of muscle cells and replacement by fat 
and connective tissue .
1
 DMD is an X-linked recessive disorder or is a consequence of de 
novo gene mutation. It is caused by a defective gene for dystrophin, an essential component of 
the dystrophin–glycoprotein complex (DGC) maintaining the membrane integrity of muscle 
fibers.
2
 DMD has an incidence of about 1: 3500 live male births.
3
 The onset of DMD 
symptoms occurs at around 2 to 6 years of age. Untreated, muscle strength deteriorates, and 
boys require the use of a wheelchair before their teens.
4 
  
Medical care for patients with DMD, which encompasses medical, surgical, and 
rehabilitation approaches, has improved the quality and duration of life. As a consequence of 
the increased duration of life, the non-fatal medical complications of the disease, among 
which mastication and swallowing difficulties, are now requiring more attention.
5  
  
The subjective experience of mastication and feeding problems in DMD has 
previously been documented using questionnaires, yet not objectively using masticatory 
performance tests. Mastication problems may induce post swallow residue, which has been 
suggested to possibly contribute to a greater risk of food aspiration.
6-9
 Video fluoroscopic 
swallow studies showed an increased pharyngeal post swallow residue of solid food in 
advanced stages of DMD.
10 
  In general, the dominant factors influencing masticatory performance are the number 
of occlusal contacts and bite force.
11
 Furthermore tongue function is of importance because of 
its role in food-bolus mixing and positioning.
12
 Since masticatory performance of DMD 
patients has so far not been assessed objectively, it is yet unclear which factors influence the 
masticatory performance in these patients.  
  The aim of this study is to compare the masticatory performance of patients with 
DMD and an age matched healthy control group, and to assess predictive factors for the 
masticatory performance. 
 
Methods 
The study was approved by the Committee on Research Involving Human Subjects of 
Arnhem and Nijmegen, the Netherlands (registration number 2009/331). 
 
Participants 
A case-control study design was used. Twenty-four patients with DMD from 6 to 38 years, 
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and 24 age-matched male healthy controls were recruited between May 2010 and February 
2012. Age limits were set above 5 years to ensure that the participants were capable of 
undergoing all physical examinations and of filling out questionnaires, whenever needed with 
the help of their caretakers.  
The patients with DMD originate from the cohort of the swallowing study of van den 
Engel-Hoek et al. 2013.
11
 They were recruited by announcements of patient organizations. 
These patients had a genetically confirmed diagnosis of DMD, or a diagnosis of DMD as 
defined by the onset of symptoms and disease course of DMD. DMD patients who were 
entirely dependent on tube feeding were excluded. 
The control group was recruited at a primary and a secondary school located in the 
western part of the Netherlands, and consisted of children and parents. Controls above 18 
years were as well recruited at the College of Dental Sciences, Nijmegen, the Netherlands. 
Exclusion criteria for healthy controls were: a history of neuromuscular disease, 
temporomandibular disorder, orthodontic treatment and the morphologic dental malocclusions 
cross bite or tendency to cross bite. 
 Eligible participants and their parents were sent information letters with an invitation 
to participate in the study. After receiving informed consent from the adults or parents, and – 
if the subjects were older than 12 years – also from the participants, the participants 
underwent all examinations in the hospital during one day.  
 
Protocol 
The participants in both the patient and the control group, completed structured 
questionnaires, and underwent a clinical examination of the masticatory system, anterior 
maximum voluntary bite force (MVBF) and food mixing ability measurements. Additionally, 
the patients underwent quantitative muscle ultrasound imaging (QMUS) of the tongue, and an 
assessment of their general physical abilities.
13
  
 
Questionnaires 
The patient group and the control group completed two questionnaires: Screen and the 
Mandibular Functional Impairment Questionnaire (MFIQ).
14-16
 Screen contains questions 
related to: (1) quantitative and qualitative aspects of pain in the head, neck and shoulders such 
as the pain location(s) (which the patient could mark on a drawing of the head, neck and 
shoulders), the pain intensity as reported on a Visual Analogue Scale (VAS), and factors 
influencing pain; (2) symptoms of temporomandibular dysfunction such as joint noises, 
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limited mouth opening and mastication difficulties; (3) oral habits, such as tooth-grinding and 
clenching; and (4) general health factors (e.g. medication, family history). MFIQ was 
designed to measure impairments of the function of the masticatory system. MFIQ consists of 
17 questions, which can be subdivided into two dimensions - functional capacity and feeding, 
and is rated on a 5-point Likert scale ranging from ‘0’ (no difficulty) to ‘4’ (very difficult or 
impossible without help). The ratings are added to give a sum score (S, range 0–68). A higher 
score indicates more perceived mandibular function impairments and a MFIQ score of ‘0’ 
indicates no impairment in mandibular functioning. The raw score of the MFIQ-scale (C, 
range 0–1) is obtained by dividing the sum of the items by four times the number of the items 
(C = S/68). The raw score can be converted to a qualitative level of impairment: no/low (I), 
moderate (II) and high (III). Previous studies have considered the MFIQ to be a reliable and 
valid tool.
17 
 
Clinical examination of the masticatory system 
All participants in this study were clinically examined following a validated procedure as 
described by Lobbezoo-Scholte et al. (1993, 1994).
18,19
 This clinical examination included, 
among others, measurement of the mandibular range of motion, palpation of the masticatory 
muscles and the temporomandibular joints and the number of occlusal contacts (OC-score). 
Moreover, the dental occlusion of the participants was evaluated regarding (tendency to) cross 
bite. OC-scores between the premolar and molar teeth of the upper and lower jaw after the 
teeth were brought into occlusion were assessed using wax records (Moyco beauty pink plate 
wax, 2270 g). A perforation in the wax record indicated an occlusal contact. Unilaterally, the 
maximum OC-score is 5 (1 OC per posterior occluding pair); bilaterally the maximum is 10. 
The dental occlusion, defined as the static relationship between the masticating surfaces of the 
maxillary or mandibular posterior teeth, was assessed regarding the presence or absence of 
uni- or bilateral abnormal transverse relationship of single or multiple posterior teeth (i.e., 
premolars or molars). Tendency to cross bite was noted when the maxillary and mandibular 
(pre)molar(s) were in cusp-to-cusp occlusion (Figure 5.1). Cross bite was noted when the 
maxillary posterior teeth are in lingual position in relation to the mandibular posterior teeth 
(Figure 5.1).  
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Figure 5.1.  Dentition in maximal intercuspal position. Dentition of a healthy subject (A), and 3 patients with 
DMD;  ambulatory stage (AS) (B), early non-ambulatory stage (ENAS) (C), late non-ambulatory stage (LNAS) 
(D). (A) Healthy subject; age 14; occlusal contacts 8; no cross bite L/R (see arrow). (B) AS; age 8; occlusal 
contacts 3; tendency to cross bite L/ R. (C)  ENAS; age 11; occlusal contacts 2; cross bite L/ R. (D)  LNAS; age 
21; occlusal contacts 2; cross bite L/ R. 
 
Measurement of the anterior maximum voluntary bite force  
To measure the bite force, the VU University Bite Force Gauge (VU-BFG) was used.
20
 It is a 
handheld device which uses a load cell (LPM 510 250lb) to measure maximum voluntary bite 
force (MVBF) in kg. The handheld device consists of a strain gauge mounted on a 
mouthpiece which is 11 mm high and 15 mm wide. The VU-BFG measures bite forces 
ranging between 0 to 490 N in a linear fashion. The bite force transducer was calibrated at the 
VU University Amsterdam, the Netherlands, before, half way and at the end of the data 
collection. Measurements were taken using the following protocol. The strain gauge element 
was placed parallel with the Frankforter horizontal, between the upper and lower central 
incisors and midway between the central maxillary incisors, with the metal edge mounted on 
the top surface of the mouthpiece against the upper central incisors. Patients and controls 
clenched as hard as possible for 3 seconds, during which the peak maximum bite force was 
recorded. They repeated clenching three times with an interval of 30 seconds rest periods; the 
highest value of the three measurements was used as the anterior MVBF. The participants 
were instructed in a similar way, by repeating the words ‘as hard as possible’ three times. The 
similar procedure was performed between the upper and lower canines on the left and right 
side. 
 
Mixing ability test 
In all participants, masticatory performance was measured using the mixing ability test.
21
 A 
wax tablet consisting of a red and a blue wax layer was offered to the subjects (tablet at room 
temperature, 20 °C). Each participant performed 20 chewing strokes on a tablet, and as a 
result the colours would mix. The degree of mixing represented the masticatory performance.  
The chewed wax is flattened and photographed from both sides with a high-quality scanner 
(Epson_ V750, Long Beach, CA, USA). The spread of the colour intensities in the combined 
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image of both sides is the measure of mixing. The images of the wax are processed using 
Adobe Photoshop, CS3 extended (Adobe, San Jose, CA, USA). The intensity distributions of 
the red and blue channels are exported as 8-bit histograms. The histograms of both sides of 
the wax are added to obtain the red and blue intensity distributions of the combined image of 
both sides of the flattened wax. These histograms are analyzed to obtain a measure for the 
mixing of the wax: the mixing index. 
 
Echo intensity imaging of the tongue  
In the patient group, QMUS was used to measure echo intensity of the longitudinal superior 
and transverse tongue muscles, and thickness of the tongue.
13
  The region of interest was 
quantified by grey-scale analysis and calculation of z scores (i.e. the amount of standard 
deviations below or above the mean of norm values); a reliable method in which changes in 
muscle architecture are assessed and compared with norm values.
22
 QMUS of the tongue 
proved to be feasible in healthy children and young adults, and is used for detection of 
structural changes of, among others, tongue muscles.
13 
 
Medical information and physical abilities  
In the patient group, information was gathered about the age of onset of DMD, body mass 
index, the use of ventilation support, swallowing difficulties, prolonged mealtime, food 
adaptation and the medication used in previous years (i.e. prednisone, and antibiotic therapy 
for chest X-ray proven pneumonia in the past year).  
  Baseline gross motor function was assessed in all patients by a physical therapist with 
expertise in paediatrics using the Motor Function Measure (MFM). MFM is a quantitative 
scale that enables measuring the functional motor abilities of a person affected by a 
neuromuscular disease. MFM consists of 3 domains: D1 standing position and transfers, D2 
axial and proximal motor function and D3 distal motor function. In this study, we used items 
13 to 23 of domain 2 and 3 which are designed to collect information about the sitting 
position, arm function, and neck and head control.
23
 The items were scored on a four-point 
Likert scale and summed to comprise a total score expressed as a percentage of the maximum 
score (range 0–100), in which the maximum represents normal motor function. In this study 
calculation of the data is performed by using the raw score of the MFM items 13 to 23 (range 
0–33).  
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Based on the ambulatory function and the MFM, the patients were divided in three 
subgroups: early and late ambulatory stage (AS), early non-ambulatory stage (able to maintain 
posture) (ENAS), or late non-ambulatory stage (upper limb function and postural maintenance 
is increasingly limited) (LNAS).
24 
 
Statistical analysis 
IBM SPSS version 20 was used to analyse the collected data. The level of significance was set 
at p = 0.05. Descriptive statistics in terms of mean and standard deviation were used to 
describe the independent scale variables in the patient and control group. Paired Student’s t-
test was used to compare between-group continuous variable outcomes, and for dichotomous 
variables the chi-square test was used. 
The collected data within the patient group were further analysed using the 3 DMD 
stages. To compare test outcomes between the DMD stages ANOVA was used for scale 
variables and chi-square test for dichotomous variables. 
Univariate linear regression analyses were performed to determine which factors 
(independent variables) possibly affect the mixing ability in the patient group (dependent 
variable). The independent variables were age, ambulatory stage, anterior MVBF, OC score, 
QMUS of the tongue and tongue thickness. The independent variables, which were possibly 
associated with the mixing ability (p < 0.01) were included in a multiple linear regression 
analysis (stepwise backward method; p-value to remove > 0.05) in order to determine the set 
of variables that best predict impaired chewing in DMD patients.  
 
Results 
Participants 
Twenty-four patients with DMD were approached for inclusion in the study. One of the 
patients was excluded from the study because DMD was not genetically confirmed, and the 
signs and symptoms did not fit into the DMD diagnosis. For analysis, the data of 23 patients 
and 23 age-matched male controls were used (Table 5.1). Patient characteristics of the total 
DMD sample as well as of the three stage groups can be seen in Table 5.2.  
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Table 5.1. Group comparison and descriptive statistics of the anterior maximum voluntary 
bite force (MVBF) in Newton and mixing ability during clinical examination in the patient 
group (MVBF, n = 23; mixing ability, n = 22) and in the control group (MVBF and mixing 
ability, n = 23). Mean and standard deviation of the measurements are referred to as x  (SD). 
 
 
 
 
 
 
 
 
 
 
 
 
 
* = Statistically significant differences.
 
a
Mixing ability: individual’s capacity to grind a two colored wax tablet during 20 strokes of chewing (n = 22 in 
patient group). 
b
Anterior MVBF: maximum vertical interocclusal bite forces between the central incisors of the upper and lower 
jaw. 
 
Questionnaires  
Screen and anamnestic information 
Thirteen patients (57%) mentioned mastication difficulties. In two patients, the mastication 
problems interfered with daily and social activities. Prolonged meal-time (> 30 min.) was 
reported during history taking by patients, parents or caretakers in 15 patients (65%). 
Swallowing difficulties were reported by 15 patients (65%) (Table 5.2). The controls did not 
report mastication difficulties. 
Mandibular Function Impairment Questionnaire  
One patient (4%) reported severe mandibular function impairment, 7 (30%) a moderate 
impairment, and 15 patients (65%) reported no/low impairment. There was a statistically 
significant difference between the ENAS and LNAS and between the AS and LNAS in terms 
of mandibular function. Information on food adaptation by the patients, derived from the 
MFIQ showed that 12 patients (52%) had to adjust their food (Table 5.2). There was a 
significant correlation between the reported food adaptation and prolonged mealtimes  
Clinical examination Patient group Control group P-value 
Age 
range 
16.7 (7.7) 
6.3 – 38.1 
16.3 (6.7) 
 6.1 – 30.2  
0.851 
Mixing ability
a 
range 
25.1 (3.7) 
17.3 – 30.2 
18.2 (2.8)  
12.7 – 22.8 
<0.001* 
Anterior MVBF
b 
range  
87.5 (35.5) 
10.8 – 171.6 
160.6 (88.4) 
43.1 – 332.4 
 0.001* 
Occlusal contacts           
range 
3.2 (2.4)  
0 – 8 
6.8 (1.3)  
4 – 8  
<0.001* 
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(p = 0.009). The controls did not report impairment of the mandibular function.  
 
Clinical examination of the masticatory system 
The OC score in the posterior teeth of the upper and lower jaws was reduced in > 50% of the 
patients (average OC score 3.2, SD 2.4, range 4–8) compared with the controls (average OC 
score 6.8, SD 1.3, range 0–8) (Table 5.1). In the patient group, reported mastication 
difficulties (p = 0.008), more masticatory functional impairment (p < 0.001), a thicker tongue 
(p = 0.001) and increased echo intensity of the longitudinal tongue muscle (p = 0.016) 
correlated with less occlusal contacts.  
In the patient group, 23 (100%) showed malocclusions; lateral cross bites on the left 
and/or right side were present in 17 patients (74%) and tendency to cross bite in 6 patients 
(26%) (Table 5.2). (Tendency to) cross bite is highly prevalent already in the AS group (viz., 
in 100% of the AS patients there was either a tendency to cross bite or a full cross bite), while 
MFM-score in this group is hardly reduced (MFM score 98.2).   
 
Maximum voluntary bite force  
The anterior MVBF was significantly weaker in the patient group compared with the control 
group (Table 5.1). The DMD group was able to exert an average anterior MVBF of 87.3 N 
(SD 35.3, range 10.8 – 171.6 N), compared with 160.8 N (SD 88.3, range 43.4 – 332.4 N) for 
the control group. In the control group the MVBF was not significant correlated with age  
(p = 0.106).   
 
Mixing ability test 
One out of 23 patients was excluded from this analysis because of fear to choke when 
chewing the tablet. The masticatory performance was significantly worse in the patient group 
(mean mixing ability index 25.1, SD 3.7) compared with the control group (mean mixing 
ability index 18.2, SD 2.8) (Table 5.1). There was a statistically significant difference 
between the ENAS and LNAS in terms of masticatory performance (Table 5.2).  
Imaging of the tongue  
The echo intensity of the tongue muscles, expressed as z-score, showed a gradual increase 
among the three DMD stages; mainly in the LNAS echo intensity of the tongue was increased 
(z > 2). There was a statistically significant difference between the ENAS and LNAS and 
between the AS and LNAS regarding the superior longitudinal and transverse muscle of the 
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tongue (Table 5.2).  
  Tongue thickness in the AS was for all patients within the normal range (z-score <2), 
but not in the ENAS and LNAS (Table 5.2). There was a statistically significant difference 
between the AS and ENAS and AS and LNAS in terms of tongue thickness (Table 5.2).  
Tongue thickness and OC score were significantly negatively correlated (p = 0.001).   
 
Physical abilities  
In our patient group, the measures of motor function by MFM showed a decline with losing 
the ambulatory function. There was a significant difference in the MFM score between the 
ENAS and LNAS and AS and LNAS regarding the MFM total score (Table 5.2). 
 
Predictive factors for masticatory performance 
Univariate linear regression analysis of potential determinant of compromised masticatory 
performance are indicated in Table 5.3. The univariate linear regression analysis revealed a 
negative correlation between masticatory performance and DMD stage (ENAS), and the 
anterior maximum voluntary bite force. Multiple linear regression analysis revealed ENAS 
DMD stage to be the most significant factor for masticatory performance (R
2
 = 0.52, Table 
5.4). 
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Table 5.2.   Characteristics of patients with Duchenne muscular dystrophy  (n = 23) presented 
by stages. Mean and standard deviation of the measurements referred to as x  (SD) and number 
of patient as n / %.  
  DMD stage p-value 
 Total  
(n=23) 
AS (1) 
(n=6) 
ENAS (2) 
(n=7) 
LNAS (3) 
(n=10) 
1-2 2-3 1-3 
Mean age, yrs.mo 
range 
16.7 (7.7) 
6.3 – 38.1 
8.4  (1.5) 
6.3 – 10.5 
15.0 (4.1) 
10.7 – 20.6 
22.8 (6.5) 
16.3 – 38.1 
0.004* 0.014* <0.001* 
MFM, total scorea 
range 
60.5 (39.0) 
0 – 100 
98.2 (3.0) 
93 – 100 
80.9 (25.2) 
30 – 100 
23.7 (22.7) 
0 – 75 
0.120 <0.001* <0.001* 
Body mass index 
range (kg / m2) 
20 (5.0) 
14 – 35 
16.3 (1.9) 
 14 – 20 
22.1 (4.7) 
16 – 29 
20.8 (5.4) 
15 – 35 
0.023* 0.624 0.089 
MFIQ raw scoreb 
range  
0.23 (0.17) 
0.36 – 0.31 
0.1 (0.12) 
0.02 – 0.34 
0.2 (0.12) 
0.02 –  0.35 
0.4 (0.15) 
0.12 – 0.56 
0.707 0.009* 0.007* 
Anterior MVBF 
range (N) 
87.3 (35.3) 
10.8 – 171.6 
97.1 (26.5) 
71.6 – 123.6 
101.0 (37.3) 
60.8 – 171.6 
73.5 (35.3) 
10.8 – 171.6 
0.876 0.161 0.268 
Mixing ability 
range  
25.4 (3.9) 
17.2 – 30.2 
24.5 (5.1) 
17.2 – 29.0 
22.6 (2.3) 
20.7 – 26.5 
28.3 (2.0) 
24.2 – 30.2 
 0.415 0.001* 0.254 
Occlusal contacts 
range 
3.2 (2.4) 
4 – 8 
5.3 (2.0) 
3 – 8 
3.9 (2.0) 
2 – 7 
1.4 (1.7) 
0 – 5 
0.203 0.013* 0.001* 
EI superior long mc 
range 
1.6 (2.3) 
-1.1 – 6.2 
-0.03 (0.8) 
-1.1 – 0.9 
0.67 (0.9) 
-0.8 – 2.2 
3.3 (2.6) 
-2.0 – 6.2 
 0.175 0.014* 0.003* 
EI transversus mc 
range 
0.6 (1.6) 
0.0 – 1.3 
-0.1 (1.7) 
-1.7 – 2.1 
-0.2 (1.1) 
-1.6 – 1.6 
1.6 (1.4) 
0.7 – 2.5 
0.876 0.012* 0.048* 
Tongue thicknessd 
range 
2.8 (2.4) 
0.6  – 1.7 
1.1 (0.4) 
0.6 – 1.7 
2.8 (1.7) 
0.08 – 5.44 
3.7 (3.0) 
-0.19 – 9.43 
0.039* 0.446 0.022* 
Prednisonee  10 / 44% 5 / 83% 4 / 75%
 1 / 10% 0.012* 
Antibioticsf 7 / 30% 0 / 0% 1 / 14% 6 / 60% 0.031* 
Ventilatory support  
  None 
  Part-time (nocturnal)  
  Continuous noninvasive 
  Continuous + tracheostomy 
 
13 / 57% 
6 / 26% 
3 / 13% 
1 / 4% 
 
6 / 100% 
0 / 0% 
0 / 0% 
0 / 0% 
 
6 / 86% 
1 / 14% 
0 / 0% 
0 / 0% 
 
1 / 10% 
5 / 50% 
3 / 30% 
1 / 10% 
<0.001* 
Mastication difficultiesg 13 /57% 3 / 50% 4 / 57% 6 / 60% 0.926 
Posterior occlusion 
  cross bite 
  tendency to cross bite 
 
17 / 74% 
6 / 26% 
 
1 / 17% 
5 / 83% 
 
6 / 86% 
1 / 17% 
 
10 / 100% 
0 / 0% 
 
<0.001* 
0.001* 
Prolonged mealtimeh 15 / 65% 3 / 50% 3 / 43% 9 / 90% 0.088 
Swallowing difficultiesi 15 / 65% 4 / 67% 3 / 43% 8 / 80% 0.288 
Food adaptationl 12 / 52% 1 / 17% 3 / 43% 8  / 80%  0.041* 
* = Statistically significant differences; DMD = Duchenne Muscular Dystrophy; AS = Early and late ambulatory 
stage; ENAS = Early non-ambulatory stage; LNAS = Late non-ambulatory stage. 
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aMFM: Motor Function Measure, domain 2, items 13 to 23 assessed axial en proximal motor capacities –12 items (total score 
33 points = 100%); MFM score per item: 0 = does not initiate movement or starting position cannot be maintained; 1 = 
partially completes the exercise; 2 = completes the exercise with compensations, slowness or obvious clumsiness; 3 = 
completes the exercise with a standard pattern. 
bMFIQ raw score: seventeen questions with answers on a five-point Likert scale, to assess the extent of the difficulties 
experienced to perform a particular mandibular task. The total score is the score of the degree of masticatory and non-
masticatory impairment that represents the total function impairment. The total score of the scale (C) is the sum of the 17  
items (S) divided by 4 times the number of items (n): C = S / 4n. 
cEI: muscle echo intensity gray value (z-score) of the image of the superior longitudinal muscle and the transversus muscle of 
the tongue; z-score > 2.0 is considered as abnormal echo intensity (Engel-Hoek et al., 2012). 
dTongue thickness: the thickness of the tongue, including the geniohyoid and genioglossal muscles, was measured from the 
raphe of the mylohoid muscle to the upper boundary of the tongue (Engel-Hoek et al., 2012).  
ePrednisone: % of patients using prednisone at base line or previously.   
fAntibiotics: patients with pneumonia in need of ≥ 1 antibiotic medication in the past year.  
gastication difficulties: rated on a 5-point scale. 0 = never; 1 = sometimes; 2 = regularly; 3 = often; 4 = very often. Patients 
with a score > 1 are considered to have mastication difficulties.  
hProlonged meal time: rated on a 5-point scale. 0 = normal; 1 = sometimes > 30 minutes; 2 = always > 30 minutes; 3 = > 45 
minutes; 4 = > 60 minutes. Patients with a score >1 are considered to have prolonged meal time.  
 iSwallowing difficulties: rated on a 5-point scale. 0 = never; 1 = sometimes; 2 = regularly; 3 = often; 4 = not applicable. 
Patients with a score > 1  are considered to have difficulty in passing the food from the mouth into the stomach.  
jFood adaptation: patients unable to eat hard biscuits, meat, raw carrots, French loaf or nuts. 
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Table 5.3.   Univariate linear regression analysis of determinants for food mixing ability in 
Duchenne muscular dystrophy patients 
 
 
Model 
 
95 % Confidence Interval 
for Effect 
 
 
 
Effect Lower Bound Upper Bound p-value R
2 
Age (in years) 0.08 -0.136 0.30 0.449 0.03 
Ambulatory stage 
   LNAS 
   AS 
   ENAS 
 
Reference 
-2,76 
-4,70 
 
 
-6.29 
-8.08 
 
 
0.77 
-1.33 
 
 
0.119 
 0.009* 
0.32 
Anterior MVBF
 
-0.04 -0.09 -0.00  0.004* 0.20 
OC -0.40 -1.10 0.30 0.247 0.07 
EI superior longitudinal tongue 
muscle (z-score) 
0.35 -0.35 1.05 0.310 0.05 
 EI transverse tongue muscle 
 (z-score) 
0.30 -0.74 1.34 0.554 0.01 
 Tongue thickness 
(z-score) 
-0.13 -0.89 0.62 0.714 0.00 
* = Statistically significant differences. 
 
 
Table 5.4. Multiple linear regression analysis of determinants for food mixing ability in 
Duchenne muscular dystrophy patients 
Model 
 
95 % Confidence Interval 
for Effect 
 
 
p-value. Effect Lower Bound Upper Bound 
(Constant) 35.2 26.8 43.5 <0.001* 
Age (in years) -0.22 -0.51 0.73 0.131 
Ambulatory stage 
   LNAS 
   AS 
   ENAS 
 
Reference 
-4.0 
-5.6 
 
 
-9.6 
-9.4 
 
 
1.5 
-1.7 
 
 
0.143 
0.008* 
Anterior MVBF
 
-0.37 -0.78 0.04 0.076 
R2 = 0.52; * = Statistically significant differences. 
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Discussion 
In this study, the impact of DMD on the masticatory system was assessed by comparing the 
masticatory performance of patients with those of a gender and age matched healthy control 
group. Also, masticatory function per ambulatory stage (AS, ENAS or LNAS) in the DMD 
group was examined. Predictive factors were established for masticatory performance in the 
patient group. This study shows that masticatory performance, anterior MVBF and OC score 
were significantly lower in patients with DMD compared to controls. The reduced masticatory 
performance in patients with DMD was primarily related to higher disease severity. 
  In healthy individuals, the relationship between the forces exerted by the masticatory 
muscles  and the tongue on the one side and craniofacial development and development of the 
dentition on the other side, has been well established.
25,26
 The progressive wasting of skeletal 
muscles in patients with DMD, including the masticatory, facial and tongue muscles, 
influences the growth and development of the craniofacial skeleton, eventually resulting in a 
malocclusion.
27-29
 These changes may lead to an impaired masticatory performance.         
 Subjective evaluation of patients with DMD shows that they rate their masticatory 
performance as compromised.
6,7
 Our study confirmed these findings expressed by subjective 
answers of the patient (Screen and oral history) in most of the cases (Table 5.2). The 
mastication difficulties are also represented in the MFIQ score: 8 patients (35%) had a 
moderate to severe mandibular function impairment.  
  The mixing ability in our patient group was 25.1, which indicates worse performance 
than in our healthy controls (18.2), and even worse than in otherwise healthy full denture 
wearers (21.2) measured using the same method by Speksnijder et al. (2009).
21
 The lower 
anterior MVBF in our patients with DMD indicates that the masticatory muscles, especially 
the mandibular closing muscles, are substantially weaker. This is in agreement with previous 
studies.
27,29,30
 Another important finding in our study is the fact that the weakness of the 
masticatory muscles starts early in the course of the disease: the AS subgroup already shows a 
significantly reduced bite force, compared to controls (Table 5.1 and 5.2). This explains the 
low masticatory performance already in young children with DMD.  
  One of the important factors influencing the masticatory performance in healthy 
subjects is the number of occlusal contacts (OC score).
11
 Although there is a correlation 
between the OC score and the subjective reports by the patients regarding their quality of 
mastication (reduced MFIQ raw score and increased mastication difficulties), the expected 
correlation between the objective chewing performance and the OC score in our patients with 
DMD did not reach significance. The absence of this correlation can be explained by the fact 
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that despite a reduced OC score the patients were still able to mix the colours of wax tablet 
using an adapted way of chewing. We observed during the mixing ability test that patients 
with a reduced OC score chewed the wax tablets mostly with their occluding anterior teeth. 
For this strategy, not the number of occluding (pre)molars, but the anterior bite force seems of 
importance for the masticatory performance. The latter is corroborated by our finding of albeit 
weak association between anterior MVBF and the mixing ability (Table 5.3 and 5.4). 
  We cannot determine whether the decline in mixing ability in the patients with DMD 
was further influenced by exposure to prednisone. Prednisone-naïve DMD patients are 
insufficiently represented in AS and ENAS to assess a statistical link between prednisone and 
masticatory muscle function. Additionally the standard of care for DMD has changed 
overtime, resulting in a different standard of treatment for LNAS than for the AS and ENAS. 
Comparing the stage groups is thereby not possible.  
  In our study, the MVBF was measured between the anterior teeth which is a frequently 
used and reliable method.
31
 The measurements of the MVBF between the canines in the 
patients and the control subjects were not always feasible because of loose, partly erupted or 
missing canines due to the transition from primary to secondary dentition. For this reason, the 
MVBF between the canines is not included in the analyses. 
  The tongue size and position play a clinically relevant role in the development of 
malocclusions in healthy individuals.
26,32
 In patients with DMD, ultrasound images indicated 
tongue enlargement as a result of (pseudo) hypertrophic changes early, and progressive 
dystrophic structural changes late in the disease process.
13
 The significant correlation found 
between the tongue thickness measured by the echo intensity, and the OC score is an 
expression of the developing occlusal changes already in early stages. It is probably the 
combination of an enlarged tongue measured with the QMUS, in combination with the 
weakness of the masseter muscle, expressed by a decrease in MVBF early in the disease 
process, that caused in our patient group tendency to cross bite and/or cross bite, already in 
the AS (83% and 17%, respectively).  
  Previous studies mention that the muscles of the hips, pelvic area, thighs and shoulders 
are affected first and that the masseter muscles follow the general progress of the disease.
29,32
 
In our cohort, decrease in the MVBF and dental changes with a corresponding reduction of 
the OC score were present early in the disease process prior to a reduction of the motor 
function assessed by the MFM (Table 5.2). This finding, together with previous report on 
early structural changes in the tongue in AS by van den Engel-Hoek et al. (2013) suggests that 
the orofacial musculature might be affected earlier in the diseases process than expected.  
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  A reduced masticatory performance might contribute to prolonged meal time and 
masticatory muscle fatigue. In the LNAS group, all patients reported prolonged duration of 
food intake. Weight loss becomes a health issue for the patients in this subgroup. Food 
adaptation (soft or chopped food) is needed to ensure a sufficient calorie intake. In healthy 
individuals, a softer diet is associated with a reduced bite force, an increased frequency of 
malocclusion and a negative influence on the masticatory performance.
35
 Food adaptation in 
our patient group had a significant correlation with reported prolonged meal times. It seems 
that when patients experience mealtime prolongation they decide to adapt their food. We 
expect that the food adaptation, indicated by the MFIQ and by Screen, may further 
compromise the masticatory system.  
  Before indicators can be suggested to use in clinical practice in the decision making 
regarding dietary adaptation, further research is needed. Until then we suggest that the 
decision to adapt food should be based on the following requirements: sufficiency of the 
airway defense mechanisms, cough strength and calorie intake. Our advice is to encourage 
patients to postpone food adaptation as long as patients meet these requirements which will 
apply mainly to AS and ENAS. In case the requirements are not met, van den Engel-Hoek et 
al. (2013) suggest to (1) adjust meals in terms of less solid food and (2) drink water after 
meals to clear the oropharyngeal area.
10
 Moreover, we suggest that masticatory exercises are 
applied in DMD as early as possible in the disease, for example, at first reports of food 
adaptation, in an effort to postpone the decline of masticatory muscle function in these 
patients. 
  The results of a previous study on boys with DMD as to the effect of low-intensity 
physical training on preservation of muscle endurance and functional abilities are promising.
36
 
The correlation of the MVBF with masticatory performance in DMD may offer possibilities 
for intervention. The masticatory exercise study of Kawazoe et al. (1982) on training the 
masticatory system in patients with DMD demonstrated an improvement of the masticatory 
function. However this exercise does not match with the latest training suggestions for 
patients with muscular dystrophy which are low intensity aerobic exercises.
37
 An example of 
a low intensity aerobic exercise is the use of chewing gum. In healthy individuals, training of 
the masticatory muscles with chewing gum influenced the functional capacity of these 
muscles and increased their strength.
38
 A training program for the chewing muscles may have 
a positive effect upon mastication as well, and may lead to improvement, maintenance or a 
slower decline of the masticatory performance. In this context, training of the masticatory 
system in patients with DMD could be beneficial. 
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Conclusion 
This study demonstrated that impairment of the masticatory system, expressed as reduced 
masticatory performance, is common among boys and men with DMD. Early recognition of 
masticatory limitations is recommended since masticatory performance deteriorates with 
DMD stage already in early stages of the disease. We suggest that there may be potential 
beneficial effects of a training program in DMD.  
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Abstract 
Objectives: Patients with Duchenne muscular dystrophy (DMD) experience negative effects 
upon feeding and oral health. We aimed to determine whether the mandibular range of motion 
in DMD is impaired, and to explore predictive factors for the active maximum mouth opening 
(aMMO).  
Methods: 23 patients with DMD (mean age 16.7±7.7 years) and 23 controls were assessed 
using a questionnaire about mandibular function and impairments. All participants underwent 
a clinical examination of the masticatory system, including measurement of mandibular range 
of motion and variables related to mandibular movements. In all patients, quantitative 
ultrasound of the digastric muscle and the geniohyoid muscle and the Motor Function 
Measure (MFM) scale were performed. The patients were divided in early and late 
ambulatory stage (AS), early non-ambulatory stage (ENAS), and late non-ambulatory stage 
(LNAS).  
Results: All mandibular movements were reduced in the patient group (p < 0.001) compared 
to the controls. Reduction of the aMMO (< 40 mm) was found in 26% of the total patient 
group. LNAS patients had significantly smaller mandibular movements compared to AS and 
ENAS (p < 0.05). Multiple linear regression analysis for aMMO revealed a positive 
correlation with the body height and disease progression, with MFM total score as the 
strongest independent risk factor (R
2
 = 0.71).  
Conclusions: Mandibular movements in DMD are significantly reduced and become more 
hampered with loss of motor function, including the sitting position, arm function, and neck 
and head control. We suggest that measurement of the aMMO becomes a part of routine care 
of patients with DMD.  
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Introduction 
Duchenne muscular dystrophy (DMD) is, with an incidence of about 1: 4200 live male births, 
one of the most prevalent hereditary muscle diseases.
1
 It is caused by a defective gene for 
dystrophin, a protein that helps to keep muscle cells intact.
2 
 DMD is characterized by progressive muscle weakness including the craniofacial 
muscles.
3,4
 The weakness of the craniofacial muscles consequently affects the development 
and morphology of the craniofacial structures.
5-8
 Weakness of the jaw muscles, in 
combination with changes in the craniofacial morphology may affect mandibular function, 
including mandibular range of motion (ROM).
4,9
 To our knowledge, predictive factors for a 
compromised mandibular ROM in patients with DMD have not been investigated yet. 
 The most important influencing factors upon the mandibular ROM in healthy subjects 
are the length of the mandible, functional capacity of the mandibular opening and closing 
muscles, morphology and status of the temporomandibular joint (TMJ), and pain conditions in 
the masticatory system.
9,10 
 Ultrasound measurements in patients with DMD of the masseter muscles and the 
suprahyoid muscles showed structural changes in these muscles indicating muscular 
dystrophy.
4,11
 Hypothetically, the structural changes may lead to decreased strength of the 
muscles involved in mandibular movement and contribute to a limited mandibular ROM. 
 Factors beyond the masticatory system may contribute to a reduction of the 
mandibular ROM as well. Recent observations suggest a functional relationship between the 
cranio-cervical and the masticatory system.
12,13
 As a consequence gross motor function 
measurement, which includes assessment of posture, neck function, and head control, might 
be predictive for the mandibular ROM. 
 The aim of our investigation was to determine whether the mandibular ROM in DMD 
is impaired compared to that in healthy subjects, and to explore predictive factors for the 
active maximum mouth opening (aMMO) in DMD. 
 
Methods 
Participants 
Twenty-four patients with DMD aged from 6 to 38 years, participating in a swallowing study 
on DMD, and 24 age-matched healthy males were examined between May 2010 and February 
2012.
11
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Patients were recruited by announcements of patient organizations. Only patients with 
an established diagnosis of DMD older than five years were eligible. DMD patients who were 
entirely dependent on tube feeding were excluded. 
 The control group was recruited at a primary and a secondary school located in the 
western part of the Netherlands. Healthy students above 18 years were recruited at the College 
of Dental Sciences, Nijmegen, The Netherlands. Exclusion criteria for controls were: a history 
of neuromuscular disease, temporomandibular disorder, orthodontic treatment and 
morphologic dental malocclusion such as crossbite and a tendency to crossbite. 
 
Protocol 
The participants in both the patient and the control group, completed a questionnaire, and 
underwent a clinical examination of the masticatory system including measurement of the 
mandibular ROM.  
  Additionally, the patients underwent quantitative muscle ultrasound imaging (QMUS) 
of the anterior belly of the digastric muscle and the geniohyoid muscle, and an assessment of 
their general physical abilities using the Motor Function Measure (MFM).
14,15 
 
Questionnaire 
All subjects completed the questionnaire Screen, which was developed to assess pain in the 
head and neck region, mandibular function and related issues.
16,17 
 
Clinical examination of the masticatory system 
All participants in this study were clinically examined following the validated procedure as 
described by Lobbezoo-Scholte et al. (1993, 1994)
18-21
 This clinical examination included, 
among others, measurement of the mandibular range of motion, palpation of the masticatory 
muscles and the TMJs. All patients and controls were examined in the upright position with 
their heads supported in a neutral position.  
The following mandibular movements were assessed: active maximum mouth opening 
(aMMO), passive maximum mouth opening (pMMO), protrusion, and left and right lateral 
ROM. The overbite and overjet were also measured. The aMMO was the distance measured 
between the mesioincisal angle of the right upper and lower front teeth plus the overbite. All 
measurements were recorded with a metal ruler (mm). We considered mandibular movements 
to be reduced:  < 40 mm for aMMO, < 8 mm for active lateral ROM and < 5 mm for 
protrusion. The mobility of the TMJ was assessed by palpation of the lateral pole of the 
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mandibular condyle during aMMO with the index finger. Sliding of the mandibular condyle 
was assessed on a 2 point scale: reduced meaning no or hardly any sliding of the lateral pole 
of the mandibular condyle; normal meaning sliding of the mandibular condyle to the crest of 
the articular eminence or beyond the crest of the articular eminence. 
The masseter and temporalis muscles were palpated to assess pain on palpation. The 
temporalis muscles were palpated bilaterally by using the index- and middle finger, applying 
firm pressure along the anterior, middle and posterior parts for 2 to 3 seconds. Then the 
origin, the body and the insertion of the masseter are individually palpated for 2 to 3 seconds. 
Finally the TMJs were palpated for 2 to 3 seconds by using the index finger. The left and right 
condyles were palpated in an open and closed mouth position. The lateral pole of each 
condyle was palpated anterior to the tragus of the ear and over the TMJ, and the posterior 
aspect of each condyle via the external acoustical meatus.  Palpation pressure was firm (2 to 4 
pounds) and was adjusted to the vulnerable patients, when appropriate.
20,22,23 
All pain reports of the participants during examination were recorded on a 5-point 
Likert scale: 0 = no pain, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe. 
 
Echo intensity imaging of the digastric and geniohyoid muscles 
In the patient group, QMUS was used to measure echo intensity of the digastric and 
geniohyoid muscles.
11
 These two muscles were selected because of their anatomical location. 
The diagnostic value of muscle ultrasound and the test–retest reproducibility for the digastric 
muscle and the geniohyoid muscles was good.
11
  
The region of interest was quantified by grey-scale analysis and calculation of z-scores (i.e. 
the amount of standard deviations below or above the mean of norm values); a reliable 
method with which changes in muscle architecture are assessed and compared with normal 
values.
24,25
 The gray value of the mean of the left and right digastrics muscles and of the left 
and right geniohyoid muscle was expressed as z-scores. Z-score of < -2 and > 2 is considered 
abnormal. QMUS of the digastric and geniohyoid muscles proved to be feasible in healthy 
children and young adults, and is used for detection of structural changes in these muscles.
14 
 
Medical information and general physical abilities 
In the patient group, information was gathered, among others, on body height, and baseline 
physical abilities were assessed by a physical therapist with expertise in pediatrics using a 
selection of MFM items. The MFM items have been previously been described.
15
 The items 
13 to 23 used in this study collect information about the sitting position, arm function, and 
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neck and head control. The MFM items were scored on a four-point Likert scale and summed 
to comprise a total raw score (range 0–33), in which the maximum represents normal motor 
function.  
Based on the ambulatory function and the MFM, the patients were divided in early and 
late ambulatory stage (AS), early non-ambulatory stage (able to maintain posture) (ENAS), or 
late non-ambulatory stage (upper limb function and postural maintenance is increasingly 
limited) (LNAS).
26 
 
Statistical analysis 
IBM SPSS version 20 was used to analyse the collected data. Mean and standard deviation 
were used to describe the average maximum mouth opening, the lateral excursions and the 
protrusion of the mandible in the patient and in control group. Paired Student’s t-test was used 
to compare between-group continuous variable outcomes, and for dichotomous variables the 
chi-square test was used. 
 Patient data were further analysed using the 3 DMD stages. To compare test outcomes 
between the DMD stages ANOVA was used for scale variables and chi-square test for 
dichotomous variables.  
Univariate and multivariate regression analyses were performed to determine which 
factors possibly affect the aMMO within the patient group (dependent variable). The 
independent variables were age, body height, MFM total scores, MFM score item 13-14, 
ultrasound score of the digastric muscle and geniohyoid muscle.  
 
Results 
Participants: Twenty-four patients with DMD were approached for inclusion in the study. 
One of the patients was excluded from the study because DMD was not genetically 
confirmed, and the signs and symptoms did not fit into the diagnosis DMD. For analysis the 
data of 23 patients and 23 age-matched males was used (Table 6.1). Patient characteristics of 
the total DMD sample as well as of the three stage groups are indicated in Table 6.2. 
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Table 6.1. Group comparison and descriptive statistics of the mandibular range of motion 
during clinical examination in the patient group (n = 23) and in the control group (n = 23). 
Mean and standard deviation of the measurements are referred to as x  (SD).  
 
 Patient group Control group  
Variables n=23 n=23 P-value 
    
Mean age, yrs.mo (SD) 
range 
16.7 (7.7) 
6.3 – 38.1 
16.3 (6.7) 
 6.1 – 30.2  
0.851 
aMMO
a  
(mm) (SD) 
range 
43.5 (11.0) 
21.0 – 59.0 
54.6 (6.2)  
40.0 – 63.0 
< 0.0001* 
pMMO
b 
(mm) (SD) 
range 
44.3 (11.1) 
21.0 – 62.0 
55.4(6.8) 
40.0 – 68.0 
< 0.0001* 
Lateral ROM
 
L/R
c
 (mm) (SD) 
range 
6.4 (3.0) 
0.0 – 13.0 
9.3 (1.7) 
5.0 – 12.0 
< 0.0001* 
Protrusion
d 
(mm) (SD) 
range 
4.7 (3.5) 
7.0 – 10.0 
9.3 (2.5) 
4.0 – 15.0 
< 0.0001* 
 
* = Statistically significant differences.
 
a
aMMO: active maximum mouth opening, the maximum interincisal distance on opening as wide as possible 
plus the vertical overbite (limited aMMO < 40mm). 
b
pMMO: passive maximum mouth opening, the maximum interincisal distance on active opening, with a slight 
overpressure on the edges of the upper and lower front teeth by the examiner plus the vertical overbite. 
 
c
Lateral ROM
 
L/R: active mandibular lateral excursion, mean value between the left and right side.  
d
Protrusion: active forward movement of the mandible. 
 
Questionnaire 
A limitation in the ability to open the mouth was noted in 3 patients (13%) and pain during 
opening the mouth was mentioned in 4 other patients (17.4%, Table 6.2). The maximum 
intensity of the recorded pain in these 4 patients was ‘mild’. 
 
Clinical examination of the masticatory system 
In 6 patients (26.1%) mild pain could be provoked during aMMO, pMMO, or palpation of the 
masseter muscle, temporalis muscle or the lateral pole of the TMJ. Four of these 6 patients 
belonged to the LNAS (Table 6.2).  
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Table 6.2.   Characteristics of patients with Duchenne muscular dystrophy  (n = 23) presented 
by stages. Mean and standard deviation of the measurements referred to as x  (SD) or number 
of patient as n / %. Statistically significant difference between the DMD stages, tested with 
ANOVA for scale variables and with chi-square test for dichotomous outcome. The 
significance in the dichotomous outcomes relates to the variable being absent or present. 
  DMD stage p-value 
Variable Total  
(n=23) 
AS (1) 
(n=6) 
ENAS (2) 
(n=7) 
LNAS (3) 
(n=10) 
1-2 2-3 1-3 
Age, yrs.mo (SD) 
range 
16.7 (7.7) 
6.3 – 38.1 
8.4  (1.5) 
6.3 – 10.5 
15.0 (4.1) 
10.7 – 20.6 
22.8 (6.5) 
16.3 – 38.1 
0.004* 0.014* <0.001* 
MFM, total raw scorea (SD) 
range 
20.1 (12.6) 
0 – 33 
32.5 (0.8) 
31 – 33 
26.9 (8.3) 
10 – 33 
7.9 (1.4) 
0 – 25 
0.123 <0.001* <0.001* 
MFM item 13-14b (SD) 
range 
3.7 (2.5) 
0 – 6 
6.0 (0) 
6 – 6 
5.4 (1.0) 
4 – 6 
1.2 (1.4) 
0 – 4 
0.172 <0.001* <0.001* 
aMMO(mm)   
range  
43.5 (11.0) 
21 – 62 
47.5 (7.9) 
40 – 62 
49.1 (9.2) 
34 – 59 
37.2 (11.1) 
21 – 55 
0.739 0.034* 0.068 
pMMO (mm) (SD) 
range 
44.3 (11.1)  
21 – 62 
48.3 (7.6) 
42 – 62 
50.1 (9.5) 
34 – 60 
37.8 (11.1) 
21 – 55 
0.717 0.031* 0.060 
Lateral ROM L/R (mm) (SD) 
range 
6.4 (3.0) 
0.0 – 13.0 
7.3 (3.3) 
4.5 – 13.0 
8.2 (1.9)  
6.5 – 10.0 
4.7 (2.7) 
0 – 7.5 
0.556 0.009* 0.097 
Protrusion (mm) (SD) 
range 
4.7 (3.5) 
7.0 – 10.0 
7.0 (1.8) 
5 – 10 
4.9 (0.4) 
4 – 5 
3.2 (4.7 
-7 – 6 
0.032* 0.296 0.082 
EI digastric m., mean L/Rc (SD) 
range (z-score) 
2.0 (3.1)  
-1.3 – 10.6 
0.5 (1.4) 
-1.3 – 2.3 
1.3 (2.5) 
-0.8 – 6.1 
3.4 (3.8) 
0.6 – 10.6 
0.517 0.221 0.052 
EI geniohyoid  (SD) 
range mc (z-score) 
6.0 (5.2) 
-1.0 – 19.7 
2.4 (3.0) 
-0.10 – 8.0 
5.6 (5.2) 
1.5 – 15.3 
8.3 (5.3) 
0.6 – 19.7 
0.209 0.297 0.024* 
Body height (cm) (SD) 
range 
158.7 (21.9) 
120 – 195 
130.8 (8.8) 
120 – 146 
160.4 (16.0) 
131–  180 
174.3 (12.8) 
155 – 195 
0.003* 0.083 <0.001* 
MMO reduced, subjd 3 / 13% 1 / 17% 0 / 0% 2 / 20% 0.585 
Reduced TMJ slidinge     1 / 4% 0 / 0% 0 / 0% 1 / 10% 1.000 
Pain provocationf 6 / 26% 1 / 17%  1 / 14% 4 / 40% 0.491 
 
* = Statistically significant differences; DMD = Duchenne muscular dystrophy; AS = Early and late ambulatory 
stage; ENAS = Early non-ambulatory stage; LNAS = Late non-ambulatory stage.  
a
MFM: Motor Function Measure, domain 2, items 13 to 23 assessed axial en proximal motor capacities –12 
items (total raw score 33 points); MFM score per item: 0 = does not initiate movement or starting position 
cannot be maintained; 1 = partially completes the exercise; 2 = completes the exercise with compensations, 
slowness or obvious clumsiness; 3 = completes the exercise with a standard pattern.  
b
MFM item 13-14:
 
item 13: Seated on the chair without support of upper limbs or leaning against the back of the 
chair, maintains the sitting position, head and trunk in the axis; score 0 – 3; item14: Seated on the chair or in 
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their wheelchair. Head in flexion: from the fully flexed position, raises the head and maintains the raised 
position, head in the axis during the movement and when maintained; score 0 – 3.  
c
EI digastric L/R and geniohyoid muscles: echo intensity gray value (z-score) of the mean value of the left and 
right digastrics muscle and of the geniohyoid muscle; z-score < -2 and > 2 is abnormal. 
d
MMO reduced, subjective: limitation in the ability to open the mouth noted by the patients in Screen or by 
anamnestic information. 
e
Sliding of the temporomandibular joint was assessed by palpation: reduced = no or hardly any sliding of the 
lateral pole of the mandibular condyle, normal = sliding to and beyond the crest of the articular eminence. 
f
Pain provocation during active mouth opening, passive mouth opening, or palpation of the masseter muscle, 
temporalis muscle or the lateral pole of the TMJ. 
 
  Active and passive maximum mouth opening, active mandibular lateral ROM and 
protrusion were significantly smaller in the patient group than in the control group (Table 
6.1). In the patient group, 6 (26%) had a reduced aMMO (< 40 mm). The difference between 
the aMMO and the pMMO in the patient and the control group was 1mm. The LNAS had a 
statistically significant smaller aMMO than the ENAS (Table 6.2).  
The active mandibular lateral ROM was reduced (< 8 mm) in 16 patients (70%); all 
patients in the LNAS had a reduced lateral ROM. The LNAS had a statistically significant 
smaller lateral ROM than the ENAS (Table 6.2). 
The active mandibular protrusion was reduced (< 5 mm) in 7 patients (30%). The 
ENAS had a statistically significant smaller protrusion than the AS (Table 6.2). 
Clinical examination of the mobility of the temporomandibular joint revealed that 22 
patients (96.0%) had a normal sliding of the mandibular condyle (Table 6.2). All controls had 
normal sliding of the mandibular condyle. 
 
Echo intensity imaging: The echo intensity of the anterior belly of the digastric muscles, 
expressed as z-score, was found to be increased (z > 2) in 16.6% of the patients in the AS, 
28.6% in ENAS and 50.0% in LNAS. The echo intensity of the geniohyoid muscles was 
increased in 50.0 % of the patients in AS, 85% in ENAS and 90.0% in LNAS. There was a 
statistically significant difference between the AS and LNAS regarding the echo intensity of 
the geniohyoid muscles (Table 6.2). 
 
General physical abilities: There was a significant difference in the MFM score between the 
ENAS and LNAS, and between AS and LNAS regarding the MFM total score (Table 6.2). 
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There was a statistically significant difference between the ENAS and LNAS, and between 
AS and LNAS regarding the MFM items 13-14 score. 
 
Predictive factors for the active maximum mouth opening:  
Univariate linear regression analysis outcomes of potential determinants of aMMO in patients 
with DMD are presented in Table 6.3. The univariate linear regression analysis revealed 
negative correlations between the aMMO and age, body height, ultrasound score of the 
digastric muscle and geniohyoid muscle, and positive correlations for the MFM variables. 
Because of the small number of patients only two variables are used in our multiple linear 
regression analysis. Age and MFM variables are strongly correlated (Pearson correlation 
0.828; p <0.001) via disease progression, making age less informative. Therefore we entered 
body height in the model which in combination with MFM total raw score improved the 
model (R
2
 = 0.71). 
 
Table 6.3.  Univariate linear regression analysis of  determinants of the impaired active maximal 
mouth opening (aMMO) in Duchenne muscular dystrophy patients. 
 
 
 
95 % Confidence Interval 
for Effect 
 
 
 
Variable Effect Lower Bound Upper Bound p-value R
2
 
Age (in years) -0.52 -1.35 0.28 0.005* 0.13 
Body height (cm) -0.12 -0.33 0.10 0.270        0.06 
MFM total raw score 0.64 0.39 0.90 <0.001* 0.57 
MFM item 13-14 2.65 1.06 4.23 0.002* 0.37 
EI digastric muscle (z-score) -1.67 -3.07 -0.27 0.022* 0.23 
 EI geniohyoid muscle (z-
score) 
-0.99 -1.84 -0.14 0.024* 0.22 
 
* = Statistically significant differences. 
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Table 6.4.  Multiple linear regression analysis of  determinants of the impaired active maximal mouth 
opening (aMMO) in Duchenne muscular dystrophy patients 
 
 
 
95 % Confidence Interval 
for Effect 
 
Variable Effect Lower Bound Upper Bound p-value 
(Constant) -14.360 -45.550 16.831   0.348 
Body height (cm) 0.247 0.078 0.415   0.006* 
MFM total raw score 0.932 0.639 1.225 <0.001* 
 
R
2
 = 0.71; * = Statistically significant differences. 
 
Discussion 
In this study the impact of DMD on the mandibular movements was assessed by comparing 
the mandibular ROM of patients with those of a gender and age matched healthy control 
group. Also, mandibular ROM per ambulatory stage (AS, ENAS or LNAS) in the DMD 
group was examined. Predictive factors were established for reduced aMMO in the patient 
group. This study shows that mandibular ROM was significantly lower in patients with DMD 
compared to controls. The decreased aMMO in patients with DMD was primarily related to 
body height and higher disease severity, expressed by the motor function. 
Measurement of the mandibular movements is a  standard procedure for evaluation of 
the musculoskeletal masticatory structures.
18,22
 As an entity on itself  the aMMO is a 
parameter that can be established reliably, regardless of the severity of the limitation; the 
interobserver intraclass correlation coefficient (ICC) was 0.98 and the intra-observer ICC and 
intersession ICC reliabilities both were 0.99.
27
  
In view of the wide range of variation of individual mandibular movements, it is difficult to 
set normal ranges and uniformity regarding the maximum movements. Suggested cut-off 
values for the aMMO in healthy subjects vary between 40–44 mm for man, 38–42 mm for 
woman and 35–40 for children.28-33 In accordance with the literature, we consider for our 
study < 40 mm for aMMO, < 8 mm for active lateral excursion and < 5 mm for protrusion as 
reduced. These values do not seem to be in conflict with other findings from the literature. 
 In our study we have incorporated the concept of the mandibular range of motion as an 
anatomical position (condyle in relation to the crest of the eminence next to the interincisal 
measurement of mandibular movements).
34
 Healthy individuals may perform normal opening 
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with highly variable amounts of condylar translation, and variation in maximum incisor 
opening is largely explained by variation in the amount of mandibular rotation.
37
  It is 
mentioned in the literature that maximum incisor opening does not provide reliable 
information about condylar translation and its use as a diagnostic indicator of condylar 
movement is limited.
35
 A combination of the interincisal measurement of mandibular opening 
and assessment of the anatomical condylar position in relation to the crest of the eminence 
will improve establishing whether the impairment is intra-articular or not.
34 
Regarding aMMO in patients with DMD compared to healthy controls, conflicting 
objective data can be found in the literature ranging from a reduced aMMO to a non-
significant difference.
3,4
 The mean reduction of the aMMO of our patient group compared to 
the age and gender matched controls was 11 mm, which is a clinically relevant difference. In 
another study, aMMOs of 39.1 mm (DMD patients, mean age 11.7 years) and 54.2 (healthy 
controls, mean age 11.9 years) were found.
4
 However, in a Japanese population, no significant 
difference between the DMD group and the control group was found, although the aMMO of 
the patients tended to be less compared to controls (mean age 21.5 vs. 21.3, aMMO 36.9 vs. 
41.0 mm).
3
 Despite the higher mean age in the latter study the aMMO was less than reported 
in the study of Botteron et al. (2009) and our study.
4
 All studies included the vertical overbite 
in their measurements. Differences in ethnicity and instructions during the examination of the 
studied population in these studies may explain the variation of the aMMO values. 
The mandibular ROM is influenced by many factors, i.e.  age, gender, body height, 
ethnicity, status of the masticatory system, cervical column function, and head and neck 
posture.
32, 36, 37
 In patients with DMD, sonography indicated fatty infiltration related to the 
dystrophic changes of the masseter muscle and the suprahyoid muscles.
4,11
 Muscle dystrophy 
may lead to muscle stiffness and consequently may hamper mouth opening and horizontal jaw 
movements. In our study, 5 out of 6 patients with a limited aMMO (< 40 mm) had a normal 
sliding of the condyle indicating that structural changes in the muscles may primarily be 
responsible for the reduced mandibular ROM in general and the aMMO specifically.  
 The differences between patients and controls regarding the mandibular ROM and not 
only maximum mouth opening  indicates a more general muscle involvement than the 
muscles responsible for mouth opening and closing. The lateral pterygoid muscles play an 
important role in mouth opening but also in the control of horizontal mandibular movements 
such as protrusion and lateral ROM.
38
 In patients with spinal muscular atrophy involvement 
of the lateral pterygoid muscle was found to play an important role in the impairment of the 
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mandibular movement in this type of neuromuscular disorder.
41
 To our knowledge, the effect 
of DMD on the lateral pterygoid muscle is not investigated by MRI. 
In healthy individuals, the strength of the vertical component of the mouth opening 
muscle force (suprahyoid and indirectly the infra-hyoid muscles) is important in mouth 
opening.
40
 The structural changes found in the anterior belly of the digastric muscles and 
geniohyoid muscles in DMD may lead to a decreased strength and contribute to a reduced 
aMMO. Our linear regression analysis confirms this hypothesis: the echo intensity of the 
digastrics and geniohyoid muscle correlated with the maximum mouth opening (Table 6.3). 
Moreover, the quantitative muscle ultrasound imaging in the patient group showed that the 
muscle echo intensity of the suprahyoid muscles increased gradually (z-sore > 2) with 
ambulatory loss.
11
 The influence of DMD on the suprahyoid (and probably the lateral 
pterygoid) muscles in our patients seems to follow a tendency like other physical 
characteristics that start to develop according to the stage of the disease.  
The study of L van de Engel-Hoek et al. (2012) showed the feasibility of quantitative 
muscle ultrasound of digastric muscles, the geniohyoid muscles in healthy subjects and 
patients with DMD.
11
 QMUS showed significant differences in echo intensity between 
healthy subjects and DMD patients, especially in the geniohyoid muscle. The anatomic 
location and structure of e.g. the mylohyoid muscle proved to be too thin to be measured and 
analyzed. However, we do not expect that other oral muscles such as the mylohoid muscles 
are spared from DMD. 
 In this cohort of 23 boys and adults with DMD, the linear regression analysis revealed 
the severity of DMD, assessed by the MFM, and the height of the patient, to be the strongest 
independent predictive factors for a reduced aMMO (Table 6.4). Although age and height are 
generally related, in patients with DMD, due to the growth disturbances, height turned out to 
be a stronger independent factor for a reduced aMMO than age (Table 6.4).  
           A reduced mouth opening may hamper feeding, oral hygiene and dental care. 
Recognizing this impairment and their predictive factors by medical staff, patients, parents 
and caretakers is a first step. Furthermore, in terms of management, it is important to take 
measures to slow down the development of the mouth opening reduction, possibly by 
developing a training program. The program has to be easy to implement in daily life and with 
low intensity aerobic exercises as suggested in other training programs for patients with 
DMD.
41,42
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Conclusion 
Mandibular movements in DMD are significantly reduced compared to the healthy controls, 
and become more hampered with loss of motor function, including the sitting position, arm 
function, and the neck and head control. We suggest that evaluation of the aMMO as an 
expression of the reduced mandibular range of motion becomes a part of routine care of 
patients with DMD. 
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Abstract  
Objectives: Duchenne muscular dystrophy (DMD) patients report masticatory problems. The 
aim was to determine the efficacy of mastication training in DMD using chewing gum for 4 
weeks.  
Methods: 17 patients and 17 healthy age-matched males participated. The masticatory 
performance was assessed using a mixing ability test and measuring anterior bite force before, 
shortly after and one month after the training.  
Results: In the patient group the masticatory performance improved and remained after one-
month follow-up, no significant changes in anterior maximum bite force was observed after 
mastication training. In the healthy subject the bite force increased and remained at the one 
month follow-up; no significant difference in masticatory performance was observed. 
Conclusions: Mastication training by using sugar free chewing gum in DMD patients 
improved their masticatory performance. Since bite force did not improve, the working 
mechanism of the improvement in chewing may relate to changes of the neuromuscular 
function and coordination, resulting in improvement of skills in performing mastication.  
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Introduction 
Duchenne muscular dystrophy  (DMD) is an inherited, progressive disorder due to mutation 
in the dystrophin gene. This leads to shortage or absence of dystrophin which results in 
generalized degenerative weakness and muscle wasting.
1,2
 Previous studies mention that the 
proximal muscles of the extremities are affected first.
3 
However, in the literature it has been 
suggested that the orofacial and masticatory musculature might be affected earlier in the 
disease process than expected, indicated by the presence of dental abnormalities and structural 
changes in the tongue prior to a reduction of the motor function of the upper part of the 
body.
4, 5
  
  Feeding, chewing and swallowing difficulties have been reported in the advanced 
stages of DMD.
 6,7
  The reported masticatory difficulties (e.g. biting of food and eating hard 
and sticky food) may be caused by masticatory muscle involvement in both ambulant and 
non-ambulant DMD patients.
8,9
 The increasing mastication difficulties in combination with 
progressive oropharyngeal and hyolaryngeal weakness will contribute to weak pharyngeal 
clearance and consequently to progressive dysphagia in advanced stages of DMD.
7
 Reduced 
bite force and reduced contacts between the upper and lower (pre) molars in patients with 
DMD compared with healthy subjects, are partly responsible for the mastication difficulties 
including less fragmentation of food.
5,10,11
 Poor fragmentation of food in combination with 
weak pharyngeal clearance may increase pharyngeal post swallow residue and may cause in 
advanced stages of DMD swallowing difficulties like choking and the feeling of sticking food 
in the throat.
.4
 Problems with feeding, including e.g. prolonged feeding times, can have a 
psychological impact like embarrassment and social isolation and this adversely affects 
quality of life.
9,12
 As a consequence patients may try to avoid prolonged feeding times, which 
may lead to inadequate nutrition and may increase the rate of disease progression.
13-15
 
When weight loss becomes a health issue for the non-ambulatory DMD patients, food 
adaptation (soft or chopped food) has to take place mainly to ensure sufficient calorie 
intake.
9,16
 In healthy individuals a softer diet is associated with a reduced bite force which 
influences negatively the chewing efficiency.
17
 We expect that the food adaptation in our 
patient group will have a similar effect on the masticatory system. Therefore, keeping the 
masticatory system active may delay, stabilize or improve masticatory function in DMD.
5
 
Before starting a disease-specific training program, it is important to know the dominant 
limitation and the underlying mechanisms of this limitation. A recent study reported that 
impairment of the masticatory system, expressed as decreased masticatory performance, was 
common among boys and men with DMD and was primarily related to higher disease 
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severity. In that cohort of DMD patients the masticatory performance was moreover 
correlated, albeit weakly, with the bite force which may offer possibilities for intervention, as 
it is a possible modifiable factor.
5
 In this pilot study we therefore focused on the effect of a 
masticatory low intensity aerobic exercise using chewing gum upon the bite force and the 
masticatory performance. 
  A previous study indicated that low intensity aerobic exercise of the legs and arms can 
stabilize functional performance in ambulant and wheelchair-dependent boys with DMD.
18 
To 
our knowledge low intensity aerobic training of the masticatoy system fitting in daily life 
routine in patients with DMD has not been described. In healthy subjects, the bite force, 
which is related to masticatory performance, was increased through exercise of the 
masticatory system. 
19-21 
 
  This study aims to assess the efficacy of training the masticatory muscles using sugar 
free chewing gum in patients with DMD. 
 
Methods 
Participants 
Twenty-three boys and adult men with DMD originating from the cohort of the swallowing 
study of van den Engel-Hoek et al. (2013) were asked to participate in the training study.
4
 
Seven of the 23 patients were not able to participate due to the following reasons: 1 patient 
was excluded because DMD was not genetically confirmed, and the signs and symptoms did 
not fit into the DMD diagnosis, 2 patients were afraid of food aspiration, 1 patient due to time 
restriction (moving), and 3 patients preferred not to take part without mentioning any reason. 
Seventeen patients and 17 age-matched healthy males participated in the training between 
May 2010 and February 2012. 
  The patients were recruited through announcements by patient organizations.  In 
younger DMD patients genetic information was available, however in older patients this was 
not the case. In these patients the clinical course of the disease was evaluated and compared to 
data of natural course and the criteria of Emery (1991).
22
 Based on the latter, when patients 
had a Duchenne phenotype and Becker phenotype they were excluded. Patients who were 
totally dependent on tube feeding were excluded. Healthy subjects up to the age of 18 years 
were recruited at a primary and secondary school located in the western part of the 
Netherlands, those above 18 years were recruited among the students of the College of Dental 
Sciences, Nijmegen, the Netherlands. Exclusion criteria for the healthy subject were: a history 
of neuromuscular disease, signs and symptoms of temporomandibular disorders, orthodontic 
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treatment or morphologic dental malocclusions. Age limits in the study were set above 5 years 
of age to ensure cooperation of the participants during the study. Exclusion criteria for the 
participants were a daily chewing gum habit, or gum chewing for more than 30 min. per 
week. Eligible participants and their guardians received a letter with an invitation to 
participate in the study. Written informed consent was obtained from all participants and if 
needed the guardians of the participants. 
 
Protocol 
In this pilot study, the patients and healthy subjects were examined at base line (T0), after four 
weeks mastication training (T1), and at 1-month follow-up (T2). All participants underwent a 
clinical examination of the masticatory system, measurement of the anterior maximum 
voluntary bite force (MVBF) and the mixing ability at T0, T1 and T2. At T0 the patients 
underwent an assessment of their physical abilities using the Motor Function Measure 
(MFM). The main outcome measures to determine the efficacy of the mastication training 
were bite force and masticatory performance (mixing ability). The participants were not aware 
of the outcome parameters of the mastication training. Possible negative side effects of the 
mastication training were evaluated by means of the clinical examination of the masticatory 
system including assessment of the mandibular range of motion and pain on palpation of the 
masticatory muscles and temporomandibular joints.  
 
Clinical examination of the masticatory system 
All participants in this study were clinically examined following the validated procedure as 
described by Lobbezoo-Scholte et al. (1993, 1994).
23, 24
 This clinical examination included 
measurement of the mandibular range of motion (ROM), palpation of the masticatory muscles 
and the temporomandibular joints. All pain reports during examination were recorded on a 5-
point Likert scale: 0 = no pain, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe. The 
number of occlusal contacts (OC-score) between the premolar and molar teeth of the upper 
and lower jaw, after the teeth were brought into occlusion, were assessed using wax records 
(Moyco beauty pink plate wax). A perforation in the wax record indicated an occlusal contact. 
Unilaterally, the maximum OC-score is 5 (1 OC per posterior occluding pair); bilaterally the 
maximum is 10.  
 
Measurement of the anterior maximum voluntary bite force  
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The VU University Bite Force Gauge (VU-BFG) is a handheld device which uses a load cell 
(LPM 510 250lb) to MVBF.
25
 The strain gauge element was placed parallel with the 
Frankforter horizontal which is defined as the line between the lowest point on the margin of 
the orbit to the highest point on the margin of the auditory meatus. The gauge is placed
 
between the upper and lower central incisors and midway between the central maxillary 
incisors. Patients and healthy subjects clenched as hard as possible for 3 seconds and repeated 
clenching three times with an interval of 30 seconds rest periods; the highest value of the 
three measurements was used. 
                       
 
 Figure 7.1. Masticatory training box distributed to all participants. The box included six 
chewing gum packs, a stopwatch and a diary.  
 
Mixing ability test 
In all participants, masticatory performance was measured using the mixing ability test, 
described by Speksnijder et al. (2009).
26 
A wax tablet, consisting of a red and a blue wax 
layer, was offered to the subjects (tablet at room temperature, 20 °C). The investigator 
(H.W.v.B.) instructed the participants as follows: chew on the tablet as if you are eating a 
piece of bread, I will give a signal to start and stop with chewing. Each participant performed 
20 mastication strokes on the wax tablet, and as a result the colours would mix. The 
investigator counted 20 strokes without informing the participant in order to avoid influencing 
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of mastication process. The chewed tablet was assessed blinded and independently and 
cleaned for analysis. The chewed wax tablets are flattened and photographed from both sides 
with a high-quality scanner (Epson_ V750, Long Beach, CA, USA). The spread of the color 
intensities in the combined image of both sides is the measure of mixing. The images of the 
wax are processed using Adobe Photoshop, CS3 extended (Adobe, San Jose, CA, USA). The 
intensity distributions of the red and blue channels are exported as 8-bit histograms. The 
histograms of both sides of the wax are added to obtain the red and blue intensity distributions 
of the combined image of both sides of the flattened wax. These histograms are analyzed to 
obtain a measure for the mixing of the wax: the mixing index. The degree of mixing 
represented the masticatory performance. A low mixing index indicates a better masticatory 
performance than a high index.  
Physical abilities  
At baseline (T0), medical information was gathered about ventilation support. The validated 
Motor Function Measure (MFM) scale, items 13 to 23, was used to evaluate the sitting 
position, function of the arms, neck and head control in the patient group.
27, 28 
 
Masticatory training 
At the start of the masticatory training all participants received a box including six chewing 
gum packs, stopwatch and a diary (Figure 7.1). All participants followed the same program 
which was written on the back side of the box and on the chewing gum wrappers. All 
participants used the same brand chewing gum to guarantee the same toughness (Stimorol 
sugar free; Dandy As, Denmark). The instructions for the mastication training consisted of 
using one piece of chewing gum of 22 grams per exercise, 3 exercises of each 30 min per day, 
5 days/week, over a period of 4 weeks. To increase compliance participants had two days rest 
per week. The participants kept a diary to check for compliance and potential complications.  
 
Stratification of the patients 
After removing 3 ambulatory patients from the data set a post hoc analysis was performed 
with 14 non-ambulatory patients. Based on the ambulatory function and the MFM, 14 patients 
were divided into two subgroups: early non-ambulatory stage (able to maintain posture) 
(ENAS, n = 7) and late non-ambulatory stage (upper limb function and postural maintenance 
is increasingly limited) (LNAS, n = 7).
14
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Statistical analysis 
Student’s t test for paired data was used to assess possible differences between measurements 
at T0, T1 or T2 within each group of participants and in a post hoc analysis within 14 non-
ambulatory patients. The level of significance was set at p = 0.05. All analyses were 
performed with IBM SPSS Statistics 20 software. 
Student’s t test for paired data was used to assess possible differences between measurements 
at T0, T1 or T2.  
 
Results 
For analysis, the data of 17 patients with a mean age of 16.6 years (S.D. 6.1, range 7.4–28.1) 
and 17 healthy age-matched males with a mean age of 16.4 years (S.D. 6.0, range 6.1–30.2) 
were used. The characteristics of the participants at baseline are indicated in Table 7.1. 
Clinical examination of the masticatory system 
The OC score in the posterior teeth of the upper and lower jaw was reduced in more than 50% 
of the patients (average OC score 3.1, SD 2.0, range 0–7) compared with the healthy subjects 
(average OC score 6.9, SD 1.2, range 5–8).  
In 4 patients (24%) mild pain could be provoked during the clinical examination: 1 patient 
during passive maximum mouth opening (pMMO) at T0, 1 patient during pMMO at T0 and 
T1, 1 patients during pMMO at T0, T1 and T2, and 1 patient during palpation of the masseter 
muscle and the lateral pole of the TMJ at T0 and T1. 
Data of the mandibular ROM are indicated in Table 7.2. In the patient group, no significant 
differences could be demonstrated between measurements at T0, T1 or T2 regarding the 
mandibular range of motion. In the healthy subjects, a significant difference could be 
demonstrated between measurements at T1 or T2 regarding the protrusion, albeit within the 
smallest detectable change of 2 mm (Table 7.2).
27
 
 
Masticatory performance 
Patients had a significant higher mixing index at T0 (less masticatory performance) than 
controls (p < 0.001), (Table 7.2). On an individual level the mixing index increased (more 
masticatory performance) in all patients, except one, after the mastication training (Table 7.1). 
The mixing ability of the patient group increased significantly after the mastication training. 
At the one-month follow-up the effect remained. In the healthy subjects, the mixing ability 
did not change significantly. 
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Table 7.1. Base line characteristics of patients with Duchenne muscular dystrophy  (DMD,  
n = 14) to determine the efficacy of mastication training using chewing gum for 4 weeks 
 
Patient 
no. 
Age 
yrs. mths 
DMD 
stage
a
 
MFM 
score
b 
Age stop walking 
yrs. mths 
Ventilatory 
support
c
 
Prednisone 
use
d
 Y/N 
Mixing index 
T0 T1 T2 
1 11.6 2 100 - 0 Y 21.1 21.4 19.5 
2 13.2 2 93 12.0 1 Y 26.5 24.2 25.1 
3 8.3 1 100 - 0 Y 28.3 20.9 22.0 
4 10.8 2 100 - 0 Y 25.0 27.3 28.2 
5 16.3 3 30 11.0 1 Y 27.8 23.6 23.9 
6 12.0 2 96 - 0 Y 20.7 19.1 18.8 
7 19.7 2 30 9.6 0 Y 21.5 21.2 23.6 
8 17.2 3 33 10.0 1 N 30.2 24.6 25.9 
9 20.8 3 27 11.0 1 N 29.7 24.7 25.4 
10 22.3 3 0 8.0 2 N 29.1 28.4 28.0 
11 28.3 3 21 11.0 1 N 26.6 23.8 23.7 
12 24.8 3 0 9.0 2 N 27.0 26.7 24.9 
13 7.4 1 100 - 0 Y 29.0 26.5 26.9 
14 9.7 1 100 - 0 Y 17.2 16.4 18.0 
15 17.4 2 72 10.0 0 N 21.1 16.6 18.3 
16 20.6 2 75 13.0 0 N 22.2 18.1 16.1 
17 21.8 3 75 12.0 0 N 24.2 23.4 25.6 
 
aDMD stage: scored as 1 = ENAS = Early non-ambulatory stage; 2= LNAS = Late non-ambulatory stage. 
b
MFM: Motor Function Measure, domain 2, items 13 to 23 assessed axial en proximal motor capacities –12 
items (total score 33 points = 100%); MFM score per item: 0 = does not initiate movement or starting position 
cannot be maintained; 1 = partially completes the exercise; 2 = completes the exercise with compensations, 
slowness or obvious clumsiness; 3 = completes the exercise with a standard pattern. 
c
Ventilatory support: scored as 0 = none; 1= part-time (nocturnal); 2 = continuous noninvasive; 3 = continuous + 
tracheostomy. 
d
Prednisone: % of patients using prednisone at base line or previously.
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Table 7.2.  Means and standard deviations of mixing ability, bite force (front) and active maximum mouth opening (aMMO) for patients (n = 17) 
and healthy subjects (n = 17) at the three measurement moments: T0, before exercise; T1, after 4 weeks of exercise; T2, 4 weeks after last 
exercise. Pat: patients; H: healthy controls. P-values are given of the differences between measurement moments (T0-T1, T0-T2 and T1-T2). 
Abbreviations: Δ, difference between measurement moments; CI, confidence interval.  
 T0 T1 T2 T0 – T1 T0 – T2 T1 – T2 
x  (SD) x  (SD) x  (SD) Δ (95% CI) P Δ (95% CI) P Δ (95% CI) P 
Mixing ability
a 
 
Pat 25.1 (3.9) 22.8 (3.7) 23.2 (3.7) 2.37 (1.09...3.65) 0.001 1.96 (-1.11...0.29) 0.008 -0.41 (0.58...3.34) 0.23 
H 17.3 (2.8) 17.6 (2.4) 17.6 (2.3) -0.23 (-1.8...1.35) 0.76 -0.29 (-1.65...1.07) 0.66 -0.06 (-1.28...1.16) 0.92 
Anterior MVBF
b 
(N) Pat 97 (33) 99 (48) 98 (41) -2.26 (19.71...13.90) 0.79 1.08 (-14.81...16.87) 0.89 5.30 (-9.52...20.11) 0.46 
H 170 (89) 207 (71) 214 (110) -35.61 (57.68...-13.44) 0.004 -42.48 (-78.77...-6.08) 0.025 -6.87 (-44.24...30.51) 0.70 
aMMO
c
 (mm) Pat 44.7 (9.9) 44.1 (9.8) 44.2 (9.9) 0.53 (-0.53...1.59) 0.31 0.41 (-0.87...1.7) 0.51 -0.12 (-1.39...1.15) 0.85 
H 55.7 (6.3) 55.9 (6.0) 56.4 (6.1) -0.24 (-1.85...1.38) 0.76 -0.65 (-2.02...0.72) 0.33 -0.41(-1.3...0.48) 0.34 
Lateral ROM L/R
d
  
(mm) 
Pat 6.7 (2.2) 6.6 (1.9) 6.9 (1.9) 0.18 (-.45...0.81) 0.56 -0.15 (-0.78...0.49) 0.63 -0.32 (-0.7...0.05) 0.09 
H 9.2 (1.9) 10.0 (1.0) 9.7 (1.6) -0.79 (-1.28...-0.3) 0.003 -0.5 (-1.26...0.26) 0.18 0.29 (-0.53...1.12) 0.46 
Protrusion
 e 
(mm) Pat 5.1 (2.1) 5.5 (1.6) 5.3 (2.0) -0.41 (-1.62...0.79) 0.48 -0.18 (-1.05...0.7) 0.67 0.24 (-0.63...1.1) 0.57 
H 9.5 (2.5) 9.2 (1.7) 9.9 (2.3) 0.35 (-0.67...1.38) 0.48 -0.35 (-1.2...0.5) 0.39 -0.71 (-1.38...-0.03) 0.041 
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a
Mixing ability: individual’s capacity to grind a two colored wax tablet during 20 strokes of mastication. A low 
mixing index indicates a better masticatory performance than a high index. 
b
Anterior MVBF: maximum vertical interocclusal bite forces between the central incisors of the upper and lower 
jaw anterior maximum voluntary bite force in Newton. 
c
aMMO: active maximum mouth opening, the maximum interincisal distance on opening as wide as possible 
corrected for the vertical over bite (limited aMMO < 40mm). 
d
Lateral ROM L/R: active mandibular lateral excursion, mean value between the left and right side.
 
e
Protrusion: active forward movement of the mandible. 
 
 
Figure 7.2.  The effect of mastication training  expressed by mixing ability and bite force using chewing gum 
in patients with DMD. (A) masticatory performance expressed as mixing ability, and (B) bite force (in N)  at 
base line (T0), afer four weeks mastication training (T1), and at 1-month follow-up (T2) for the patients with 
DMD and the healthy subjects.  
 
Anterior Maximum Voluntary Bite Force 
Patients had a significant lower MVBF than controls at T0 (p = 0.001), (Table 7.2 and Figure 
7.2 B). MVBF in the patient group did not change, whereas in healthy subjects a significant 
increase after the mastication training was observed at T1. After the 1-month follow-up this 
effect remained (Figure 7.2 B). 
 
Age effect  
Scatter plots were used to scan for the presence of age specific effects of the masticatory 
training. This was done for mixing ability, anterior MVBF, aMMO, lateral ROM L/R and 
protrusion. For all of these outcomes age specific effects were not seen.  
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Compliance and side effects 
All participants started the training followed the 4-week program according to the 
instructions. Analysis of the diaries of the patient group and healthy subjects showed that the 
compliance was high; in the patient group an average of 94% and in the healthy subjects an 
average of 99% of the required hours of training. 
  During T1 and T2 no serious adverse events were observed or reported in the 
questionnaires. One 12 year old patient had to reduce the intensity of the training in the 
second week because of catching flu. Another, 24 year old, patients with non-invasive 
ventilatory support mentioned temporomandibular pain symptoms during the T1 examination. 
One healthy subject developed headache after the training session during the second day of 
training which diminished after a few minutes. Other participants did not indicate any other 
side effects in terms of pain, fatigue in the masticatory system, choking chewing gum nor 
were other unexpected effects reported. 
 
Post hoc analysis 
The mixing ability of the 14 non-ambulatory patients increased significantly after the 
mastication training. At the one-month follow-up the effect remained. MVBF in the 14 non-
ambulatory patients did not change.  
 
Discussion  
The present study investigated the efficacy of mastication training in patients with DMD by 
assessing the MVBF and the masticatory performance. Mastication training significantly 
improved the mixing ability in patients with DMD whereas their MVBF did not change.  
  Eating is a social activity and plays an important role in nutrition intake and health. 
Eating is disturbed by progressive dysphagia in the advanced stages of DMD.
4
 Poor 
mastication of food in combination with weak pharyngeal clearance may increase pharyngeal 
post swallow residue and choking.
 8,30
 If masticatory performance is trainable this may have a 
positive effect on pharyngeal residue and choking. 
  Previous studies in healthy individuals demonstrated an increase of the bite force after 
masticatory training using chewing gum.
19,20
 In these studies, hard chewing gum was used. 
Such hard gum can, however, be too hard to chew upon by patients with DMD. Therefore, in 
our study we used a softer type in order to make the training for the patients feasible. The 
training, modified for gum hardness as well as for duration and frequency, was tested also in 
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healthy subjects. Despite the differences in training compared to previous studies, our healthy 
subjects demonstrated an increase of MVBF as well, indicating the efficacy of our training 
program. The improvement of the masticatory performance in our patient group was 
significant, although they did not reach the level of the healthy controls (Figure 7.2 B). Their 
masticatory performance reached the level of patients wearing full dentures (mixing ability 
21.2, SD 3.6). Keeping in mind the small numbers in this pilot study, in the post hoc analysis 
there was no difference in efficacy of the training between the early and late non-ambulatory 
patient group. Since OC and MVBF did not change after the training period, it is striking to 
observe an improvement of the masticatory performance. The skill to move the chewing gum 
around the mouth and keeping it between the teeth was trained for 4 weeks. Chewing the wax 
tablet is very much alike. Therefore the improvement of masticatory performance in the DMD 
group after mastication training may be caused by improvement of motor control and 
coordination resulting in an improvement of skills in performing mastication as the specific 
task rather than by changes of the masticatory muscle force. The study of Jansen et al. 
described a similar phenomenon when bicycle training for the extremities was applied in 
DMD.
18
  
  The study of Kawazoe et al. regarding training the masticatory system in patients with 
DMD does not fit the criteria suggested for exercise programs for patients with NMD.
31
 As a 
part of that training program the patients had to clench the jaws as hard as possible for 5 
minutes which is not a low intensity aerobic exercise. Moreover, clenching the jaws may be 
too difficult to perform for DMD patients because of the early loss of MVBF and the loss of 
posterior occlusal contacts between the jaws in a later stage of the disease. The study of 
Nozaki et al. describes a range of motion exercise and demonstrates a significant increase of 
the occlusal force and the patients’ satisfaction with meals.32 Both training methods cannot be 
performed by the patient himself and are difficult to fit into daily life routine. 
  Training of masticatory muscles by using chewing gum fits the criteria suggested for 
exercise programs in DMD; the training is safe, low in intensity, rhythmic, continuous, and 
aerobic, fits in the daily life routine and can start at a young age.
33-35 
The compliance of the 
patient group and healthy subjects was high. Moreover, sugar free chewing gum contains 
polyols which are alcohol derivates of sugar. Polyols improve oral health by stimulating 
salivary flow, which results in an increased buffering capacity after sugar intake.
36
 The polyol 
xylitol in the chewing gum used in this study reduces the amount of Streptococcus mutans, 
which plays an important role in the development of the amount of caries inducing bacteria.
37 
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If mastication training would cause negative side effects, development of signs and symptoms 
of temporomandibular dysfunction (TMD) during or after the training would be expected. The 
main signs and symptoms of TMD, e.g. reduced mandibular ROM, mandibular deviation on 
opening, pain on palpation of the masticatory muscles and temporomandibular joint, did not 
occur throughout the training except in one patient. This 24 year old patient with non-invasive 
ventilatory support mentioned TMD symptoms during the T1 examination. After instructing 
how to adjust the air tube, the pain symptoms disappeared at T2. We may conclude that the 
pain symptoms in this patient were caused by the poorly positioned air tube. In the 3 patients 
we could provoke pain during the clinical examination by opening the mouth passively. We 
suggest that this can be attributed to contracture of the masseter muscle rather than to TMD 
symptomatology. The patient who catched flu consulted the investigator and started training 
again in the second week after 3 days rest. In the healthy subject with headache after the 
training session, the headache diminished already after a few minutes. 
  The following limitations within this study have to be taken into account. First, ideally 
a group of patients would be randomized and controlled, e.g. training vs. no training would be 
contrasted. In orphan diseases, such a study design is not or hardly feasible. Since we 
designed our study as a pilot, in future studies a baseline measurement 4-6 weeks before the 
training starts would give more strength to the results. Second, the wax tablets may have been 
too tough for mixing by patients with DMD. It is suggested to offer the wax tablet at a higher 
temperature in patients with severely compromised masticatoy performance.
25 
Prior to the 
start of the study, we offered tablets at a temperature of 30 °C to three subjects. Under these 
conditions, pieces of wax were sticking to the teeth and a coherent bolus could not be 
collected which lead to the decision to offer the wax tablets at room temperature. Third, due 
to the small number of patients in our pilot study, it is not possible to state whether the 
mastication training is more effective in subgroups of patients stratified by age or motor 
function. We used scatter plots to establish age specific effects of the masticatory training on 
each of the variables masticatory performance, anterior MVBF, aMMO, lateral ROM L/R and 
protrusion. For all these outcomes age specific effects were absent. The post hoc analysis with 
14 non-ambulatory patients showed the same results compared to the group of 17 DMD 
patients. Fourth, we cannot determine whether the increase in masticatoy performance in the 
patients with DMD was further influenced by exposure to prednisone. The post hoc analysis 
did not give additional information on this issue.   
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  Changes in the masticatory system like dystrophic changes in submental muscles and 
the tongue, dental abnormalities and decrease of the MVBF and labial force are developing 
early in the disease process.
4,5,10
 These changes lead to deterioration of the masticatory 
performance already in the ambulatory stage of DMD.
5
 When dystrophic changes in the 
masticatory and the submental muscles are present, patients may be less responsive to the 
mastication training.
5,8
 This may indicate that masticatory training has to start as early as 
possible. In the advanced stage when patients have to adjust to a soft diet because of health 
issues, e.g. insufficient food intake because of prolonged mealtime, mastication training can 
activate the masticatory system.
5
 Mastication training may postpone the deterioration of the 
masticatory system and preserve functional skills.  
  To preserve functional skills of the mastication system we suggest patients with DMD 
to (1) treat the patient with DMD within a multidisciplinary setting to integrate stimulation of 
the masticatory system in a safe feeding plan (2) keep the masticatory system active by eating 
solid food as long as it is safe regarding health issues; the airway defense mechanisms, cough 
strength and calorie intake has to be sufficient (3) supplement eating by mastication training 
using sugar free chewing gum at the age of  6 and older when it is safe to use chewing gum; 
the child only chews and never swallows the gum (4) when adjustment to a soft diet has to 
take place because of health issues, continue the mastication training. 
  Future research is needed to investigate (1) if an increase of the duration (e.g. 16 
weeks) of the training will increase its efficacy and (2) if patients in an early disease stage are 
more responsive to masticatory training compared to patients in a late disease stage. 
 
Conclusion 
Mastication training by using sugar free chewing gum in patients with DMD improved the 
masticatory performance. The working mechanism of this improvement was not related to an 
increase of the MVBF, but might be related to changes of motor control and coordination 
followed by improvement of skills in performing mastication as the specific task. 
Future research is needed to assess the efficacy of masticatory training in a larger number of 
patients, ideally using a randomized controlled design. 
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Introduction 
Medical care for patients with a neuromuscular disorder (NMD) has improved the quality of 
life and increased longevity.
1,2
 However, the increased longevity has resulted in non-fatal 
medical complications of the disease, such as limitations in mandibular function, which 
become more prominent and require more attention. While the medical care for patients with 
NMD includes medical, surgical, and rehabilitation approaches an assessment of mandibular 
function is not yet included. 
 Impaired mandibular function, which is often reported by children and adults with 
NMD, is an important causal factor for feeding and swallowing difficulties which can 
adversely affect health.
3-5
 Mastication problems may induce post swallow residue, which is 
known to lead to complications like choking and the perception of food stuck in the throat.
6-9
 
A possible cause of these problems appears to be related to deterioration of the masticatory 
function and therefore a deepened understanding of the prevalence and the mechanisms 
behind mandibular dysfunction in NMD is needed. This thesis aimed to contribute to these 
insights and improve quality of life of patients with SMA and DMD as well, and take first 
steps to develop interventions, such as training in DMD, to maintain adequate masticatory 
function as long as possible. 
 In this chapter the results of this thesis are discussed for each research question. The 
differences between SMA and DMD in clinical presentation and underlying mechanisms are 
addressed and the need for disease specific training is discussed. Training recommendations 
for SMA and DMD, methodological considerations, conclusions and suggestions for future 
research are provided. 
 
PART I: Spinal muscular atrophy (SMA) 
 
The Dutch patient organization noticed that a significant number of their members with SMA 
experienced a progressive restriction in mouth opening. The department of Oral-Maxillofacial 
Surgery, Prosthodontics and Special Dental Care at the University Medical Center Utrecht, 
the Netherlands was invited to investigate the mechanism behind this symptom and formulate 
an advice to their members. 
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 What is the prevalence of impaired mandibular function in SMA? 
 
The question of the SMA patient organization led to a master graduation project of two 
physiotherapists, followed by a pilot study in 12 children and adolescents with SMA type 2 
compared to healthy subject (chapter 2). During this study, collaboration started with the 
department of Neurology at the UMC Utrecht and the department of Oral function and 
prosthetic dentistry and the department of Rehabilitation (rehabilitation medicine and speech 
therapy) at the Radboud university medical center, the Netherlands. The patients filled out 3 
questionnaires regarding mandibular function; Screen, Mandibular Function Impairment 
Questionnaire (MFIQ) and Patient Specific Approach (see chapter 2). The participants 
underwent a clinical examination of the masticatory system. The study demonstrated that 
impaired mandibular function was common among young patients with SMA type 2; active 
maximum mouth opening with an aMMO ≤ 30 mm was present in 75% of the patients. Forty-
five % of the patients with an aMMO ≤ 30 mm scored a low function impairment in the 
MFIQ, indicating a discrepancy between these limitations and the awareness of the patients, 
parents and care takers. Mild pain could be provoked in 2 out of 12 patients during traction 
and translation of the temporomandibular joint (TMJ) and in 8 out of 12 patients during 
assisted maximal mouth opening; no pain was reported in the control group. Pain is not 
characteristic for SMA and may be attributed to internal structure changes of the masseter 
muscle.
10
 The pilot study made clear that there is a need to inform patients regarding the 
impact of SMA on the mandibular function. 
 Two additional SMA studies took place between July 2010 and July 2013 in patients 
who visited the outpatient clinic of the UMC Utrecht, the Netherlands.  
Study A: the home visit study (chapter 3).  
Patients with SMA type 2 and type 3, listed in the Dutch SMA registry were informed by 
letter to participate in a study of mandibular function. Sixty patients with SMA type 2 and 3 
were examined through home visits. 
Study B: cross-sectional study in 145 patients with SMA types 1-4 (chapter 4). 
Patients with SMA types 1-4, listed in the Dutch SMA registry, were examined at the 
outpatient clinic of the University Medical Center Utrecht, the Netherlands. Measurement of 
the aMMO took place and in 12 patients muscle groups relevant for mouth opening and 
closing and mandibular condylar surface and condylar sliding were visualized by magnetic 
resonance imaging (MRI). 
1 
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  The cross-sectional study demonstrated an influence of SMA type on aMMO (p < 
0.01). The reduced mouth opening was common in SMA types 1-3a. During the home visit 
study, the first research question was addressed more extensively by adding the variables bite 
force and the masticatory performance to the protocol of the pilot study. The questions in the 
Patient Specific Approach questionnaire overlapped with the questions in Screen and MFIQ; 
for this reason this questionnaire was removed from the protocol. The study demonstrated that 
all mandibular movements and the MVBF were significantly reduced in patients with SMA 
compared to the controls, with type 2 more affected by the disease than type 3a and 3b. The 
masticatory performance was not significantly different in the patient group compared with 
the control group, neither between the three SMA types. Masticatory performance is, next to 
bite force, primarily influenced by the number of functional tooth units (occlusal contacts) in 
healthy subjects.
11
 Although there was a high percentage of (tendency to) cross bites in our 
patient group, the mean number of occlusal contacts (OC score) was only one occlusal contact 
lower than in the control group and is still sufficient to mix the wax tablets. Patients were 
asked to chew 20 times on the two-coloured wax tablet, which may be insufficient to capture 
fatigability, an important additional problem to weakness in patients with SMA.
12
  
  A reduced mouth opening may hamper oral hygiene and dental care. Inadequate oral 
hygiene is encouraging the bacteria colonizing in the oral cavity and dental plaque. Oral 
hygiene Gram-negative (anaerobic) bacteria in the oral cavity in frail elderly are reported to 
be a source of infection for aspiration pneumonia.
13
 Since SMA patients are at risk of 
dysphagia, which is closely associated with aspiration pneumonia, oral hygiene is, like in frail 
elderly, an important issue in patients with SMA.
13-16
 Control of oral biofilm formation by 
improved oral hygiene, reduces the numbers of potential respiratory pathogens in the oral 
secretions, which in turn reduces the risk for pneumonia .
17-19
 To date, there is no definitive 
agreement about the most effective oral care protocol. Optimal measures of oral hygiene by 
brushing with regular toothbrush and rinsing with chlorhexidine mouthwash in critically ill 
patients are reported.
20 
 
 Is the bulbar muscle function affected by SMA type 2 and 3? 
 
Multiple linear regression analysis in the cross-sectional study in 145 patients with SMA 
types 1-4 revealed other determinants for aMMO than the home visit SMA study due to a 
difference in SMA types. In the home visit study, patients with SMA types 2 and 3 listed in 
2 
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the Dutch SMA registry participated; in the cross-sectional study 145 patients with SMA 
types 1, 2, 3 and 4 were investigated. 
 In the home visit study the aMMO and the anterior MVBF were considered the main 
outcome variables. A striking finding is the correlation between the aMMO and the 
subjectively reduced mouth opening, which was not reported in the previously performed 
pilot study (chapter 2). This correlation may be due to the awareness of a reduced mandibular 
function in patients with SMA and their caretakers increased over the last 3 years, possible by 
informing the SMA patient organization and their members and thus a higher awareness after 
the pilot study was published. Multiple linear regression analysis revealed SMA type, MFIQ, 
difficulties in biting of food and food adaptation as determinants for reduced aMMO, SMA 
type, MFIQ, difficulties biting of food and food adaptation for a reduced anterior MVBF 
(chapter 2). 
 In this cross-sectional study, the determinants for reduced aMMO were SMA type, 
age, muscle weakness and dysphagia (p < 0.05). ROC curves were generated to analyze the 
predictive value of clinical motor scores and aMMO for the presence of dysphagia. Reduced 
aMMO reflect a more widespread process of degenerative changes of bulbar muscles and may 
represent an easy tool to assess the risk for dysphagia in patients with SMA, but this needs 
further study. 
 
 What is the underlying mechanism for the impairment of mandibular function in SMA?  
 
To be able to fully open the mouth, both rotation and sliding of the mandibular must occur. 
Reduced sliding of the TMJ will lead to a reduction of aMMO. In chapter 2 we suggested that 
the reduced mandibular range of motion (ROM) of the patient group compared to that of the 
controls may be caused by changes in the morphology of the TMJ. Inadequate mandibular 
movement caused by a progressive weakening of mastication and neck muscles might initiate 
these changes. Magnetic resonance imaging (MRI) data from 12 patients with SMA type 2, 3 
and 4 demonstrated in the 7 patients with the most severe reduction of aMMO (range 10–30 
mm) evident atrophy and fatty infiltration of the lateral pterygoid muscle with only mild 
changes in other mouth opening muscles, i.e.digastric and geniohyoid muscle. This may 
provide an explanation of the pathophysiology of the reduced aMMO. Comparing MRI in 
open and closed mouth position revealed limitation of the condylar mobility. The mandibular 
condyles did not show structural changes of the articular surfaces. Degenerative changes of 
3 
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the lateral pterygoid muscle, mediating mouth opening by condylar sliding, play an important 
role in the development of reduced aMMO, but other factors cannot be ruled out. Mild 
changes in the suprahyoid muscles such as contracture or degenerative changes with a 
resulting stiffness of the masticatory system may have a similar effect on the aMMO because 
of the longer distance between their bony insertions to the mandible and the TMJ. Although 
MRI sequences may detect bony changes, CT imaging is more appropriate than MRI for 
assessing structural changes of the articular surfaces of the TMJ.
21
  
 Surprisingly, masticatory performance was not significantly different in the patient 
group compared with the controls, neither between the three SMA types. The home visit study 
addressed the influence of bite force, but there are other aspects of mastication performance, 
particularly fatigability, that we have not addressed. In a previous study on skeletal muscles, 
the 6-minute walk test demonstrated a correlation between weakness and fatigue; 
longitudinally weakness did not change, but fatigue increased significantly.
12
 Future studies 
on the role of fatigue in reduced mastication performance may consider an amended study 
design using the mixing ability index. Additional mixing ability assessments up to e.g. three 
sequential tests in one measurement session and time indication per test may show a 
difference in fatigability between patients with SMA and healthy controls. Another aspect that 
may be the subject of future research is how the recruitment of motor neurons is affected in 
reduced mastication performance. 
 
PART II: Duchenne muscular dystrophy 
 
Research support from Duchenne Parent Project was received to perform a pilot study on the 
prevalence and mechanisms of mandibular dysfunction related to DMD, and their relationship 
with swallowing problems (chapter 5 and 6). Part of this project was dedicated to the 
evaluation of masticatory training in patients with DMD (chapter 7). 
 
 What is the prevalence of impaired mandibular function in DMD?  
 
Twenty-three patients, originating from a swallowing study of van den Engel-Hoek and co-
authors at the department of Rehabilitation, Radboud university medical center, Nijmegen, the 
Netherlands, and 23 age and gender matched healthy controls were investigated during home 
visits, following the protocol described in chapter 3.
8
 In the patients, quantitative muscle 
4 
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ultrasound imaging (QMUS), a quantitative echo intensity analysis, of the tongue and motor 
function measurement (MFM) were added to the protocol. The MFM is collecting, among 
other items, information about the sitting position, arm function, and neck and head control.
22
 
Based on the ambulatory function of the patient and the MFM, patients were divided in three 
subgroups: early and late ambulatory stage (AS), early non-ambulatory stage (able to maintain 
posture, ENAS), or late non-ambulatory stage (upper limb function and postural maintenance 
is increasingly limited, LNAS) (chapters 5 and 6).
2
  
  The results of this study demonstrated a reduced masticatory performance, reduced 
bite force, high percentage of dental abnormalities (cross bite and tendency to cross bite) and 
prolonged mealtime as early signs of motor function deterioration, even before MFM changes 
became obvious in patients with SMA compared to healthy subjects. These early changes 
suggest that training of the mandibular function has to start early in the disease process. 
Mandibular movements were significantly reduced in the patient group compared to the 
controls but none of the patients reported problems with these limitations (chapter 5).  
  Limitations in the masticatory performance appear to be a dominant problem as 
reported by our patients with DMD in Screen and MFIQ (Chapter 5). Poor mastication of 
food in combination with weak pharyngeal clearance may increase pharyngeal post swallow 
residue and choking and possibly contribute to an increased risk of food aspiration.
3,6-8,23
 In 
healthy dentate subjects, chewers with a low masticatory performance do not necessarily 
chew longer before swallowing than chewers with a high masticatory performance. As a 
consequence bad chewers in this healthy cohort would, on average, swallow larger food 
particles (Fontijn-Tekamp 2004).
24
 To our knowlegde, there is no clear evidence or reports in 
the DMD literature of a correlation between poor mastication leading to swallowing large 
pieces of food and aspiration, hospitalizations and life-threatening pneumonia.  
 
 What are predictive factors for mandibular function in DMD?  
 
Masticatory performance 
To study the association between masticatory performance and each predictive factor, 
univariate linear regression analyses were performed. These analyses revealed a negative 
correlation between masticatory performance and DMD stage (ENAS), and the anterior 
MVBF. Because of the small number of patients only two variables were used in the multiple 
linear regression analysis, which indicated the stage of the disease as the strongest predictive 
5 
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factor for masticatory performance (R
2
 = 0.52).  
 
Active maximum mouth opening 
Univariate linear regression analyses for aMMO were performed and revealed negative 
correlations between aMMO and age, body height, ultrasound score of the digastric muscle 
and geniohyoid muscle, and positive correlations between aMMO and MFM. According to 
the multiple regression analysis MFM was the strongest predictive factor (R
2
 = 0.52). The 
correlation between the aMMO and the MFM can be explained by the reported correlation 
between the muscular function of the cervical vertebral column and the mandibular 
function.
25,26
 Patients with DMD develop a progressive cervical lordosis, rigid neck 
hyperextension and poor head control in their teens.
27-29
 As MFM item 13 and 14 are designed 
to collect information about the head and neck control, the MFM score might be associated 
with aMMO. In chapter 6, the low scores on MFM item 13 and 14, mainly in patients 
classified as LNAS demonstrated the poor trunk position and head control. In this ambulatory 
stage 6 out of 10 patients (60%) had a limited mouth opening. We suggest that poor trunk 
position and head control may have an effect on the mandibular range of motion. 
 
 What is the underlying mechanism for the impairment of mandibular function in DMD? 
 
Masticatory performance 
The dominant factors influencing masticatory performance in healthy subjects are, as 
mentioned before, the number of occlusal contacts and the bite force.
30
 Furthermore, tongue 
function is of importance because of its role in food-bolus mixing, formation and 
positioning.
31
 In this study, the anterior MVBF, representing the strength of the mandibular 
closing muscles, and the number of occlusal contacts were significantly lower in patients with 
DMD compared to controls (chapter 5). A previous sonographic study indicated fatty 
infiltration related to the dystrophic changes of the masseter muscle in patients with DMD 
which explains the low anterior MVBF.
10
 The occlusal changes expressed as (tendency to) 
cross bite, developed early in the course of the disease and is due to an increase in tongue 
thickness without structural changes in ENAS (hypotrophy) and later dystrophic change (i.e. 
the infiltration of fat and fibrous tissue, hypertrophy) of the transverse tongue muscle in 
LNAS.
8
 The increased tongue thickness and dystrophic changes and weakness of the masseter 
6 
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muscle in combination with the early occlusal changes play an important role in the 
development of a low masticatory performance in our study (chapter 5).
 
  From the literature we know that a reduced range of hyoid movement in DMD patients 
was strongly associated with an increased risk of post-swallow residue.
23
 Oral phase problems 
and post-swallow residue with solid food were observed, mostly in the LNAS.
8
 We suspect 
that reduced masticatory performance leads to swallowing of larger pieces of food and an 
increased post-swallow residue. Because this residue is likely to spill into the open airway, it 
places patients at risk for aspiration pneumonia. A previous study reported medication use for 
pneumonia in 54% of the patients in the LNAS in the past year.
8
 The missing link between 
poor mastication, swallowing large pieces of food and aspiration remains to be studied.  
 
Mandibular range of motion 
As mentioned earlier, sonography indicated degenerative changes related to the dystrophic 
changes of the masseter muscle and the suprahyoid muscles in DMD patients.
8,10
 Muscle 
dystrophy may lead to muscle stiffness and consequently may hamper mouth opening and 
horizontal jaw movements as reported in chapter 5. Protrusion and mandibular ROM were 
reduced in patients compared to controls, although the reduction of protrusion and mandibular 
ROM leaves room for condylar sliding. This is confirmed by results of the clinical assessment 
of condylar movement capacity relative to the crest of the eminence: 80% of the patients with 
aMMO smaller than 35mm (4 of 5 patients) had a normal condylar sliding, and just 20% (one 
patient) had a limited sliding relative to the eminence crest. It seems that the TMJ is not 
involved. Whether the lateral pterygoid muscle is involved has not yet been investigated. MRI 
could reveal the influence of DMD on the lateral pterygoid muscle, as was reported in patients 
with SMA (chapter 4). Our results together with the observations reported in the literature 
about dystrophic changes of the masseter muscle and the suprahyoid muscles indicate that 
structural changes in the masticatory muscles may primarily be responsible for a reduced 
mandibular ROM in general, and for aMMO in particular.
8,10
 
  In conclusion, the results of this study illustrated that mandibular ROM and 
masticatory performance in DMD patients are significantly reduced compared to the healthy 
subjects; limitations of the masticatory performance as reported in the questionnaires were a 
dominant problem for patients with DMD. 
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 What is the efficacy of training the masticatory muscles using chewing gum in DMD? 
 
There is a lack of evidence for advising an appropriate exercise program for skeletal muscles 
as well as for masticatory muscles in patients with DMD.
2,32
 Inappropriate activities may 
exacerbate the dystrophic process. On the other hand, reduced physical activity may lead 
secondary to ‘’disuse’’ muscle atrophy. The gold standard is a suitable monitoring of the 
balance between rest and activity.
33
 A recent study in boys with DMD on the effect of 
assisted, low-intensity bicycle training on preservation of skeletal muscle endurance and 
functional abilities reported promising results.
35
 
  In healthy subjects, chewing during meals 3 times per day is considered optimal 
regarding the use of the masticatory muscles. But a reduced activity of masticatory muscles in 
healthy Japanese children through a preference for soft food, led to a decrease in muscle 
strength with a negative influence on the masticatory performance.
35,36 
In DMD a reduced 
masticatory performance contributes to prolonged meal time and masticatory muscle fatigue. 
In the study described in chapter 5, patients in LNAS reported prolonged duration of food 
intake leading to weight loss and food adaptation. Food adaptation, defined as unable to eat 
hard biscuits, meat, raw carrots, French loaf or nuts, was reported in 52% of the patients with 
DMD, which is in agreement with other reports.
23
 Eating soft and chopped food leads to 
underloading of the masticatory system, including the muscles of mastication. In DMD, also 
bite force is reduced compared to the healthy subjects, suggesting that the masticatory 
muscles are involved. Muscle training seems a possibility to reduce chances of deterioration 
or postpone detoriation of the masticatory muscles. A correlation was found between the 
MVBF and masticatory performance (chapter 5), offering a possibility for intervention in 
DMD. 
  Two studies in DMD investigated the effect of masticatory muscle training. The 
training program described by Kawazoe et al. improved the masticatory performance by 
means of jaw-clenching for 5 min. each time followed by mandibular and neck ROM 
exercises.
37
 Another training program that included a therapist-assisted training twice a week, 
application of hot pack on the cheeks, massage of the masseter muscles, and (before each 
meal) self-training including passive stretching exercise by opening the mouth to the 
maximum degree, increased the bite force without influencing MMO.
38
 The training of 
Kawazoe et al. does not match with the latest training suggestions for patients with muscular 
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dystrophy, which are low intensity aerobic exercises.
37
 Moreover, clenching the jaws is 
difficult because of the early loss of bite force and the loss of the number of occlusal contacts, 
described in chapter 5. These limitations will limit the feasibility of the training of Kawazoe 
and coworkers
37
. Both studies do not fit in daily life routine and are too demanding for 
patients as training of the masticatory muscles should be continued as long as it is safe for the 
health of the patient.
37,38
 
  Although masticatory muscles are different in histology and functional properties 
compared to skeletal muscles, we decided to develop a training program inspired by the 
dynamic, active-assisted bicycle training performed by Jansen and co-authors in 2013.
34
 Use 
of a soft type of chewing gum is a low intensity aerobic exercise, low resistant, easy to 
implement in daily life routine and common activity among youngsters which result in a good 
compliance. Furthermore the sugar free chewing gum used in this study contains xylitol, 
which improves oral health. The results in our study indicate that masticatory training by 
using sugar free chewing gum 4 weeks is indeed feasible and safe, and is improving the 
masticatory performance in the patient group. Because the bite force in our study did not 
improve, the working mechanism of the improvement in mastication performance may relate 
to changes of the neuromuscular function and coordination, resulting in improvement of skills 
in performing mastication. 
 
PART III: Comparison, integration and implementation 
 
I. What are the similarities between SMA and DMD? 
Patients with SMA and DMD report both feeding and swallowing problems although the 
pathogenesis of each disease is distinct, and each disease has distinguishing characteristics.
3-
5,39
 Feeding problems are represented in patients with SMA and DMD by a reduced 
mandibular function (chapter 2–6). As described in chapters 2 to 6, the weakness of the 
masticatory muscles, dental malocclusions and reduced mandibular range of motion in 
combination with previously mentioned abnormal craniofacial growth patterns and reduced 
function of the tongue, are all involved in the development of mandibular dysfunction in both 
children and adults with SMA and DMD.
40-44 
 Video fluoroscopic swallow studies showed that impaired swallowing leads to 
pharyngeal post swallow residue of solid food in advanced stages of SMA and DMD and 
increase in volume with age.
6,8,9,45
 When large amounts of post swallow residue remain, the 
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risk for aspiration is increased when the patient inhales after the swallow and the airway 
opens naturally.
46 
Food adaptation might start as soon as patients are concerned about food 
aspiration. 
  
II. Are there differences between SMA and DMD in clinical presentation and underlying 
mechanisms in the masticatory system?  
How much influence the muscular environment has on mandibular function depends of the 
origin of the NMD. Each type of NMD is showing specific signs and symptoms of impaired 
mandibular function. In SMA, mandibular dysfunction is induced directly via the bulbar 
motor neurons with secondary peripheral muscular sequels (chapters 3 and 4); In DMD, the 
pathophysiological substrate is located peripherally with primary affection of the muscles.
 
Although promising therapies are currently being developed there is still no cure for 
patients with SMA and DMD.
48
 A difference between SMA and DMD is that the use of 
corticosteroids as a symptomatic treatment demonstrates beneficial effect on muscle strength 
and function in boys with DMD but no beneficial effect in SMA.
49,50 
 In this thesis the answers in the questionnaires Screen en MFIQ, the range of motion 
tests of the mandible, MVBF and the chewing efficiency reveal differences in function of the 
masticatory system between SMA and DMD.  
 
Spinal muscular atrophy 
Chapters 3 and 4 provide further evidence for clinically relevant bulbar involvement in 
patients with SMA. Bulbar involvement leads to at least two dominant impairments of 
mandibular function, i.e. mandibular ROM and MVBF are diminished in patients with SMA 
types 2 and 3. The fatty degeneration of the lateral pterygoid muscle is playing an important 
role in the development of a reduced aMMO but other factors cannot be ruled out. Weakness 
of neck muscles may further contribute to impaired mandibular function. Head retraction by 
the neck muscle in an attempt to stabilize the balance of the head may increase reduction of 
the opening capacity of the mouth (chapters 2 and 3).
45
 Our data support a model for 
mandibular dysfunction caused by gradually increasing weakness of muscles that mediate 
mouth opening and closing, leading to MVBF reduction and development of progressive 
contractures of the TMJ.
 
Because of the relatively high percentage of our patients who report problems with 
chewing it was somewhat surprising that masticatory performance did not differ between 
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patients and control groups. Although mastication performance was maintained, the MVBF 
was reduced in the patients compared to the controls, more in SMA type 2 than type 3a and 
3b.The mixing ability index in our studies measured 20 chewing strokes, which does not 
include fatigability. It is advised to address the fatigability issue in future studies.  
 
Duchene muscular dystrophy 
In DMD, the masticatory performance is the dominant impairment with disease severity as the 
strongest predictive factor for masticatory performance.  
  MVBF, number of occlusal contacts and masticatory performance in DMD are 
severely reduced. It is probably the combination of an enlarged tongue, weakness of the 
masseter muscle, expressed by a decrease in MVBF early in the disease process that cause the 
loss of number of occlusal contacts. The loss of occlusal contacts in combination with a 
reduced anterior MVBF is playing an important role in the development of a reduced 
masticatory performance in boys and man with DMD. 
  We cannot determine whether the decline in masticatory performance or the efficacy 
of the chewing training in the patients with DMD was further influenced by exposure to 
prednisone (chapters 5 and 7). Prednisone-naïve DMD patients are insufficiently represented 
in ambulatory stage and early non-ambulatory stage to assess a statistical link between 
prednisone and masticatory muscle function. Additionally, the standard of care for DMD has 
changed overtime, resulting in a different standard of treatment for older compared to younger 
patients.  
 
III. Is there a need for specific training advice for SMA and DMD? 
The studies in this thesis demonstrated that there is a need for a specific training program for 
SMA and for DMD patients. Mandibular function, expressed as mandibular ROM, 
masticatory performance and MVBF, were different in their presentation due to the distinct 
pathology and characteristics of each disorder. Very likely each NMD e.g. myasthenia gravis, 
myotonic dystrophy, congenital myopathies will present disease specific symptoms of the 
mandibular function and need a desease specific training program. Each NMD requires a 
tailored approach to help the patient to cope with the encountered difficulties he / she is posed 
for and to delay the process of deterioration.  
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IV. Which disease-specific recommendations for training protocols can be given in SMA 
and DMD? 
Because of the complexity of the disorders, patients with SMA and DMD have to be treated 
within a multidisciplinary setting. Different impairments are influencing each other, like 
sitting position, head balance, swallowing and respiratory function. In order to integrate 
stimulation of the masticatory system in rehabilitation and modern management of 
complications a safe feeding plan has to be present. The multidisciplinary team should consist 
of e.g. orthopedic surgeon, pulmonologist, cardiologist, dentist, physiotherapist, occupational 
therapist, speech therapist, dietician, and social worker.  
  For specific recommendations for SMA and DMD explorative cross-sectional research 
with larger groups is needed to study the mechanisms behind the impairments of the 
mandibular function. After the cross-sectional studies randomised clinical design studies are 
required. Until RCT data are available; we only can make suggestions for training of the 
mandibular system. 
  For both SMA and DMD in the non-ambulatory stage of the disease, the complications 
of dysphagia and weight loss, due to pronged meal time, lead to food adaptation.
4,5,20,51,52 
Since there are no cut-off values for aMMO and mixing ability, when effecting swallowing 
negatively, the decision to adapt food should be based on sufficiency of the airway defense 
mechanisms, cough strength and calorie intake, which falls under the care of the medical 
specialist. Education of patients, parents and caretakers, making them aware of the probability 
of a limited mandibular function, must be an integral part of the total care in SMA and DMD.  
 
Spinal muscular atrophy 
In SMA, the main limitation of the mandibular function is the mandibular ROM and the 
MVBF. We suggest that a training protocol has to focus on active movements and stretching, 
and be easy to implement in daily life in combination with keeping the maticatory system 
active. Advised physical exercises include passive stretching of the mouth opening and 
passive movement of the mandible in all horizontal directions. The timing of therapeutic 
passive stretching exercises and its effectiveness, once severe limitation of the mandibular 
ROM is present, remain unclear. Based on MRI information and clinical experience, the 
training can start when the patient is still in the ambulatory stage, before muscle involvement 
has progressed to an irreversible stage (Table 8.1). 
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Duchene muscular dystrophy 
In DMD, the main limitation of the mandibular function is the masticatory performance. We 
suggest that a training protocol has to focus on training mastication with low intensity aerobic 
exercises. The training should be easy to implement in daily life. Our findings advocate the 
advice to encourage patients with DMD to postpone food adaptation as long as the airway 
defense mechanisms, cough strength and calorie intake are sufficient. If food adaptation is a 
necessity for quality and duration of life, food adaptation needs to take place. The suggestion 
applies mainly to patients in the early and late ambulatory stage and the early non-ambulatory 
stage of the disease because patients in these two groups usually meet these requirements. In 
case the requirements are not met, the suggestions of van den Engel-Hoek et al. (2013) are 
relevant: (1) adjust meals in terms of less solid food and (2) drink water after meals to clear 
the oropharyngeal area.
8
 Moreover, we suggest that masticatory exercises (chapter 7) are 
applied in DMD as early as possible in the disease. For example, at first reports of food 
adaptation, in an effort to postpone the decline of masticatory muscle function in these 
patients (Table 8.1).  
 
Table 8.1. Recommendations for mandibular function training in patients with SMA and 
DMD 
 
SMA DMD 
Treat the patient within a multidisciplinary setting to integrate stimulation of the masticatory system 
in a safe feeding plan. 
Keep the masticatory system active by eating (semi) solid food  
Airway defense mechanisms, cough strength and calorie intake must be sufficient. 
Start physical exercises of the masticatoy system 
as early as possible. 
When adjustment to a soft diet has to take place, 
start mastication training. 
Physical exercise: stretching of the mouth 
opening and active movement of the mandible in 
all horizontal directions. 
Mastication training: one piece of soft sugar free 
chewing gum per exercise, 3 x / day, 
 30 min / session, 5 days / week. 
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Reflection on clinical outcome measures  
In this thesis, first we described the main parameters expressed as mandibular ROM, the 
anterior MVBF and the masticatory performance, to assess the mandibular function. Second, 
we discussed the medical data of the motor function from the department of rehabilitation of 
the Radboud university medical center, Nijmegen and the department of Neurology and 
Neurosurgery and Spieren voor Spieren Kindercentrum, University Medical Center Utrecht, 
the Netherlands. 
 
Mandibular ROM  
Suggested cut-off values for reduced aMMO in population based studies vary between 40 – 
44 mm for men, 38–42 mm for women and 35–38 mm for and for horizontal movements of 
the mandible (protrusion, right and left lateral movements) is 5–8 mm.53-58 In view of the wide 
range of variation of individual mandibular movements due to e.g. anthropologic factors, 
morphology and status of the masticatory system it is not practical to suggest cut-off values 
for mandibular ROM per age category.
11,56, 59,60
 Moreover, the range of motion always needs 
to be evaluated in the full context of the patient. In this thesis the values of the mandibular 
movements are discussed as reduction of the mandibular movements compared to healthy 
controls rather than as cut-off values.  
 
Anterior maximum voluntary bite force 
When measuring MVBF in human subjects, the reliability of the measurements within subject 
and between sessions differed considerably in previous studies.
61
 In longitudinal studies, the 
total reliability, after controlling for age, was better for incisor MVBF than for molar 
MVBF.
61
 The measurement of anterior MVBF between the upper and lower canines is not 
always feasible because of loose, partly erupted or missing canines, due to changing from 
primary to secondary dentition. The posterior MVBF may be severely complicated or 
impossible due to e.g. reduced mouth opening, posterior cross bites, and loss of contact in the 
molar region. With reference to these complications, during assessment of MVBF in this and 
in future longitudinal research, the MVBF needs to be measured between the upper and lower 
central incisors. 
 
Masticatory performance 
In the majority of the studies on masticatory performance, the degree of breakdown of food 
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has been determined by sieving the food particles. A natural test food has the advantage that it 
is normally consumed, so that subjects are accustomed to it.
11
 In our vulnerable patient groups 
with an increased risk of aspiration, we decided to use wax tablets which form a 
homogeneous bolus after mastication. In the literature it has been suggested to offer the wax 
tablet at a higher temperature in patients with severely compromised masticatory 
performance.
62
 Prior to the start of the study, we offered tablets at a temperature of 30 °C to 
three subjects. Under these conditions, pieces of wax were sticking to the teeth and a coherent 
bolus could not be collected which lead to the decision to offer the wax tablets at room 
temperature. As an alternative for the mixing ability test a two-colour chewing gum test for 
assessment of masticatory performance could be used.
63 
 
Motor function 
Multidisciplinary setting of this thesis allowed combining of medical and dental data. One of 
the medical variables we used was the motor performance of the patients. Different tools for 
assessment of motor performance are used in a variety of medical settings like in our study. 
At the department of Rehabilitation of the Radboud university medical center, Nijmegen, the 
Netherlands, the Motor Function Measure (MFM) is used and at the department of Neurology 
and Neurosurgery and Spieren voor Spieren Kindercentrum, University Medical Center 
Utrecht, Utrecht, the Netherlands, the Expanded Hammersmith Functional Motor Scale 
(HFSME) is used to assess the motor function in patients with NMD. MFM and HFSME are 
both validated scales and can be used in SMA and DMD.
22,64
 Apart from items also present in 
HMFSE, MFM includes items on head balance including neck function, and sitting balance in 
relation to head positioning. These items showed a strong association with our results. 
 
Methodological issues  
Case-control studies are particularly appropriate for studying rare diseases since they start 
with including diseased individuals. This selection allows for enrolment of a sufficient 
number of patients. We have to realize that case-control studies may prove an association but 
they do not demonstrate causal relationships. The conclusions made in this thesis raise 
questions that can be investigated in longitudinal studies and hypotheses to be tested in 
RCT’s. 
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Future perspectives 
Some of the following future perspectives have been mentioned in the general discussion 
previously. In this final section a brief summary of these perspectives is presented. 
  In rare diseases, such as NMD, the evidence available for clinical guidance and 
decisions regarding the masticatory system is often lacking. SMA and DMD share many 
challenges with other rare diseases, such as limited access to resources required to start a 
clinical trial (including collaborations and funding), and difficulties of recruiting a sufficient 
number of patients. Solutions to these barriers will require multicentered and perhaps 
multinational collaboration, partnership with patient organizations, training of a new 
generation of researchers interested in NMD, and organising funding. 
 Future research in SMA and DMD is needed to investigate the efficacy of a training of 
the mandibular function that prevents progression using a randomized controlled design. 
Because of two existing databases in the Netherlands for patients with SMA and for patients 
with DMD, a randomized controlled design study may be possible. Cut-off values for 
masticatory performance or bite force acting as indicators for the timing to adjust food 
consistency in routine NMD clinical practice are missing. There is a need for establishing 
these values in order to improve clinical practice. Fatigability is a frequent complaint in SMA 
as well as in DMD and may play a role in the reduction of mandibular function due to 
tiredness and loss of strength of the masticatory muscles during function.
65
 The 
pathophysiology of fatigability is not entirely clear. It may be due to e.g. (1) reduction in the 
initial median frequency, probably because of the reduced number of motor units, (2) specific 
fatigue impairment at a muscle fiber level because of the greater activation required to 
achieve a desired muscle force, (3) failure of central activation as a result of reduced 
motivation or fear of physical activity, (4) central nervous system adaptations following 
disuse, or (5) reduced sensory input with movement.
34,66-68
 Not only fatigability but also 
endurance are aspects of muscle function and must be taken into consideration in future 
training studies. 
  The collaboration between the various departments involved in this study has 
improved the knowledge of the underlying mechanisms of an impaired mandibular function in 
SMA and DMD, but there are still unanswered questions. Future research has to focus on the 
association between limitations of the mandibular function and swallowing problems. The 
correlation between mandibular dysfunction, swallowing problems and aspiration, 
hospitalizations and life-threatening pneumonia is unclear when taking anatomy and 
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physiology into account; the exact mechanisms behind the impairments need to be clarified in 
order to improve oral function and swallowing in patients with DMD and SMA. Longitudinal 
evaluation of aMMO in order to predict the need for training in the various disease categories 
is needed. 
 
Conclusions 
In summary, the conclusions from this thesis are: 
 There is a clinically relevant difference between the measured outcomes of mandibular 
function in SMA and DMD compared to healthy subjects. 
 In SMA the dominant impairments of the mandibular function are the mandibular 
range of motion and bite force; in DMD the dominant impairment of the mandibular 
function is the masticatory performance.  
 Reduced mouth opening in patients with SMA type 2 is primarily induced by selective 
fatty infiltration of the lateral pterygoid muscles. 
 In order to establish the need for training in the various disease categories, longitudinal 
evaluation of mandibular function is a necessity. 
 There is a need for disease-specific training programs for patients with SMA and 
DMD.  
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Neuromuscular disorders are defined as a wide range of chronic degenerative diseases 
associated with severe muscle weakness, which also affect the masticatory muscles. Two of 
the most common types of neuromuscular disorders are spinal muscular atrophy (SMA) and 
Duchenne muscular dystrophy (DMD). Structural changes and weakness of the masticatory 
muscles and impaired tongue function may cause specific abnormalities in mandibular 
function. As SMA and DMD have its distinct pathophysiology, each disorder may have a 
different impact on the masticatory system.  
  The primary aim of this thesis was to explore the impact of SMA and DMD upon 
aspects of mandibular function of patients with SMA and DMD focusing on mastication and 
mandibular mobility. The second aim was to establish whether the differences in 
pathophysiology and clinical presentation of SMA and DMD cause distinct patterns of 
compromised mandibular function. A third aim was to investigate whether specific training 
provides a positive impact on masticatory function in DMD.  
  The aim of chapter 2 was to investigate the mandibular function in 12 patients with 
SMA type 2 compared to a matched control group. Participants completed questionnaires 
about mandibular function and underwent a clinical examination of the masticatory system. 
Fifty percent of the patients reported a moderate to severe impairment of the mandibular 
function. An active maximum mouth opening (aMMO) less than or equal to 30 mm was 
observed in 75% of the patients. In patients with a severe reduction of the mandibular range of 
motion, the temporomandibular joint mainly rotated during mouth opening instead of the 
usual combination of rotation and sliding. The severity of the limited aMMO correlated with 
the severity of the disease, expressed as motor function measurement (MFM). This study 
demonstrated that mandibular dysfunction is common amongst 6  to 19 years old patients with 
spinal muscular atrophy type 2.   
Chapter 3 describes an investigation on the mandibular function, as reflected by 
masticatory performance, mandibular range of motion, and bite force in 60 patients with SMA 
type 2 and 3. Participants completed questionnaires about mandibular function. In addition, 
some predictors of mandibular dysfunction were explored. Patients with SMA type 2 and 3 
showed significant impairment of mandibular movements compared to healthy controls (p < 
0.001). Maximal bite force was 19% lower in patients than in controls. SMA type and neck 
muscle strength were relevant determinants of these complications. In this study further 
evidence for clinically relevant bulbar involvement evolved from the reduced mobility and 
bite force presented by the SMA type 2 and 3 patients. 
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  In the study described in Chapter 4 the prevalence of reduced aMMO was determined 
and its association with dysphagia, as a sign of bulbar dysfunction, was analyzed. A cross-
sectional study of aMMO in 145 patients with SMA types 1-4 and 119 healthy controls was 
performed and used Magnetic Resonance Imaging (MRI) in 12 patients to visualize 
mandibular condylar shape and sliding and the tissue characteristics of muscle groups relevant 
for mouth opening and closing. aMMO ≤ 35 mm was found in 100, 79, 50 and 7% of patients 
with SMA types 1, 2, 3a and 3b/4, respectively and in none of the healthy controls. MRI 
showed severe fatty degeneration of the lateral pterygoid muscles that mediate mouth opening 
by initiating mandibular condylar sliding, but relatively mild fatty degeneration of the mouth 
closing muscles in patients with reduced aMMO. Reduced aMMO was associated with SMA 
type, age, muscle weakness and dysphagia. Reduced aMMO is a sign of bulbar dysfunction in 
SMA. 
  Chapters 5 and 6 describe two studies on mandibular function in 23 patients with 
DMD, aged 5 – 38 years and matched with 23 healthy subjects. Participants completed two 
questionnaires about mandibular function, underwent a clinical examination of the 
masticatory system and measurements of anterior bite force and masticatory performance. In 
addition, quantitative ultrasound of the tongue, the digastric muscle and the geniohyoid 
muscle and MFM was performed in the patient group. The patients were categorized into 
ambulatory stage (early or late, AS), early non-ambulatory stage (ENAS), or late non-
ambulatory stage (LNAS). 
Compared to the controls masticatory performance, anterior bite force and number of 
occlusal contacts were reduced in the patient group (all p < 0.001) (Chapter 5). Mastication 
abnormalities were present early in the disease process prior to a reduction of MFM. The 
early non-ambulatory and late non-ambulatory stage groups showed less masticatory 
performance compared to the ambulatory stage group (p < 0.028 and p < 0.010, respectively). 
Multiple linear regression analysis revealed that the stage of the disease was the strongest 
independent predictive factor for the masticatory performance (R
2
 = 0.52).  
  In the patient group all mandibular movements were reduced (p < 0.001) compared to 
the controls (Chapter 6). Reduced aMMO (< 40 mm) was found in 26% of the patient group. 
LNAS patients had significantly smaller mandibular movements compared to AS and ENAS 
(p < 0.05). Multiple linear regression analysis for aMMO revealed a positive correlation with 
the body height and disease progression, with MFM score as the strongest independent 
predictive factor (R
2
 = 0.71). Mandibular movements in DMD are significantly reduced and 
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become more hampered with loss of motor function, particularly in relation to the sitting 
position, arm function, and neck and head control.  
  The efficacy of mastication training in DMD using chewing gum for 4 weeks was 
determined in the study described in Chapter 7. Masticatory performance and bite force were 
assessed in 17 patients and 17 healthy age-matched males before, shortly after and one month 
after a specific mastication training program. In the patient group masticatory performance 
improved and remained improved after one-month follow-up, but no significant changes in 
anterior maximum bite force were observed after mastication training. In the healthy subjects 
bite force increased and remained increased at one month follow-up without significant 
changes in masticatory performance. It was concluded that mastication training, using sugar 
free chewing gum improved masticatory performance in DMD patients. Since bite force did 
not improve, the working mechanism of action of the improvement in chewing efficacy may 
relate to changes of the neuromuscular function and coordination 
The research questions posed in chapter 1 are discussed in Chapter 8, including differences 
between SMA and DMD patients in their clinical presentation and underlying mechanisms. 
Also masticatory training recommendations for SMA and DMD are presented.  
 In conclusion, we found clinically relevant differences between mandibular function in 
SMA and DMD compared to healthy subjects. Differences in pathophysiology in SMA and 
DMD led to specific signs and symptoms of impaired mandibular function. The dominant 
limitation of the mandibular function in SMA was the mandibular range of motion and the 
bite force; in DMD this was the masticatory performance. In SMA, reduced mouth opening 
was primarily induced by selective fatty infiltration of the lateral pterygoid muscles. In DMD, 
mastication abnormalities were present early in the disease process prior to a reduction of 
motor function of the upper part of the body and was associated with the stage of the disease.  
Furthermore we noted a need for disease-specific training programs for patients with SMA 
and DMD. Until randomized clinical trials (RCT’s) are available, only suggestions for 
training of the mandibular system can be made. It is advised to encourage SMA and DMD 
patients to postpone food adaptation as long as it is medically safe. In SMA, we suggest that 
training starts when the patient is still in the ambulatory stage, focusing on active and passive 
movements of the mandible in vertical and horizontal directions; in DMD, training should 
start as early as possible in the disease, at first reports of food adaptation and has to focus on 
training mastication with low intensity aerobic exercises. Explorative cross-sectional research 
with larger groups is suggested to study the mechanisms behind the impairments of the 
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mandibular function and develop further specific recommendations for SMA and DMD. After 
these cross-sectional studies randomised clinical design studies are required.  
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Neuromusculaire aandoeningen zijn syndromen en ziekten die de spieren en hun aansturing  
beïnvloeden. Op de voorgrond tredende symptomen zijn progressieve spierzwakte en 
verminderd fysiek uithoudingsvermogen. De twee meest voorkomende neuromusculaire 
aandoeningen zijn Duchenne musculaire dystrofie (DMD) en spinale musculaire atrofie 
(SMA). DMD wordt veroorzaakt door een mutatie van het dystrofine gen gelokaliseerd in het 
X-chromosoom. Dit veroorzaakt een tekort aan het eiwit dystrofine, nodig voor de stevigheid 
van de spiercelwand; de spiercellen beschadigen, sterven op den duur af, vervetten en 
bindweefsel komt hiervoor in de plaats. SMA wordt doorgaans veroorzaakt door deletie of 
genconversie in het ‘survival’-motorneuron (SMN) 1-gen, waardoor degeneratie van de 
motorische voorhoorncellen in het ruggenmerg optreedt. Deze degeneratie beïnvloedt het 
signaal naar de spieren negatief. De spieren worden geleidelijk dunner en zwakker. Bij SMA 
en DMD blijken ook de spieren van het kauwstelsel te zijn betrokken, waardoor de 
mandibulaire functie gecompromitteerd kan zijn. Ondanks het veelvuldig vermelden van 
problemen met het eten, zijn de onderliggende mechanismen van een beperkte mandibulaire 
functie nauwelijks in kaart gebracht en de tandheelkundige behandelopties m.b.t. 
mandibulaire disfunctie vrijwel onbekend. 
 
Het globale doel van het in dit proefschrift beschreven onderzoek was het onderzoeken 
van de mandibulaire functie bij mensen met SMA en DMD in vergelijking met gezonde 
mensen en de daaraan gerelateerde voorspellende factoren. Het tweede doel was om vast te 
stellen of de verschillen in pathofysiologie en klinische presentatie van SMA en DMD een 
karakteristiek onderliggend mechanisme van mandibulaire disfunctie laten zien. Bij mensen 
met DMD is bovendien gekeken naar de effectiviteit van een kauwtraining.  
Het doel van hoofdstuk 2 was het onderzoeken van de mandibulaire functie bij 12 
patiënten met SMA type 2 die werden gematched met gezonde personen. Deelnemers vulden 
vragenlijsten in over mandibulaire functie en ondergingen een klinisch onderzoek van het 
kauwstelsel. Vijftig procent van de patiënten rapporteerde een gemiddelde tot ernstige 
beperking van de mandibulaire functie. Een actieve maximale mondopening (aMMO) kleiner 
of gelijk aan 30 mm werd gezien bij 75% van de patiënten. Bij de mensen met een ernstig 
beperkte aMMO liet het kaakgewricht tijdens het openen van de mond een rotatiebeweging 
zien in plaats van de gewoonlijk gecombineerde rotatie en translatie. Dit zou kunnen wijzen 
op een structurele verandering in het kaakgewricht. De ernst van het ziektebeeld, 
weergegeven als motorische vaardigheid, liet een associatie zien met een gereduceerde 
aMMO in vergelijking met de controlegroep. De uitkomsten van dit onderzoek maakten 
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duidelijk dat vervolgonderzoek wenselijk is bij een grotere patiëntengroep met verschillende 
typen SMA. 
  Hoofdstuk 3 beschrijft de invloed van SMA type 2 en 3 op de mandibulaire functie bij 
60 patiënten, weergegeven als het kauwvermogen, de mandibulaire bewegingen en de 
bijtkracht. Deelnemers vulden vragenlijsten in over mandibulaire functie. Aanvullend werden 
de voorspellende factoren van mandibulaire disfunctie onderzocht. Het onderzoek toonde aan 
dat de aMMO, de laterale en proale bewegingen van de onderkaak en de bijtkracht beperkt 
waren ten opzichte van de controle groep (p < 0.001). Voorspellende factoren voor deze 
beperkingen waren het SMA type en de sterkte van de nekspieren. Het kauwvermogen, 
bepaald met een kauwtest bij patiënten en de controlegroep, was vergelijkbaar. Het onderzoek 
droeg bij aan aanvullend bewijs voor bulbaire betrokkenheid bij patiënten met SMA type 2 en 
3. 
  In het onderzoek beschreven in hoofdstuk 4 werden de prevalentie van een 
verminderde aMMO, de onderliggende mechanismen en de associatie tussen een beperkte 
aMMO en slikproblemen bepaald. Het onderzoek werd uitgevoerd bij 145 patiënten met SMA 
type 1-4 en 119 gezonde controles; bij 12 patiënten werd een MRI genomen om het 
oppervlakte, de proale beweging van het kaakkopje en de anatomie van spiergroepen, relevant 
voor het openen en sluiten van de mond, te visualiseren. Een aMMO kleiner of gelijk aan 35 
mm werd vooral gezien bij SMA type 1-3a. De beperking werd vooral veroorzaakt door 
vervetting van de m. pterygoideus lateralis die mede verantwoordelijk is voor de 
mondopening door de kaakkop naar voren te trekken. Een mondopening kleiner of gelijk aan 
35 mm was geassocieerd met het SMA type, de leeftijd, spierzwakte en slikproblemen en is 
een teken van bulbaire disfunctie bij SMA.  
  Hoofdstuk 5 en 6 beschrijven twee onderzoeken waarin de mandibulaire functie bij 
23 patiënten met DMD in de leeftijd van 6 tot 38 jaar werd onderzocht en vergeleken met die 
van gezonde personen. Deelnemers vulden twee vragenlijsten in over mandibulaire functie, 
ondergingen een klinisch onderzoek van het kauwstelsel en metingen van bijtkracht en 
kauwvermogen. Daarnaast werd in de patiëntengroep kwantitatieve echografie van de tong, 
m. digastricus en de m. geniohyoideus uitgevoerd en werden de motorische vaardigheden 
bepaald. De patiënten werden in drie groepen verdeeld op basis van de fase van hun ziekte: 
vroege en late loopfase (fase 1, n=6), vroege rolstoelfase (fase 2, n=7) en late rolstoelfase 
(fase 3, n=10). 
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  Het kauwvermogen, de bijtkracht en het aantal occlusale eenheden in de 
patiëntengroep waren sterk gereduceerd ten opzichte van de controle groep (alle p < 0.001) 
Deze veranderingen waren al vroeg in het ziekteproces aanwezig, nog voordat reductie van de 
motorische vaardigheden zichtbaar was (Hoofdstuk 5). De fase waarin de ziekte zich bevindt, 
was de voorspellende factor voor het kauwvermogen. 
  In de patiënten groep bleken alle mandibulaire bewegingen gereduceerd (p < 0.001) in 
vergelijking met de controle groep (Hoofdstuk 6). Bij 26 % van de patiënten werd een 
aMMO < 40 mm waargenomen. LNAS patiënten vertoonden een significant gereduceerde 
mandibulaire beweging in vergelijking met AS and ENAS patiënten (p < 0.05). Meervoudige 
lineaire regressieanalyse liet een positieve associatie zien tussen aMMO en lichaamslengte, en 
aMMO  en ziekteprogressie waarbij de motorische vaardigheid de sterkste onafhankelijke 
variabele was (R
2
 = 0.71). Beperkingen van de aMMO namen toe met het afnemen van 
motorische vaardigheden, inclusief de vastgestelde afname van de rompstabiliteit (positie van 
het zitten), de armfunctie en nek- en hoofdcontrole.  
  De effectiviteit van een 4 weken durende kauwtraining met suikervrije kauwgom in 
DMD werd vastgesteld in het onderzoek dat is beschreven in hoofdstuk 7. Bij 17 patiënten en 
17 gezonde personen werd het kauwvermogen en de bijtkracht bepaald direct vóór, direct na 
en één maand na de training. De kauwtraining liet bij patiënten met DMD een verbetering 
zien van het kauwvermogen en deze verbetering hield aan tot tenminste één maand na de 
training. Er werden echter geen significante veranderingen in de bijtkracht waargenomen na 
de kauwspiertraining. Bij de gezonde personen nam de bijtkracht toe en die bleef verhoogd na 
een maand follow-up zonder significante veranderingen van het kauwvermogen. 
Concluderend mag worden gesteld, dat training van het kauwstelsel met behulp van 
suikervrije kauwgom het kauwvermogen bij patiënten met DMD verbeterde. Aangezien de 
bijtkracht onveranderd bleef, kan het werkingsmechanisme van de verbetering van het 
kauwvermogen toegeschreven worden aan neuromusculaire veranderingen en verbeterde 
coördinatie, hetgeen resulteerde in verbetering van het kauwen, vastgesteld met de mixing 
ability test. 
  De onderzoeksvragen en antwoorden van dit proefschrift worden bediscussieerd in 
hoofdstuk 8. Verschillen tussen patiënten met SMA en DMD ten aanzien van de klinische 
presentatie en de onderliggende pathofysiologische mechanismen van mandibulaire disfunctie 
worden aangegeven. Ook worden suggesties gegeven voor oefeningen gericht op behoud van 
de mandibulaire functie.  
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  Uit dit onderzoek kan worden geconcludeerd dat er een klinisch relevant verschil in 
mandibulaire functie is tussen patiënten met SMA en DMD. Verschillen in pathofyiologie in 
SMA en DMD leiden tot specifieke tekenen en symptomen van mandibulaire disfunctie. Bij 
patiënten met SMA waren de voornaamste beperkingen de mandibulaire bewegingen en de 
bijtkracht en bij patiënten met DMD was dit het kauwvermogen. In SMA werd de beperking 
van de mondopening vooral veroorzaakt door vervetting van de m. pterygoideus lateralis. In 
DMD speelden de verzwakte kauwspieren en een reductie van de occlusale eenheden een rol 
bij het ontstaan van een beperkt kauwvermogen. Bovendien is er behoefte aan ziekte-
specifieke trainingsprogramma ’s voor patiënten met SMA en DMD. Totdat gerandomiseerde 
en gecontroleerde onderzoeken (RCT’s) beschikbaar zijn, kunnen alleen suggesties gegeven 
worden voor het trainen van het kauwstelsel. Patiënten met SMA en DMD wordt geadviseerd 
om het kauwstelsel actief te houden door het aanpassen van voedsel zo lang mogelijk uit te 
stellen mits dit medisch verantwoord is. Training bij SMA patiënten zal gericht moeten zijn 
op het rekken van de mondopening en het actief bewegen van de onderkaak in het horizontale 
vlak (lateraal en proaal). De training kan starten in de vroege ambulante (loop) fase van het 
kind. Training bij DMD patiënten zal gericht moeten zijn op het kauwvermogen, 
voornamelijk middels een kauwtraining met een lage intensiteit. Aangeraden wordt om zo 
vroeg mogelijk met de kauwtraining te beginnen, zodra patiënten ervaren dat zij hun voedsel 
moeten aanpassen. Exploratief cross-sectionele onderzoeken van de mandibulaire functie in 
grotere groepen patiënten en gerandomiseerd onderzoek met een controlegroep zijn nodig om 
ziektespecifieke trainingsprogramma's voor SMA en DMD te ontwikkelen.  
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Abbreviations used throughout this thesis 
 
aMMO Active maximum mouth opening 
AS Ambulatory stage  
DMD Duchenne muscular dystrophy 
EI Echo intensity 
ENAS Early non-ambulatory stage 
HFMSE Hammersmith functional motor scale expanded 
LNAS Late non-ambulatory stage 
MFIQ Mandibular function impairment questionnaire  
MFM Motor function measure 
MRI Magnetic resonance imaging 
aMVBF Anterior maximum voluntary bite force 
N Newton 
NMD Neuromuscular disorders  
OC Occlusal contacts 
pMMO  Passive maximum mouth opening 
QMUS Quantitative muscle ultrasound imaging 
ROM Range of motion 
SMA Spinal muscular atrophy 
SMN Survival motor neuron  
TMD Temporomandibular disorders 
TMJ Temporomandibular joint 
VAS Visual analogue scale 
VFSS Videofluoroscopic swallow study 
 
